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The DNA damage response is a pathway responsible for the maintenance of genome 
integrity. In my thesis I focused on the investigation of the modulation of ATM activity, a 
DNA damage response master kinase, by NOTCH1 receptor. 
Here I show that NOTCH1 inhibits DNA damage response activation. This inhibitory 
effect of NOTCH1 is not mediated by its transcriptional activity, but it is the result of 
direct binding between NOTCH1 and ATM kinase. I show that NOTCH1 binds to the 
FATC domain of ATM, and this results in an inhibition of ATM kinase activity. 
Furthermore, I provide evidence that NOTCH1-mediated ATM inhibition does not result 
from the impairment of ATM recruitment to DNA double-strand breaks. Rather, I show 
that NOTCH1 competes with FOXO3a transcription factor for the binding to the FATC 
domain of ATM and that over-expression of FOXO3a prevents NOTCH1-mediated ATM 
inhibition. As the exact function of FOXO3a in ATM activation was unclear, I sought to 
understand molecular mechanisms underlying NOTCH1-mediated ATM inactivation and 
the role of FOXO3a as an opposing factor in this process. I discovered that FOXO3a forms 
a direct complex with KAT5 lysine acetyl transferase that is critical for ATM activation 
upon DNA damage. Moreover, I observed that FOXO3a was necessary for the formation 
of a complex between ATM and KAT5. Surprisingly, I observed that NOTCH1 was not 
only impairing ATM-KAT5 interaction, but also FOXO3a-KAT5 one. This unexpected 
observation led me to the discovery that FOXO3a-KAT5 interaction is restricted to the 
formation of this three-protein complex together with the ATM kinase. Next, I 
demonstrated that induction of FOXO3a nuclear localization as well as inhibition of 
NOTCH1 increases ATM activation in NOTCH1-driven cancer cells, which leads to 
augmented DNA damage-induced cell death.  
Finally, I show that, in addition to ATM, NOTCH1 interacts also with other PI3K-like 
kinases: DNA-PKcs and ATR. Although I did not observe a significant impact of 
NOTCH1 on ATR kinase activation in the experimental settings I used, I observed an 
	  14	  
impaired activation of DNA-PKcs, which however did not result in a significant reduction 
of DNA damage repair in NOTCH1-expressing cells. 
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DNA damage response 
The DNA damage response (DDR) is a signaling pathway, which is responsible for 
sensing discontinuities in the DNA and transmitting this signal further into the cell. 
Outcomes of this signaling will depend on the amount of DNA damage that cells need to 
cope with as well as genomic location of this damage itself, therefore DDR activation 
might result in the activation of different cellular processes and pathways. Upon DNA 
damage DDR activation will results in cell cycle checkpoint activation and induction of the 
DNA damage repair pathways. If the amount of the DNA damage is too big or damage is 
impossible to repair, cells will induce programed cell death (apoptosis) or will enter an 
irreversible cell-cycle arrest described as cellular senescence. 
DDR is a complex pathway that involves many factors, which often act on many different 
levels of the response. Below I will try to discuss what we know about the DDR and more 
specifically about its most important player that is the ataxia-telangiectasia mutated kinase 
(ATM). 
 
An overview of the DDR 
Upon DNA damage, ATM is recruited to the DNA double-strand breaks (DSBs) by its 
interaction with the MRN complex (MRE11, RAD50, NBS1)(Nakada et al., 2003), which 
is thought to be one of the first factors that recognize DSBs (Polo and Jackson, 
2011)(Figure 1). MRN complex is composed of three proteins: Nijmegen breakage 
syndrome 1 (NBS1), meiotic recombination 11 (MRE11) and RAD50. NBS1 does not 
posses any enzymatic activity, but it stimulates activities of MRE11 and RAD50 (Paull and 
Gellert, 1999). Additionally, NBS1 mediates interaction between ATM and MRN complex 
(Falck et al., 2005). RAD50 is a DNA helicase, which is necessary for DNA unwinding 
and tethering together DNA ends (Paull and Gellert, 1999). MRE11 is both an endo- and 
exonuclease, whose activity and DNA processing is necessary for the DSB repair (Paull 
and Gellert, 1999; Shibata et al., 2014)(for more details see the ”DNA damage repair” 
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chapter in the introduction). Once ATM-MRN complex is associated with DSB, ATM 
undergoes the complicated and yet not entirely elucidated process of activation. First ATM 
is acetylated by lysine acetyl transferase 5 (KAT5)(Sun et al., 2005). This process favors 
ATM autophosphorylation and monomerization (Bakkenist and Kastan, 2003; Sun et al., 
2005). At this stage ATM is considered as fully activated. Activated ATM starts 
phosphorylating its substrates, which will result in the DDR activation, initiation of the 
repair and checkpoint activation to prevent cell from entering S or M phase with damaged 
DNA.  
ATM-mediated DDR activation starts with the phosphorylation of histone H2AX at Serine 
139 (γH2AX)(Burma et al., 2001)(Figure 1). This phosphorylation event is a key step in 
the DDR cascade, as it is recognized by other DDR factors and primes their accumulation 
at the site of DNA damage. Indeed it has been shown that cells lacking H2AX have 
impaired accumulation of the DDR factor at DSBs (Celeste et al., 2003). γH2AX is 
recognized by the mediator of DNA damage checkpoint 1 (MDC1), which recruits more 
MRN-ATM complexes to the DSBs in a positive feedback loop (Stucki et al., 2005). 
MDC1 is further phosphorylated by ATM, which results in the recruitment of ring finger 
protein 8 (RNF8), a E3 ubiquitin ligase, which will ubiquitinate histone H1. This 
ubiquitination will result in the recruitment of yet another E3 ubiquitin ligase, RNF168 that 
will ubiquitinate histone H2A (Doil et al., 2009; Mailand et al., 2007; Thorslund et al., 
2015). Ubiquitination of H2A, methylation of H4 (carried out by MMSET methyl 
transferase) and phosphorylation of histone H2AX are a scaffold for the recruitment of p53 
binding protein 1 (53BP1) (Doil et al., 2009; Kleiner et al., 2015; Pei et al., 2011), which 
will promote accumulation of additional factors necessary for DNA damage repair like: 
Rap1 interacting factor 1 (RIF1) and Melanoma associated antigen mutated 1 (MUM1) as 
well, which will impact on the DNA repair pathway choice between non-homologous end 
joining and homology directed repair, by regulating DSB resection (for more details see 
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the ”DNA damage repair” chapter in the introduction) (Chapman et al., 2013; Huen et al., 
2010). 
One of the most important roles of the DDR is to spread information about DNA damage 
throughout the cell, which will result in cell cycle checkpoint activation. G1/S phase cell 
cycle checkpoint activation will prevent cells from initiating DNA replication with 
damaged DNA. The G2/M phase cell cycle checkpoint on the other hand will prevent cells 
form entering mitosis until damaged DNA is not fully repaired. ATM activates G1/S phase 
checkpoint by impacting on the stability of p53. Upon DNA damage, activated ATM will 
phosphorylate checkpoint kinase 2 (CHK2) (Matsuoka et al., 2000), which in turn will 
phosphorylate p53 on Serine 20 leading to an increase of its stability (Shieh et al., 2000). 
ATM by itself also phosphorylates p53 on the Serine 15, which leads to an increase of p53 
transcriptional activity (Dumaz and Meek, 1999). This will result in the accumulation of 
p21 (a transcription target of p53). p21 binds to the cyclinE/CDK2 (cyclin dependent 
kinase) complex and inhibits it, which results in the G1 phase cell cycle arrest (Harper et 
al., 1995). 
G2/M cell cycle phase checkpoint regulation as G1/S is regulated by DNA damage 
checkpoint kinases 1 and 2 (CHK1 and 2). Upon DNA damage ATR and ATM 
phosphorylate CHK1 and 2 kinases respectively. Activated CHK1 and CHK2 
phosphorylate cdc25 phosphatase (Chen et al., 2003; Falck et al., 2001). This leads to the 
nuclear re-localization of cdc25 to the cytosol in 14-3-3-dependent manner (Peng et al., 
1997). The role of cdc25 is to dephosphorylate the CDK1 kinase, which will result in 
CDK1 activation and cell cycle progression into mitosis (Nilsson and Hoffmann, 2000). 
DNA damage repair activation upon DSB formation will be described in a separate 
chapter. Here I would like to briefly discuss the role of ATM kinase in DNA damage 
repair. Although ATM is a DDR master kinase, it seems that the role of ATM in the DNA 
damage repair is fairly limited. It has been shown that ATM knockout cells repair DSBs 
almost as efficiently as wild type cells (Riballo et al., 2004). It has been reported that ATM 
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is strictly necessary for the repair of no more then 10% of induced DNA DSBs (amount 
varies depending on the type of DNA damaging agent used). Those DSBs have been 
identified to be preferentially localized in heterochromatic regions. In this context, ATM 
activation leads to the phosphorylation of KRAB associated protein 1 (KAP1), which leads 
to the dissociation of KAP1 together with other heterochromatic markers like 
heterochromatin protein 1 (HP1) and suppressor of variegation 3-9 homolog 1 (Suv39h1) 
methyl transferase from the chromatin resulting in chromatin relaxation necessary for 
repair factors to access DNA (Ayrapetov et al., 2014; Goodarzi et al., 2008). Moreover, it 
has been recently suggested that ATM is required for the repair of blocked DSBs. 
Interestingly, it has been shown that this mechanism of ATM action is independent from 
the chromatin compaction status (Álvarez-Quilón et al., 2014).  
Apart form the role of ATM in the repair of this small (10%) amount of DSBs, it has been 
reported that ATM kinase activity is necessary for the control of DNA end resection by 
phosphorylation of MRE11 and CTIP (Jazayeri et al., 2006; Kijas et al., 2015; Peterson et 
al., 2013), regulation of the KU70/80 heterodimer ubiqutnation by RNF138 and its 
removal from the DSBs (Ismail et al., 2015). Additionally it was suggested that ATM may 
play a role in the homology directed repair downstream of RAD51 nucleofilament 
formation (Bakr et al., 2015; Koecher et al., 2012), although this role could be 
compensated (to some extent) by ATR activity in ATM absence.  
Over all, it is difficult to pinpoint a single function of ATM in the DNA DSB repair, and 
still its impact is not huge. As most of the DNA breaks are repair by the non homologous 
end joining repair pathway (NHEJ), it has been shown that ATM is necessary only for the 
repair of the non-compatible DNA ends by NHEJ and that the repair of compatible DNA 
ends is independent from ATM activity necessary for end processing (Zhu and Peng, 
2016). 
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Figure 1. DDR cascade. Scheme of DDR. In short: MRN complex recognizes the discontinuity in 
the DNA in the form of a DSB and brings ATM to the site of damage. ATM phosphorylates its 
substrates, mainly histone H2AX, which will scaffold the recruitment of further DDR proteins like 
53BP1 and MDC1, responsible for DDR signal propagation. Adapted from (d'Adda di Fagagna, 
2008). 
 
PI3K-like kinases  
Phosphatidylinositol 3 kinase-like kinases (PI3K-like kinases) have a structure similar to 
PI3 kinases. PI3K-like kinases are involved in DNA damage signaling, repair, RNA 
biology and energy sensing and they posses catalytic activity to phosphorylate their protein 
substrates on Serine or Threonine residues.  
Six members of this family of kinases have been characterized: ATM, ATM and Rad3-
related protein (ATR), DNA-dependent protein kinase catalytic subunit (DNA-PKcs), 
SMG1, mammalian target of rapamycin (mTOR) and transformation/transcription domain-
associated protein (TRRAP). ATM, ATR and DNA-PKcs are master kinases involved in 
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DDR and repair. mTOR is responsible for sensing of the energy status and regulating 
protein synthesis. SMG1 has been described to play role in the processing of RNA. 
TRRAP, although it does not posses any detectable kinase activity (Vassilev et al., 1998), 
plays a role in DDR as a part of the NuA4 complex. 
 
ATM - PI3K like kinase - structure 
We can distinguish five different domains in the ATM structure (Figure 2). α-helical 
repeats called HEAT repeats (Huntingtin, elongation factor 3 protein phosphatase 2A 
TOR1 repeats) extend from the N-terminal part of ATM throughout most of the ATM 
structure. It has been shown that many ATM interacting proteins like NBS1, hMOF or 
cABL bind within the N-terminal region covered by the HEAT repeats (Gupta et al., 2005; 
Shafman et al., 1997; You et al., 2005). N-terminal region has been recently implicated to 
the formation of the ATM dimer structure (Lau et al., 2016; Sawicka et al., 2016). FRAP, 
ATR, TRRAP domain (FAT) and the FAT C-terminal domain (FATC) surround the ATM 
kinase domain. FATC domain has been shown to play a critical role in the ATM activation 
process, as it is a binding site for the KAT5 acetyl transferase, which acetylates ATM in 
the PI3K-like kinase regulatory domain (PRD), which is necessary for ATM kinase 
activation upon DNA damage (Sun et al., 2007). Interestingly, it has been shown that the 
FATC domains of ATM, ATR and DNA-PKcs are functionally equivalent (Jiang et al., 
2006). The ATM kinase domain is located between the FAT and the FATC domains at the 
C-terminal end of the protein. It is worth to note that in the recently published structures of 
ATM and ATR dimers (Lau et al., 2016; Sawicka et al., 2016), it has been suggested that 
although ATM kinase domains are positioned in front of each other (in the dimer state) 
there is a possibility for substrates to be phosphorylated as there is enough free and 
accessible space between such kinase domains in this conformation (Sawicka et al., 2016). 
This kind of feature has not been suggested for the ATR kinase. ATR kinase domains have 
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been reported to be tightly packed with each other with no possibility for substrate to 
access and be phosphorylated by ATR dimer (Sawicka et al., 2016). Among all of PI3K 
like kinases, only TRRAP has been shown to not posses any kinase activity (Vassilev et 
al., 1998). 
 
 
Figure 2. Structure of the PI3K-like kinases. Scheme of the structure of: ATM, ATR, DNA-PKcs, 
mTOR, SMG-1 and TRRAP. Color code: green - FAT domain; blue - kinase domain; light blue - 
PRG domain; red - FATC domain. For explanations of the abbreviations please see text. Numbers 
on the left represent length of each of the kinases [aa]. Adapted from (Paull, 2015). 
 
Ataxia telangiectasia disorder 
Mutations in the ATM kinase gene that result in the impairment of ATM function, 
decrease or ablation of its expression cause ataxia telangiectasia disorder (A-T). A-T had 
been discovered and characterized before ATM gene was identified in 1995 (Boder and 
Sedgwick, 1958; Savitsky et al., 1995).  
Frequency of A-T occurrence in the population spans between 1 in 50.000 to 1 in 100.000. 
Although, once diagnosed, A-T patients are monitored with a special care which results in 
an increase of their life span, on average they do not live longer then 25 years. A-T patients 
suffer from severe ataxia, which results in mobility problems. Neurodegeneration is 
another characteristic feature of A-T patients, which results in the degeneration of cerebral 
neurons that is responsible for the observed ataxia symptoms. The other main feature of A-
T is telangiectasia. It is characterized by the presence of the wide blood vessels in the eyes 
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and skin. From the molecular point of view, deletion or lack of functional ATM kinase 
results in DNA damage hypersensitivity, which is the main feature of A-T patients. Cells 
from A-T patients have been characterized to be hypersensitive to DNA damaging agents 
and, as a result, they display elevated levels of genome instability. This leads to an 
increased risk of cancer in A-T patients. A-T patients suffer form many types of cancer, 
with particular susceptibility to the development of leukemias and lymphomas (Chun and 
Gatti, 2004; Pagon et al., 1993; Shiloh, 1997; Shiloh and Lederman, 2016). 
Interestingly, two syndromes have been characterized to recapitulate some symptoms of A-
T patients. Those syndromes are: ataxia telangiectasia like disorder (ATLD) and Nijmegen 
breakage syndrome (NBS), which result from mutations in the MRE11 and NBS1 genes, 
respectively. As mentioned above, NBS1 and MRE11 are a part of MRN complex, which 
is necessary for ATM recruitment to DNA damage sites. This explains similarities between 
A-T, ATLD and NBS patients. Similar to A-T cells, cells from ATLD or NBS patients 
display increased genome instability and hypersensitivity to DNA damage and increased 
cancer risk (Shiloh, 1997; Stewart et al., 1999; Taylor et al., 2004; Varon et al., 1998). 
 
KAT5 
KAT5 is a Lysine acetyl transferase 5 (KAT5), known also as Tip60 - Tat interacting 
protein 60 kDa. KAT5 is a very conserved protein. Its orthologues are expressed in yeast 
(Saccharomyces cerevisiae - Esa1) and lower organisms (Drosophila melanogaster - 
DmeI). KAT5 is a Lysine acetyl transferase that can perform acetylation of not only 
histones but also other proteins, therefore it is involved in many cellular processes such as 
DDR, apoptosis, chromatin modifications and transcription.  
Roles of KAT5 in the DDR can be at least two: one related to ATM functions, the other to 
the NuA4 complex. The ATM-related role of KAT5 is linked to its involvement in ATM 
activation and initiation of DDR (Sun et al., 2007)(for more details about DDR please see 
“An overview of the DDR” chapter of the introduction). In addition, KAT5 has been 
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shown to be part of the chromatin remodeling complex called NuA4. NuA4-KAT5 
complex has been shown to be involved in the acetylation of histone H4, thus regulating 
DDR and repair at the chromatin level (Murr et al., 2006). Relevant to my work, below I 
will focus on these two aspects of KAT5 function. 
KAT5 was reported to interact with the FATC domain of ATM. It has been shown that this 
interaction results in ATM acetylation (Jiang et al., 2006), which is indispensable for ATM 
activation. It has been suggested that KAT5-mediated ATM acetylation is one of the first 
steps involved in the process of ATM activation at DSBs, upon MRN-mediated 
recruitment (Sun et al., 2007). To activate ATM, KAT5 has to be stimulated by the 
interaction with tri-methylated histone H3 at the Lysine 9 residue (H3K9m3). Upon MRN-
mediated recruitment to the DSBs together with ATM, KAT5 binds to H3K9m3 through is 
chromodomain. Methylation of H3K9 at the site of damage is mediated by SUV39h1 
methyl transferase in a complex with HP1 and KAP1 proteins (Sun et al., 2009). Indeed it 
has recently been shown that upon DNA damage repressive chromatin is formed around 
DSB and it is necessary for KAT5-mediated ATM activation, which in a negative feedback 
loop will phosphorylate KAP1 leading to the removal the KAP1, HP1, SUV39h1 complex 
from the DSBs, facilitating chromatin relaxation (Ayrapetov et al., 2014). 
Although it has been shown that H3K9m3 chromatin mark is specifically loaded at the 
DSB surroundings, it is worth remembering that it is also a transcriptional repressive mark 
that is distributed throughout the genome. Therefore, likely as a fail safe mechanism, 
KAT5 needs to undergo additional post transcription modification to be able to acetylate 
ATM. Indeed it has been recently reported that upon DNA damage KAT5 is 
phosphorylated on a Tyrosine residue (Tyr44) by the cAbl kinase. This phosphorylation 
event has been shown to facilitate interaction between KAT5 and H3K9m3 which is 
necessary for KAT5-mediated ATM acetylation and consequent activation. (Kaidi and 
Jackson, 2013). It is worth remembering that ATM was shown to interact with cAbl, to 
mediate its phosphorylation upon DNA damage and to stimulate its kinase activity 
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(Baskaran et al., 1997). This suggests a possible positive feedback loop mechanism 
resulting in the boosting of ATM activation. Upon DNA damage induction cAbl mediates 
KAT5 phosphorylation, which leads to the activation of KAT5 and KAT5-mediated ATM 
acetylation. Acetylated and activated ATM in return phosphorylates cAbl leading to the 
increase of cAbl kinase activity that will boost further KAT5 phosphorylation.  
NuA4 is a large multisubunits protein complex involved in histone acetylation. KAT5 has 
been described as a key component of the NuA4 complex. The role of NuA4-KAT5 
complex in the DDR is complex and not yet fully understood. It has been shown that 
NuA4-KAT5 complex plays a role in the DDR by facilitating fast chromatin compaction 
changes at the DSB site. First, p400, a component of NuA4-KAT5 complex, facilitates 
exchange of histone H2A for H2A.Z at the site of damage (Xu et al., 2012). Next, the 
ANP32E histone chaperone and INO80 remodeling complex remove H2A.Z accumulated 
around the DSB. This is a key step that allows the acetylation of histone H4 by the NuA4-
KAT5 complex, which promotes chromatin relaxation (Alatwi and Downs, 2015; Gursoy-
Yuzugullu et al., 2015). It has been proposed (consistent with the previously-mentioned 
chromatin methylation on H3K9 around the DSB) that, due to the exchange of H2A with 
H2A.Z a transient compaction of the chromatin that occurs around the DSBs is necessary 
for the initiation of the DDR. After that, the histone H2A.Z is removed allowing for the 
acetylation of H4 by NuA4-KAT5 (carried out by KAT5) complex, which leads to 
chromatin relaxation necessary for DNA damage repair (Gursoy-Yuzugullu et al., 2016).  
The structure of KAT5 is typical for an acetyl transferase. Human KAT5 is composed out 
of 513 amino acids. We can distinguish four characteristic domains of KAT5. On the N- 
terminal part there is a chromodomain that allows KAT5 to recognize and bind to 
chromatin marks like H3K9m3 or other proteins like methylated p53 (Kurash et al., 2008). 
At the center of the protein there is the Acetylo-CoA binding domain and Zinc finger 
domain. Acetylo-CoA binding domain is necessary for the binding of Acetylo Coenzyme 
A, which is a source of the acetyl groups in KAT5-mediated acetylation reactions. In 
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addition, Zinc Finger domain that promotes interaction of KAT5 with other proteins, like 
for example NOTCH1 (Kim et al., 2007a). At the very C-terminal region of KAT5 there is 
a nuclear receptor binding domain that has been characterized to be necessary for the 
interaction between KAT5 and nuclear receptors (Gaughan et al., 2001).  
 
DNA damage repair  
DNA damage needs to be repaired as fast as possible and as accurately as possible to avoid 
introduction of mutations in the genome. We can distinguish several DNA repair pathways 
in the cell: base excision repair, mismatch repair, nucleotide excision repair, non 
homologous end joining and homology-directed repair.  
In the chapters below I will described more in the details the two main pathways necessary 
for the repair of the DSBs: non homologous end joining and homology directed repair. 
Non homologous end joining (NHEJ) is a repair pathway active throughout the cell cycle 
and it is responsible for the repair of the vast majority of the DSBs. NHEJ is characterized 
by the direct ligation of the broken DNA ends. When DNA ends are not compatible, small 
end processing by removing or adding nucleotides occur. As a result, NHEJ leads to the 
introduction or deletion of nucleotides therefore it is considered to be an error prone repair 
mechanism. When NHEJ pathway is perturbed, DNA DSBs can be repaired by an 
alternative pathway that involves microhomology search between two DNA ends. 
Differently from the previously described NHEJ, homology directed repair (HDR) is an 
error-free DNA repair mechanism. The mechanism standing behind it depends on the 
utilization of the sequence of sister chromatid as a template for the recovery of the correct 
nucleotide sequence of a broken DNA. As this repair pathway requires a sister chromatid, 
its usage is limited to the S/G2 phase of the cell cycle. 
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Homology directed repair 
As mentioned above, homology directed repair (HDR) is a DSB repair pathway that is 
error-free. Upon DNA damage induction, MRN complex is recruited to the DSB. MRE11 
together with the help of the C-terminal binding protein (CtIP), exonuclease 1 (EXO1) and 
DNA nuclease/helicase (DNA2) resects double stranded DNA to produce 3’ overhanging 
single stranded DNA ends (Nimonkar et al., 2011). CtIP has been shown to stimulate 
MRE11 endonuclease activity, which is necessary for the processing of blocked DNA ends 
(Cannavo and Cejka, 2014; Sartori et al., 2007). Additionally, MRN complex has been 
shown to be necessary for the processivity and recruitment of both: DNA2 and EXO1 
nucleases (Nicolette et al., 2010; Nimonkar et al., 2011). The 3’ single stranded DNA ends 
are promptly bound by the replication protein A (RPA) that protects it from degradation 
(Wold, 1997). RPA recruitment brings ATR kinase to the resected DSB through ATR 
interacting protein (ATRIP), which results in its activation (Jazayeri et al., 2006). DNA 
ends resection prevents KU70/80 heterodimer from binding to the DNA ends and therefore 
prevents non homologous end joining repair (Foster et al., 2011).  
Once the resection is finished and single stranded DNA covered with RPA, BRCA2-
RAD51 complex is recruited to DNA ends. Breast cancer type 2 (BRCA2) initiates 
RAD51 loading and stabilization on single stranded DNA (Carreira et al., 2009; Esashi et 
al., 2007), by exchanging RPA. RAD51 binding to the single stranded DNA forms a 
nucleofilament that will perform an invasion to the sister chromatid and search for the 
homology sequence. RAD51 interaction with the single stranded DNA is indispensable for 
the homology search (Sung et al., 2003). After finding of matching sequence, RAD54 
promotes disassembly of RAD51 that binds to the double stranded DNA molecules. This 
step is believed to be necessary for the DNA polymerase processing, which will synthetize 
the DNA lost due to the damage. In this process, DNA polymerase utilizes 3’ end of the 
invading strand as a primer and sister chromatid sequence as a template (Mazin et al., 
2010). Once synthesis is finished synapsis is resolved and DNA break repaired.  
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Non-homologous end joining  
Non homologous end joining repair (NHEJ) is the main repair mechanism of the DSBs and 
it is composed from several steps that have been depicted below in the Figure 3. For 
simplicity steps: 1-7 presented in the Figure 3 has been also indicated in the text below. 
NHEJ repair is initiated by the recruitment of the KU70/80 heterodimer to the DSB within 
seconds after DSB formation (1) (Uematsu et al., 2007). KU70/80 heterodimer binds to 
DNA ends (2). Upon formation of the complex between KU70/80 heterodimer and the 
DNA end, DNA-PKcs is recruited to the DSB (3) (Gottlieb and Jackson, 1993). As result 
of that KU70/80 heterodimer slides inside to the DSB, which triggers DNA-PKcs kinase 
activation (Yoo and Dynan, 1999). In addition to DNA-PKcs recruitment, KU70/80 plays a 
scaffold role for the association of X-ray repair cross-complementing protein 4 (XRCC4), 
LIGASE IV and XRCC4 like factor (XLF) complex (Nick McElhinny et al., 2000). At this 
stage of NHEJ presence of DNA-PKcs at DNA ends is believed to inhibit DNA ends 
ligation by the LIGASE IV complex probably due to the DNA ends masking function, 
which allows for DNA end processing to occur first (3)(Jiang et al., 2015). DNA-PKcs 
undergoes ATM-mediated transphosphorylation and/or autophosphorylaton, which is 
necessary for the recruitment of ARTEMIS nuclease that will induce DNA end processing 
if ends are not compatible (4)(Goodarzi et al., 2006; Jiang et al., 2015). Although DNA-
PKcs kinase activity is strictly indispensable for the NHEJ repair, the direct substrates of 
DNA-PKcs phosphorylation that are critical for repair are yet poorly known. Unfortunately 
most of DNA-PKcs-mediated phosphorylation sites on its substrates have been 
characterized to be dispensable for repair, like: ARTEMIS nuclease (Goodarzi et al., 2006; 
Ma et al., 2002), LIGASE IV (Kim et al., 1999; Wang et al., 2004) or XRCC4 (Matsumoto 
et al., 2000; Sharma et al., 2016; Yu et al., 2003). What is known is that DNA-PKcs 
autophosphorylation, together with the ATM-mediated transphosphorylation, has been 
shown to regulate the kinetic of DNA-PKcs disassociation from DSBs (5-6). DNA-PKcs 
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mutants that cannot be phosphorylated neither by itself nor by ATM display delayed 
disassociation from the DNA break (Uematsu et al., 2007). Once DNA end processing is 
finished, DNA-PKcs disassociates from DNA ends allowing for the LIGASE IV-mediated 
ligation (7). 
It is necessary to mention that apart from the already mentioned NHEJ repair core 
components, there are yet many more proteins and enzymes that assemble at DNA repair 
foci. Those are mostly DNA processing enzymes like: werner syndrome nuclease (WRN) 
or recently discovered paralog of XRCC4 and XLF (PAXX), which has been shown to be 
necessary for the stabilization of the NHEJ factors at DNA ends (Ochi et al., 2015). 
Recruitment of those factors is mediated by KU70/80 heterodimer (Li and Comai, 2001; 
Ochi et al., 2015) 
 
Figure 3. Sequence of events of NHEJ repair pathway. In brief: upon DNA damage induction, 
KU70/80-DNA-PKcs heterodimer is recruited to the DSB. DNA-PKcs kinase undergoes activation, 
which is necessary for the processing of DNA ends by the Artemis nuclease (Art.), followed by the 
disassociation of DNA-PKcs and break ligation by the Ligase IV (Lig4) and XRCC4 (XR4) complex. 
1!
2!
3!
4!
5!
6!
7!
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Color code: red “P” - ATM or DNA-PKcs transphosphorylation of DNA-PKcs; blue “P” - 
autophosphorylation of DNA-PKcs. For more details please see the text. Adapted form (Jiang et al., 
2015). 
 
Notch family of transcription factors  
The mammalian Notch family of proteins consists of four different transmembrane 
transcription factors, NOTCH1-4. Notch receptors are conserved among other species, 
from the Caenorhabditis elegans (Glp1; Lin12) through Drosophila melanogaster 
(dNotch) and mammals (NOTCH1, NOTCH2, NOTCH3 and NOTCH4). Notch receptors 
play crucial roles in many cellular processes like: embryogenesis, neurogenesis, 
hematopoiesis, differentiation of T-cells, neurons, keratinocytes and more (Andersson and 
Lendahl, 2014). Therefore it is not surprising that Notch receptors are being expresseed in 
many tissues: skin, reproductive system, nervous system, cardiovascular, connective tissue 
etc. (for more details regarding Notch expression see (Baldi et al., 2004)).  
Notch was first discovered in Drosophila melanogaster as the gene in which a mutation 
leads to the formation of abnormal wings. Later on Notch was linked to the formation of T-
cell acute lymphoblastic leukemias (T-ALL)(Pear et al., 1996). More then fifty percent of 
all T-ALL tumors show mutations in the NOTCH1 gene or other genes that regulate 
functions of NOTCH1 (Weng et al., 2004). Indeed it has been shown that the majority of 
NOTCH1 mutations detected in T-ALL cells were NOTCH1 activating mutations resulting 
in: decreased degradation of NOTCH1, ligand independent receptor activation and 
increased stabilization of the intracellular part of NOTCH1 (Weng et al., 2004). 
Additionally, NOTCH1 has also been shown to drive tumorgenesis in the breast tissue, 
where NUMB, a negative regulator of NOTCH1, is frequently mutated (Pece et al., 2004).  
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Structure of the mammalian Notch receptors  
Since all Notch receptors have similar structure I will use NOTCH1 as an example while 
describing the individual domains of Notch receptors. NOTCH1 is a large transmembrane 
protein composed of 2555 aminoacids (aa). We can distinguish eight domains, each with 
its own separate function (Figure 4). From the structural point of view, we can distinguish 
the N-terminal part (extracellular part) of NOTCH1 composed of EGF like repeats, Lin-
like repeats and a heterodimerization domain. The C-terminal part (intracellular part) 
consists out of: RBP-Jκ binding site (RAM), Ankyrin repeats, transcription activation 
domain (TAD) and Proline, Glutamic acid, Serine and Threonine rich domain (PEST). C- 
and N-terminal portions are connected through the transmembrane domain. 
EGF like repeats are responsible for the interaction with the ligand. The number of repeats 
differs among different species and different Notch receptors. Heterodimerization domain 
is processed by the furine convertase, which will result in the formation of the heterodimer 
between NOTCH1 N- and C-terminal part (Logeat et al., 1998). This is an important step 
of NOTCH1 activation process since the heterodimerization domain and Lin-like repeats 
domain will mask the S2 cleavage site. This will protect NOTCH1 from further processing 
and activation in the absence of the ligand. Interaction between a ligand and Notch 
receptor will result in structural changes of the extracellular part of NOTCH1, which will 
lead to the unmasking of S2 cleavage site, that will become accessible for the processing 
enzymes (Gordon et al., 2007). Transmembrane domain is a single-membrane transpassing 
domain that hooks NOTCH1 on the cellular membrane. Ankyrin repeats (seven repeats) 
together with the RAM domain have been shown to be responsible for its interaction with 
CBF1 (Recombining binding protein suppressor of hairless), a NOTCH1 coactivator and 
DNA binding protein (Nam et al., 2007; Tamura et al., 1995). Ankyrin repeats are also 
responsible for the binding with mastermind like protein 1 (MAML1) coactivator (Wu et 
al., 2000). TAD domain is present in NOTCH1 and 2, NOTCH3 seems to bear only a 
partial fragment of the TAD domain and NOTCH4 does not have it at all. TAD domain has 
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been shown to interact with the transcription coactivators in order to facilitate transcription 
and increase the stability of the complex between NOTCH1, CBF1 and MAML1 (Gerhardt 
et al., 2014). PEST domain plays a role in the control of NOTCH1 stability as it is a target 
for post translational modifications that induce NOTCH1 degradation after transcription 
initiation (Oberg et al., 2001). 
 
 
Figure 4. Structure of NOTCH1 receptor. Abbreviations: EGF - epidermal growth factor like 
repeats; LRN - Lin like repeats; HD - heterodimerization domain TMD - transmembrane domain; 
S1-3 - cleavage sites for proteases; RAM - RAM domain ARK - Ankyrin repeats; TAD - 
Transactivation domain; PEST - Pest domain. Adapted from (Andersson and Lendahl, 2014) 
 
NOTCH1 signaling 
NOTCH1 signaling consists of two different signaling pathways: canonical and non-
canonical. Canonical signaling of NOTCH1 is connected with its role as the 
transmembrane receptor and it is dependent on the interaction with a specific ligand that 
will result in the translocation of NOTCH1 from the membrane to the nucleus in order to 
induce transcription of its target genes. 
NOTCH1 interacts with one of its ligands that belongs to the DSL family of trans-
membrane ligands: Delta like (Delta like 1; Delta like 3; Delta like 4), Jagged1 and 
Jagged2 (D'Souza et al., 2010). Upon interaction with the ligand NOTCH1 undergoes 
sequential cleavage processes, but first before NOTCH1 will interact with its ligand, it 
undergoes proteolytic cleavage by the Furine convertase at the S1 site (Figure 4). This 
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cleavage occurs in the Golgi apparatus and will result in the expression of inactive form of 
NOTCH1 receptor on the plasma membrane (Logeat et al., 1998). Next, after activation of 
NOTCH1 by the interaction with its ligand, a disintegrin and metalloprotease (ADAM) 
cleaves NOTCH1 at the S2 site in the intracellular space (Figure 5). This cleavage results 
in the formation of NOTCH1 with a truncated extracellular domain (Brou et al., 2000). 
NOTCH1 processed in this way is next cleaved again by γ-secretase, a trans-membrane 
protein complex (hooked at the intracellular part of the plasma membrane, opposite to 
ADAM protease (Figure 5)) composed of several proteins: PRESSELIN1, PRESSELIN 
ENCHANCER2, NICASTRIN and APH-1. At this stage, intracellular part of NOTCH1 is 
released from the plasma membrane and translocates to the nucleus (Strooper et al., 1999). 
This is a key step of NOTCH1 activation and it has become a target for many inhibitory 
drugs, which prevent NOTCH1 processing at this step. As these drugs act directly on γ-
secretase, inducing its inhibition, they have been called γ-secretase inhibitors (GSIs).  
In the nucleus, intracellular part of NOTCH1 forms a protein complex with CBF1, a DNA 
binding transcriptional repressor and mastermind like coactivator (MAML1)(Hsieh et al., 
1996). This complex initiate transcription of NOTCH1 target genes such as hairy enhancer 
of split (HES1) and many more.  
Recently it is has been revealed that apart from CBF1, MAML1 and NOTCH1 more 
proteins take part in the formation of this transcriptional active complex. These include 
chromatin remodelers like LSD1 and PHF8 demethylases, p300 acetyl-transferase and 
nucleosome remodeling complex PBAF (Yatim et al., 2012). It is important here to 
underline a newly discovered role of LSD1 in the regulation of NOTCH1 transcription. 
LSD1 forms a transcriptional repressive complex together with the CBF1 by demethylating 
histone H3K4me2, but upon interaction with the intracellular part of NOTCH1 it becomes 
indispensable for transcription activation by mediating demethylation of the histone 
H3K9me2. A NOTCH1-mediated change in LSD1 substrate recognition is an example that 
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shows how NOTCH1 just by its interaction with the other protein can affect their substrate 
specificity (Yatim et al., 2012). 
After transcription initiation, NOTCH1 is phosphorylated by cyclinC:cdk8, which binds to 
the transcriptionally active complex though MAML1 (Fryer et al., 2004). This results in 
the phosphorylation of NOTCH1 at the PEST and TAD domains. This modification of 
NOTCH1 is recognized by F-box and WD repeat domain containing 7 (FBW7) ubiquitin 
ligase that will ubiquitinate NOTCH1 at the PEST domain, resulting in the prompt 
proteasomal degradation of NOTCH1 and transcriptional inhibition (Wu et al., 2001). 
Apart from FBW7-mediated ubiquitination, another NOTCH1-regulatory ubiquitination 
has been described. ITCH is an ubiqutine ligase, which has been reported to ubiqutinate 
NOTCH1 outside the nucleus (McGill and McGlade, 2003; Qiu et al., 2000). Regulation of 
NOTCH1 activity by the ITCH mediated degradation is very important. Since T-ALL 
leukemias have been frequently observed in A-T patients (Takeuchi et al., 1998) and 
recently it has been shown that ATM regulates ITCH activity by its phosphorylation, this 
suggests a potential  possible role of ATM in the suppression of NOTCH1 activation and 
T-ALL development (Santini et al., 2014). A part form ubiqitination, other post 
transcriptional modifications like methylation and acetylation have been shown to regulate 
NOTCH1 stability and connected with that its transcriptional ability (Guarani et al., 2011; 
Hein et al., 2015). 
As described above, mechanism of NOTCH1-mediated transcription regulation by fast 
degradation of NOTCH1 complex is very important, therefore it is not a surprise that in 
many tumors even in the absence of a direct NOTCH1 mutations, mutations in the 
NOTCH1 regulators like NUMB or FBW7 have been frequently found (Neumann et al., 
2014; Pece et al., 2004).  
For simplicity, steps of NOTCH1 activation upon interaction with its ligand have been 
depicted in the Figure 5. 
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Figure 5. NOTCH1 signaling. Abbreviations: NRR - Negative regulator region a domain 
composed from Lin like repeats and heterodimerization domain (for more details please see text); 
NICD - NOTCH1 intracellular domain; MAM - MAML1 transcription activator. CLS - CBF 
transcriptional coactivator. Adapted form (Bray, 2016). 
 
FOXO3a transcription factor  
Like Notch, FOX transcription factors were first discovered in Drosophila melanogaster. 
FOX transcription factors family is characterized by the presence of the specific DNA 
binding domain called Forkhead box. FOXO1, FOXO3a FOXO4 belong to the FOX-O 
transcription factors subfamily. The FOX-O subfamily of transcription factors is one 
among many others that have been described, ranging from A to S, each of them playing 
different roles in many cellular processes, from differentiation, stress response, cell death, 
proliferation and longevity (Greer and Brunet, 2005). 
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Apart from FOXO1/3a/4 that were characterized initially, FOXO6 was then discovered 
(Jacobs et al., 2003). FOXO6 possesses structural similarities to the other FOX-O members 
but due to its specific expression (mainly in the brain tissue) and different regulation I will 
not be describing it in more details. FOXO3a is uniformly expressed among different 
tissues. FOXO1 although is expressed in many tissues its high levels were identified in 
ovaries. FOXO4 seems to be very highly expressed in muscle cells (for more details see 
the reference) (Biggs et al., 2001). 
FOX-O family members are conserved among different species. In Caenorhabditis elegans 
there is just one FOX-O family member called daf-16. The same is true in the Drosophila 
melanogaster, which expresses only dFOXO gene. As mentioned above, in mammals there 
are four FOX-O members: FOXO1/3a/4/6. A lot has been learnt about the roles of FOX-O 
proteins through the studies in knockout mice performed in Ronald DePinho’s as well as in 
other laboratories. Considering that FOX-O proteins are involved in many cellular 
processes vital for the organism results of the knockout experiments in mice were very 
surprising. FOXO4 knockout mice are born alive and more unexpectedly with no obvious 
defects (Hosaka et al., 2004). FOXO3a knock-out mice are also born alive and healthy, 
with only female littermates developing sterility connected with the impairment in the 
growth of the ovarian follicles (Castrillon et al., 2003). Differently, mice missing FOXO1 
die before birth (Furuyama et al., 2004). This dramatic phenotype was connected with 
problems in the vascular development of embryos. Interestingly, triple inducible knockout 
of FOXO1/3a/4 revealed the great importance of FOX-O factors. Mice missing 
FOXO1/3a/4 displayed increased tumorigenesis, decreased survival and impairment in 
vasculogeneisis (in agreement with the results of single FOXO1 knockout). These results 
proved the tumor suppressive roles of FOX-O factors (Paik et al., 2007). Lack of 
differences between FOXO3a and FOXO4 knockout mice as well as the dramatic effects 
of the triple FOXO1/3a/4 depletion in mice suggest that there might be a possible 
redundancy between those transcription factors. This is a big problem for researchers, 
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which may impact proper understanding the physiological function of each single FOX-O 
transcription factor.  
 
FOXO3a structure and regulation 
FOXO3a is a tightly regulated protein. Regulation of the FOXO3a transcription activity is 
connected with the regulation of its cellular localization. The main player in this process is 
protein kinase B (PKB/AKT). Under normal conditions (absence of the stress signals, 
presence of growth factors, insulin) FOXO3a is localized in the cytosol were it is subjected 
to proteasomal degradation. This process is regulated by AKT kinase, which under those 
conditions phosphorylates FOXO3a at three residues: Threonine 32; Serine 252 and 315. 
These phosphorylations result in the recognition of FOXO3a and binding by the chaperone 
protein 14-3-3 (Brunet et al., 1999). Binding of 14-3-3 also induces conformational 
changes of FOXO3a resulting in the inhibition of its DNA binding abilities and unveils its 
nuclear export signal. Binding of 14-3-3 directly masks the nuclear localization signal of 
FOXO3a, which results in the export of FOXO3a to the cytosol and its degradation (Vogt 
et al., 2005). 
In the presence of stress conditions (for example: oxidative stress) or absence of grow 
factors, ATK-mediated FOXO3a phosphorylation is suppressed, allowing for the nuclear 
accumulation of FOXO3a. In has been shown that apart from AKT-mediated 
phosphorylations, also other post transcriptional modifications like acetylation or 
dephosphorylation can regulate localization and function of FOX-O factors (Matsuzaki et 
al., 2005; Singh et al., 2010). Once FOXO3a localizes in the nucleus, it induces 
transcription of its target genes: GADD45α, p21, BIM, Bcl-2 etc. to contribute to the stress 
response of the cell. 
The structure of FOX-O factors (FOXO1/3a/4/6) is very similar to each other (Figure 6). 
The DNA binding domain, called Forkhead domain is a key characteristic domain of FOX 
family members. In all of FOX-O factors it is localized in the N-terminal part of protein, 
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but in some cases it can be also in the C-terminal part (egz. FOX-P family). Forkhead 
domain allows for the recognition of a specific DNA binding site. For all of FOX-O 
members it is TTGTTTAC (Furuyama et al., 2000). This suggests a possible overlap in the 
transcriptional regulation between different FOX-O members. Moreover we can 
additionally distinguish three conserved regions (1-3) localized in the very N-terminal, 
middle and very C-terminal parts respectively. Conserved region 3 is known as a 
transactivation domain (TAD) that was shown to mediate FOX-O interaction with other 
transcription factors, and more recently also with ATM kinase (Nasrin et al., 2000; Tsai et 
al., 2008). The conserved regions (1-2) are targets of posttranscriptional modifications that 
regulate FOXO3a activity (like AKT-mediated phosphorylation). 	  
	  
Figure 6. Structure of FOXO3a transcription factor. Abbreviations: FHD - conserved regions; 
FHD - Forkhead domain/DNA binding domain; NLS - nuclear localization signal; NES - nuclear 
exporting signal; TAD - transactivation domain. Adapted form (Lam et al., 2013) 
 
FOXO3a in the DDR 
Among many cellular processes, recently FOXO3a has been implied to play an active role 
in the DDR by regulation of ATM kinase activation. In its role as a transcription factor 
FOXO3a has already been shown to facilitated transcription of many genes that are known 
for their role in preventing DNA damage induction or involved in DNA damage repair, 
like manganese superoxide dismutase (Kops et al., 2002), preventing oxidative DNA 
damage by scavenging reactive oxygen species or GADD45α that has been shown to be 
involved in basic excision and nucleotide excision repair (Tran et al., 2002). 
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Few years ago a Mikey Hu group published two seminal studies showing a novel function 
of FOXO3a: ATM kinase regulation. In the presented results authors demonstrated that 
upon DNA damage ATM forms a direct protein complex with FOXO3a. Formation of this 
complex is necessary for ATM activation, its autophosphorylation and phosphorylation of 
its substrates (Tsai et al., 2008). Lack of ATM-mediated phosphorylation of CHK2 and 
p53 in FOXO3a deficient cells results in impaired DNA damage-induced apoptosis (Chung 
et al., 2012a). Additionally, a report has been published showing that overexpression of 
FOXO3a in cells not exposed to any DNA damaging treatment, was able to induce ATM 
activation as assessed by ATM autophosphorylation and phosphorylation of its substrate 
(cAMP response element binding protein - CREB)(Geiger et al., 2012).  
It is possible that FOXO3a as well as other FOX-O family members may play additional 
role in the DDR as well as repair independently form the described above mechanism, but 
this will need further elucidation. 
 
  
	  40	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 	    
	   41	  
Cell culture and treatments  
In my project I used a number of human and mouse cell lines to study NOTCH1-mediated 
DNA damage response inhibition. All cell lines were grown at 37°C and 5%CO2 
conditions. HEK293T cells were grown in Dulbecco's modified eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin, L-glutamine. 
CUTLL1 cells were kind gift of A. Ferrando (Columbia University)(Palomero et al., 2006) 
and were cultured in the Roswell park Memorial Institute medium (RPMI 1640) 
supplemented with 10% FBS, penicillin/streptomycin and L-glutamine. TALL-1 cells from 
German collection of microorganisms and cell cultures (DSMZ) were grown in the RPMI 
1640 medium supplemented with 15% FBS, penicillin/streptomycin and L-glutamine. 
HeLa cells from American Type Culture Collection (ATCC) were cultured in the DMEM 
Glutamax medium supplemented with 10% FBS, penicillin/streptomycin and non-essential 
aminoacids. MCF10a cells (ATCC) were grown in the DMEM/F12(1:1) medium 
supplemented with 5% horse serum, 0,5mg/ml hydrocortisone, 10µg/ml human insulin, 
100ng/ml cholera toxin and 20ng/mlEGF. Mouse embryonic stem cells (mESC) were 
grown in the DMEM Glutamax medium supplemented with 15% FBS, 
penicillin/streptomycin, non-essential aminoacids, sodium piruvate, leukemia inhibitory 
factor (LIF) and β-mercaptoethanol. 
To inhibit NOTCH1 translocation to the nucleus I used different gamma-secretase 
inhibitors (GSI). GSI I (t-3,5-DMC-IL-CHO or N-trans-3,5-dimethoxycinnamoyl)-Ile-
leucinal)(Merck Chemicals) was dissolved in dimethyl sulfoxide (DMSO) and used at 
10µM concentration 3h prior to the experiments. Compound E (N-[(1S)-2-[[(3S)-2,3-
Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-
oxoethyl]-3,5 difluorobenzeneacetamide) (Tocris) was dissolved in DMSO and used at 
1µM concentration 24h prior to the experiment. DAPT (N-[N-(3,5-difluorophenacetyl)-l-
alanyl]-S-phenylglycine t-butyl ester)(Sigma) was dissolved in DMSO and used at the 
10µM concentration 16h (HeLa cells) or 4h (TALL-1 cells) prior to the experiment. 
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To check the dependency of DNA damage induced cell death on ATM activation, I treated 
cells with an ATM inhibitor (ATMi) (Kudos60019)(Selleck Chemicals). ATMi was 
dissolved in DMSO and used at the 10µM concentration, 16h prior to the experiment.  
To induce DNA damage (DNA double-strand breaks) in my work I used two tools: X-ray 
generating machine (Faxitron X-Ray Corporation) generating 2 Grays/minute or 
neocarzinostatin (NCS). Cells were irradiated with the amount of Greys (G) indicated in 
the figure legends. In case of NCS cells were treated with 50 ng/ml for 10 minutes and 
then left for 50 minutes for the recovery.  
To induce FOXO3a nuclear localization, I treated TALL-1 cells with Metformin, which is 
an AMP-activated protein kinase (AMPK) activator at the concentration 500nM (dissolved 
in water) or SB203580 a p38 mitogen activated protein kinases (p38) inhibitor at the 
concentration of 10µM (dissolved in DMSO). In both cases TALL-1 cells were pretreated 
with the drugs 24h before induction of DNA damage. 
 
Calcium phosphate transfection method (for HEK293T and Phoenix cells)  
I mixed 439µl of water with 10ug of DNA and subsequently with the 61µl of CaCl2 (2M). 
Next, I added this solution into 500µl of 2xHBS, constantly mixing. After 10 minutes 
incubation at room temperature, I added the mixture to the cells. 
 
Lipofectamine (for HeLa cells) 
For this transfections I mixed: 10µl of Lipofectamine (Invitrogen) and 3µg of DNA in 
500µl of OPTIMEM (Invitrogen), and incubated for 20 minutes at the room temperature 
before adding the mixture to the cells’s medium. 
 
Lipofectamine 2000 (for the mESC) 
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For this transfections I incubated separately: 6µl of the Lipofectamine 2000 (Invitrogen) in 
500µl of OPTIMEM (Invitrogen) medium and 3µg of DNA for 5 minutes. Next, I mixed 
together both solutions and after 20 minutes at the room temperature I added the 
transfection mixture to the cells. 
 
RNAiMAX (for the siRNA transfections) 
The procedure of the transfection was similar to that of Lipofectamine 2000 with the 
exception of the initial mixtures preparation: I mixed 4µl of lipofectamine RNAiMAX 
(Invitrogen) and used 20nM of final concentration of siRNA targeting the indicated genes 
(Dharmacon). 
 
Plasmids 
Human N1ΔE-Flag construct was kindly provided by of P.P. Di Fiore (Istituto Europeo di 
Oncologia). Human N1ΔEΔANK-Flag construct was cloned by Jelena Vermezovic 
(Vermezovic et al., 2015). Human N1ΔE-Myc construct was obtained from G. Del Sal 
(University of Trieste). Human N1IC in MIGR1 construct was a kind gift of J. Aster 
(Brigham and Women's Hospital). Human GFP-N1IC-NLS, CD8-N1IC-GFP, GFP-N1IC-
NES and EGFP constructs were a gift of A. Sarin (National Centre for Biological 
Sciences). Human Myc-ATM (2-797, 798-1964, 1965-3056aa) fragments were a kind gift 
of S. J. Kim (CHA University)(Park et al., 2015b). Human Flag-ATM construct was a kind 
gift of M. Kastan (Duke cancer institute) (Bakkenist and Kastan, 2003). Flag-ATMΔFATC 
(1-2992aa) construct, was generated by the IFOM Biochemistry unit. GST-ATM 
fragments (1-247, 250-522, 523-769, 772-1102, 1098-1371, 1245-1435, 1439-1770, 1764-
2138, 2141-2428, 2427-2841, 2842-3056, 2682-3012aa) were kindly provided by A. 
Behrens (Francis Crick Institute)(Khanna et al., 1998). Mouse 3xFlag-KAT5 (1-258, 69-
290, 158-395, 285-513aa) fragments were obtained from H. S. Park (Chonnam National 
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University)(Kim et al., 2007a). Human Flag-KAT5 construct was a generous gift of S.P. 
Jackson (Gurdon Institute)(Kaidi and Jackson, 2013). Myc-KAT5 (450-513aa KAT5 
fragment) was PCR-amplified using primers described in the Table 2 and cloned into the 
BamHI and XhoI restriction sites of Myc-pcDNA3 plasmid (Wang et al., 2008). GST-
KAT5 as well as GST-FOXO3a were PCR-amplified using primers described in the Table 
2 and cloned into the BamHI and SalI restriction sites of pGEX2rbs. Human Myc-
FOXO3a construct was obtained from K. Yamamoto (Nagasaki University)(Wang et al., 
2008). Myc-FOXO3a (1-300, 1-500, 500-673, 500-650, 500-620aa) fragments were PCR-
amplified using primers described in the Table 2 and cloned into the BamHI and XhoI 
restriction sites of Myc-pcDNA3 plasmid (Wang et al., 2008). Human N1IC-Flag construct 
for expression in insect cells was obtained by PCR amplification of the intracellular part of 
NOTCH1 from N1ΔE-Flag construct and cloned into the BamHI and SalI sites of 
pFastBac1 (Invitrogen)(Vermezovic et al., 2015). 
 
Fluorescence-activated cell sorting of transfected cells 
In order to obtain homogenous population of the cells transiently transfected with GFP-
tagged human N1IC, I performed Fluorescence-activated cell sorting (FACS). For this 
purpose I transfected HEK293T cells with different constructs carrying EGFP or N1IC-
GFP-NLS (see section “Plasmids and constructs”). 24h after transfection cells were FACS-
sorted, plated and left for 8h for recovery. After this time cells were subjected to 
irradiation, collected and lysed according to the experimental setup.  
 
Virus infections 
For the purpose of some experiments to obtain homogenous population of cells expressing 
the indicated constructs, I infected HeLa or MCF10a cells with the virus carrying specific 
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constructs: human N1IC or the empty vector (MIGR1), which allows to sort infected cells 
according to GFP expression. 
First, I transfected the indicated constructs into amphotrophic Phoenix cells. One day after 
transfection, I replaced the medium and added half of the volume of medium to 
concentrate the virus. 2 days after transfection, I collected the medium from transfected 
Phoenix cells, filtered it through the 0,45µm filter, add polybryne (8mg/ml) and added it to 
the targeted cells. After 4h incubation I repeated the procedure adding freshly collected 
supernatant from Phoenix cells to the targeted cells. After another 4h I replaced virus 
medium with normal medium. 3 days post transfection I repeated all of the steps from the 
2nd day. On the 4th day post transfection, FACS sorting was performed after which cells 
were re-plated and kept in the culture for no more then 3 days. 
 
RNA extraction and revers transcription 
For RNA extraction cells were harvested in 350µl of RNeasy lysis buffer (RLT)(Qiagen) 
supplemented with 1% β-mecaptoethanol. Next, I added 350µl of 70% ethanol to the 
sample, mixed it and spun (8x103g for 15 seconds) on the RNeasy Mini spin column. Next, 
samples were washed with 350µl of RW1 buffer (Qiagen) followed by DNase treatment 
(Qiagen) on the column for 15 minutes at the room temperature followed by a short spin, 
one wash with 350µl of RW1 buffer (Qiagen), two consecutive washes with the 500µl 
RPE buffer (Qiagen) and one empty spin. At the end samples were resuspended in 50µl of 
water. RNA was quantified by nanodrop (GE Healthcare) and equal amounts of RNA were 
used for the revers transcription step.  
 
Reverse transcription reactions  
To allow the amplification of the signal with the use of DNA primers in the quantitative 
real time PCR (qRT-PCR) reaction, I first reverse-transcribe 200-1000ng of mRNA.  I 
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incubated it in the SuperScript™ III Reverse Transcriptase (Invitrogen) mix for 1h at 42°C 
in the VILO™ Reaction Mix (Invitrogen). The reaction was stopped by the incubation of 
the samples at 85°C for 5 minutes. As a negative control for qRT-PCR analyses, I 
performed always one reaction in the absence of the Reverse Transcriptase. cDNA was 
next used in the qRT-PCR analysis. 
 
qRT-PCR  
The qRT-PCR analysis is a method that allows to detect expression levels of the transcripts 
in a very precise and quantitative way with the use of the fluorescent dyes that intercalate 
into the newly synthetized DNA double helix in the PCR reaction, measured and acquired 
in real time. For my qRT-PCR analyses, I used the LightCycler® 480 SYBR Green I 
Master kit, which contained SYBR Green I dye. Reactions were performed in the Light 
Cycler 480 Roche machine with the use of indicated primers (Table 2)(500nM) in 20µl 
volume. qRT-PCR reaction was set as follows:  
1) Pre-incubation for 5 min at 95°C 
2) 50 cycles of the 3 steps: denaturation for 10 seconds at 95°C; annealing for 10 seconds 
at 65°C; amplification for 1 second at 72°C. 
3) Melting curves - to visualize quality of the amplified product 
 
Western blot analysis  
To analyze protein levels and modifications in my experiments I performed a number of 
western blot analyses. In these experiments cells were lysed in TEB150 lysis buffer 
(50  mM HEPES pH 7.4, 150  mM NaCl, 2  mM MgCl2, 5  mM EGTA pH 8, 1  mM 
dithiothreitol (DTT), 0.5% Triton X-100, 10% glycerol, protease inhibitor cocktail set III 
(Calbiochem) and Benzonase 1:1000 (Sigma)) for 45 minutes at 4°C, followed by spinning 
for 15 minutes at 16x103 g at 4°C. Concentration of the protein lysates obtained in this way 
	   47	  
was measured with the use of Bradford dye-binding method (Bio-rad). Next, equal 
amounts of protein lysate of each sample were taken and incubated with 4x sample buffer 
(final concentrations: 50mM Tris-HCl pH 6,8, 2%SDS, 10% glycerol, 100µM DTT, 
12,5mM EDTA and 0,02% bromophenol blue) for 10 minutes at 95°C. 
Samples prepared in this way were resolved by SDS-PAGE followed by protein transfer 
(400mA; 1h) on Nitrocellulose membrane (0,45mm) followed by blocking the membrane 
with the 5% milk solution in TBS-Tween (0,1%) for 1h at room temperature. Membranes 
were further incubated with the primary antibody at the indicated concentrations (Table 1) 
overnight at 4°C. Next, membranes were washed with TBS-Tween (0,1%) 3 times for 10 
minutes and incubated with secondary HRP-conjugated antibodies (Bio-rad). Membranes 
were washed 3 times for 10 minutes with TBS-Tween (0,1%) and subjected to 
chemiluminescent reaction with the ECL (GE Healthcare). Chemiluminescent signals were 
acquired with the use of	  chemiluminescence sensitive films (Sigma).  
 
Protein lysate fractionation  
To obtain different cellular protein fractions from cell lysates, I first trypsinized and 
pelleted cells. After one wash with PBS, I resuspended cells in nuclear isolation buffer 
(0.25M Sucrose, 10mM Tris HCl pH 7.4, 5mM MgCl2 supplemented with protease 
inhibitor cocktail set III (Calbiochem)) and incubated them for 20 minutes at 4oC followed 
by centrifugation of the samples at 5x103g at 4°C for 20 minutes. I took the supernatant 
and marked it as the cytosolic fraction. Pelleted nuclei were resuspended in nuclear lysis 
buffer (NLB) (150mM KCl, 25mM Tris HCl pH 7.4, 5mM MgCl2 and 0.5% NP40, 
protease inhibitor cocktail set III (Calbiochem)) and incubated for 30 minutes at 4oC 
followed by centrifugation of the samples at 16x103g at 4°C for 30 minutes. I took such 
supernatant and marked it as the nuclear soluble fraction. Next, I resuspended the 
remaining pellet in NLB with Benzonase nuclease (1:300)(Sigma) and incubated it for 30 
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minutes at 4°C followed by centrifugation of the samples at 16x103g at 4°C for 30 minutes. 
I took the supernatant and marked it as the chromatin fraction. 
 
In vitro ATM kinase assay  
For that I harvested and lysed HeLa cells in TEB 150 (without phosphatase inhibitors) for 
30 minutes on ice followed by spinning for 15 minutes at 16x103g at 4°C. 0.5mg of protein 
lysate was pre-cleared with 30µl of Protein G beads (Zymed Laboratories)(1.5h) followed 
by the incubation with anti ATM antibody (Sigma)(0.5µg in 500µl volume, 1.5h) and then 
with 30µl of protein G beads (1.5h). Beads were pulled down and washed sequentially: 
once with TEB150, once with TEB150 supplemented with 0.5M LiCl, once with 0.5M 
NaCl TEB150, twice with TEB150 and at the end with a kinase buffer (without ATP) - 5 
minutes each wash. Next, beads were incubated with the recombinant NIC-Flag or ATMi 
for 2h on ice in kinase buffer (without ATP) followed by the addition of 50nM GST-p53, 
10ng of DNA 1kb ladder (NEB) and ATP, all in 20µl volume (kinase buffer: 50mM Hepes 
pH=7.5; 50mM KCl; 5mM MgCl2; 1mM ATP; 1mM DTT; 10% glycerol). Beads were 
incubated for 90 minutes at 30°C.  Reactions were stopped by the addition of sample 
buffer. 
 
Immunoprecipitation 
HEK293T cells were harvested and lysed in the TEB150 lysis buffer for 45 minutes 
followed by spinning for 15 minutes at 16x103g at 4°C. Next, supernatant was collected 
and protein concentration was assessed by spectrophotometer (595nm) with use of 
Bradford dye-binding method (Bio-rad). 1mg or more of the protein lysate was used per 
each immunoprecipitation in a reaction volume of 500µl (equalized for each sample). At 
the same time 1% of the immnoprecipitation reaction was collected and denatured in the 
sample buffer (50 mM Tris-HCl pH 6.8; 2% SDS; 10% glycerol; 12.5 mM EDTA; 0,02 % 
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bromophenol blue; 100µM DTT) for 10 minutes at 95°C, as the loading/expression 
control. To reduce the background from unspecific binding of proteins to the beads, 
samples were pre-cleared with Protein G beads (50µl)(Zymed Laboratories) for 1h at 4°C. 
Followed by the short spinning (1,5 minute at 370g) and supernatant removal, samples 
were incubated with the indicated antibodies (Table 1) overnight at 4°C. Next, 40µl of the 
Protein G beads was added to the samples and incubated for 2h followed by 3-6 washes 
with lysis buffer. Immunoprecipitated proteins were released by the addition of sample 
buffer and incubation at 95°C for 10 minutes. 
 
Protein purification  
Bacterial expression constructs of GST-ATM (pGEX5X-1), GST-KAT (pGEX2rbs), GST-
FOXO3a (pGEX2rbs) and p53 (pGex4T3) were transformed into Esherichia Coli BL21 
bacteria. Expression of the proteins was induced when growing bacteria reached optical 
density of 0,6-0,8 (at 600nm) with the use of Isopropyl β-D-1-thiogalactopyranoside 
(IPTG)(0,4mM). After induction, bacteria were incubated overnight at 20°C. 
Recombinant GST-ATM fragments were purified as follow. Bacteria were spun for 25 
minutes at 4°C and resuspended in the lysis buffer (50mM Tris-HCl pH 7,9, 300mM KCl, 
1% Triton X-100, 2mM DTT and protease inhibitor cocktail set III (Calbiochem) 1:200). 
Next, cells were sonicated 3 times for 20 seconds at the amplitude of 5 impulses and power 
of 75% followed by centrifugation of the samples at 20x103g at 4°C for 90 minutes. 
Supernatant was next incubated with the Gluthatione sepharose beads (GE Healthcare) for 
2h at 4°C, followed by 3 consecutive washes with three different buffers (30 minutes at 
4oC): Buffer I (PBS, 1% Triton X-100, 2mM DTT and protease inhibitor cocktail set III 
(Calbiochem) 1:200); Buffer II (300mM KCl, 50mM Tris-HCl pH 8, 2mM DTT and 
protease inhibitor cocktail set III (Calbiochem) 1:200); Buffer III (100mM KCl, 50mM 
Tris-HCl pH 8, 2mM DTT, 10% glycerol and protease inhibitor cocktail set III 
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(Calbiochem) 1:200). Next captured proteins were flash-frozen in liquid nitrogen and 
stored until use.  
Recombinant GST-KAT, GST-p53 and GST-FOXO3a proteins were purified in a similar 
way to the GST-ATM fragments with few exceptions. For this purification I used different 
a lysis buffer (2xTBS, 10% glycerol, 1mM EDTA, 1mM DTT and protease inhibitor 
cocktail set III (Calbiochem) 1:200). The three post-capturing washes were performed 
with: one wash with the lysis buffer containing 1M NaCl and 2 sequential washes just with 
the lysis buffer. For the purpose of some experiments, GST-tagged proteins were eluted as 
described above but for other experiments GST tag was removed by the incubation with 
PreScission protease for 2h at 4°C. Next, supernatants were taken and concentrated on the 
Millipore Centrifugal Filter (10kDa), which was combined with the buffer exchange to the 
PBS supplemented with the 10% Glycerol. 
Recombinant human N1IC-Flag was purified by IFOM crystallography unit from Hi5 
insect cells (Vermezovic et al., 2015). 
 
Immunofluorescence  
To visualize the activation and accumulation of DNA damage response factors at sites of 
DNA double-strand breaks, I performed a number of immunofluorescence stainings. To do 
this I fixed cells grown on coverslips in 4% solution of paraformaldehyde (PFA) in PBS 
for 10 minutes at room temperature or in Methanol/Acetone (1:1) solution for 2 minutes at 
room temperature. Next, in case of PFA fixation, cells were subsequently permeabilized 
with 0,2% solution of Triton X-100 for 10 minutes. To decrease unspecific binding of the 
antibodies, cells were incubated 1h in PBG solution (solution of 0,5% BSA and 0,2% 
Cold-water-fish gelatin in PBS) followed by 1h incubation with indicated primary antibody 
(Table 1) in PBG at room temperature. After washing out primary antibody (3 times for 5 
minutes) with PBG, coverslips were incubated with the secondary antibody conjugated 
with a fluorophore (Alexa488, Alexa555 or Alexa647) for 1h at room temperature. At the 
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end coverslips were washed 3 times with the PBG solution, cells nuclei were stained with 
DAPI for 5 minutes and coverslips were mounted on slides with Moviol. 
 
Proximity ligation assay (PLA) 
Cells were fixed in 4% solution of PFA in PBS. Next, cells were permeabilized with the 
use of 0,2% solution of Triton X-100 for 10 minutes, blocked for 1h with PBG solution 
and incubated with the primary antibodies of different species for 1h. After 3 washes with 
PBG, coverslips were incubated with the secondary antibodies containing oligonucleotide 
probes (plus and minus) for 1h at 37°C, followed by 2 washes for 5 minutes with buffer A 
(Sigma) and 30 minutes ligation of the connector oligonucleotides at 37°C. Next, 
coverslips were washed twice for 2 minutes in buffer A and incubated for 90 minutes at 
37°C with DNA polymerase which performs a rolling circle amplification (RCA) allowing 
for the hybridization of detection probes to the RCA products. After that, coverslips were 
washed twice with buffer B (Sigma) for 10 minutes and once with 1% solution of buffer B 
for 1 minute. At the end cell nuclei were stained with DAPI and coverslips were mounted 
on slides in Moviol. 
 
Image analysis  
PLA signals as well as quantification of the number of phosphorylated histone γH2AX foci 
were analyzed with the use of the Cell Profiler software (2.1.0). For this purpose raw 
images were uploaded to the software. Signal threshold was constant within each 
experimental replicate – due to stainings variation it might be slightly different between 
different replicas. PLA signals were always normalized to the untreated cell. 
Immunofluorescence analysis of the activation of DNA damage response factors were 
performed manually and expressed as a percentage of DNA damage response positive 
cells. Cells with more then four foci per nucleus were counted as a positive. 
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Statistical analysis 
Statistical analysis of the immunoblot and immunofluorescence quantifications as well as 
PLA analysis were performed with the use of two tailed Student’s t-test and represented as 
a mean ±SEM. Asterisk in the figures indicates p value <0.05. 
 
Antibodies 
Antibodies used together with the concentration at which they were used is described in 
the table below. 
 
Table 1. Antibody information. 
 
Antibody: Provider: Use: Cat. No.: Species: 
ATM Abcam WB 1:6000 5% Milk ab32420 Rabbit 
ATM Sigma 
WB 1:2000 5% Milk 
IP 1: 500                       
IF 1:200 
A1106 Mouse 
DNA-PKcs Millipore WB 1:6000 5% Milk 04-1024 Rabbit 
pT2609DNA-
PKcs 
Biolegend WB 1:3000 5% Milk 612902 mouse 
pT2047DNA-
PKcs 
Abcam WB 1:3000 5% Milk ab61045-100 Rabbit 
pS2056DNA-
PKcs 
Abcam WB 1:3000 5% Milk ab18192 Rabbit 
Celavaded Cell Signaling WB: 1:1000 5% BSA 9661 Rabbit 
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CASPASE 3 
pS1981ATM Rockland  
WB 1:3000 5%Milk 
IF 1:200  
200-301-400 Mouse 
NOTCH1 Santa Cruz  WB 1:1000 5% Milk sc-6014 Goat 
N1IC Cell Signaling WB 1:2000 5% BSA 4147 Rabbit 
GFP  Santa Cruz  WB 1:6000 5% Milk sc-9996 Mouse 
Flag  Sigma 
WB 1:6000 5% Milk 
IP 1:500 
F1804 Mouse 
Flag  Cell Signaling WB 1:6000 5% Milk 2368 Rabbit 
Myc Santa Cruz  
WB 1:6000 5% Milk 
IP 1:500 
sc-40 Mouse 
Myc Cell Signaling WB 1:6000 5% Milk 2272 Rabbit 
FOXO3a Cell Signaling IF 1:200 2497 Rabbit 
FOXO3a Abcam WB 1:6000 5% Milk ab109629 Rabbit 
FOXO3a Santa Cruz  IP 1:50 sc-11351 Rabbit 
FOXO1 
LifeSpan 
BioSciences 
WB 1:8000 5% Milk 
IP 1:250 
LS-C287207 Rabbit 
FOXO4 Abcam 
WB 1:8000 5% Milk 
IP 1:500 
Ab128908 Rabbit 
KAT5 
LifeSpan 
BioSciences 
WB 1:5000 5% Milk LS-C109474 Rabbit 
KAT5 Santa Cruz  
WB 1:1000 5% Milk 
IP 1:30 
sc-5725 Goat 
KAT5 
Kind gift of B. 
Amati (Frank et 
al., 2003) 
WB 1:1000 5% Milk x Rabbit 
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pS15p53 Cell Signaling WB 1:10000 5% BSA 16G8 Rabbit 
H2AX Abcam WB 1:6000 5% Milk ab11175 Rabbit 
pS139H2AX Millipore WB 1:6000 5% Milk 05-636 Mouse 
SMC1 Bethyl WB 1:8000 5% Milk A303-834A Goat 
pS966SMC1 Bethyl WB 1:6000 5% Milk A300-050A Rabbit 
KAP1 Abcam WB 1:8000 5% Milk ab10484 Rabbit 
pS842KAP1 Bethyl WB 1:6000 5% Milk A300-767A Rabbit 
CHK2 Millipore WB 1:6000 5% Milk 05-649 Mouse 
pT68CHK2 Cell Signaling WB 1:1000 5% BSA 2661 Rabbit 
pS317CHK1 Cell Signaling WB 1:6000 5% BSA 2344 Rabbit 
pS345CHK1 Cell Signaling WB 1:6000 5% BSA 2341 Rabbit 
CHK1 Santa Cruz WB 1:2000 5% Milk sc-8408 Mouse 
53BP1 Novus IF 1:2000 NB100-304 Rabbit 
MEIS Santa Cruz WB 1:6000 5% Milk Sc-10599 Goat 
H3K9m3 Abcam WB 1:6000 5% Milk 8898 Rabbit 
GST 
Biochemistry 
Facility, IFOM 
WB 1:8000 5% Milk x Rabbit 
NBS1 Novus 
WB 1:1000 5% Milk 
IP 1:500 
NB  100-143 Rabbit 
TUBULIN Sigma WB 1:8000 5% Milk T6074 Mouse 
VINCULIN Sigma WB 1:8000 5% Milk V9131 Mouse 
H3 Abcam WB 1:8000 5% Milk ab10799 Mouse 
H4 Abcam WB 1:8000 5% Milk ab10158 Rabbit 
NUCLEOLIN  Novus WB 1:8000 5% Milk NB  600-241 Rabbit 
 
WB - Westen blot; IF - immunofluoresncece; IP - immunoprecipitation 
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Primers 
Primers used together with their sequences are described in the table below. 
 
Table 2. Primers information. 
 
Primers used:  Sequence (5'->3'):  
qRT-PCR: 
GADD45α 
Fr  TTTGCAATATGACTTTGGAGGA 
Rv  CATCCCCCACCTTATCCAT 
HES1 
Fr  GAAGCACCTCCGGAACCT 
Rv  GTCACCTCGTTCATGCACTC 
B2M 
Fr  TTCTGGCCTGGAGGCTATC 
Rv  TCAGGAAATTTGACTTTCCATTC 
Cloning: 
GST-KAT5 
Fr  GATCGGATCCATGGCGGAGG            
Rv  GATCGTCGACTCACCACTTCCC 
Myc-FOXO3a 1-300 
Fr  GATCGGATCCATGGCAGAGGCACCGG        
Rv  
GATCCTCGAGTCAACTGCTGCGTGACGTGGG 
Myc-FOXO3a 1-500 
Fr  GATCGGATCCATGGCAGAGGCACCGG           
Rv  GATCCTCGAGTCACACAGCGGTGCTGGCC 
Myc-FOXO3a 500-673 
Fr  GATCGGATCCATGTCTGCCCAGAATTCCC 
Rv  GATCCTCGAGTCAGCCTGGCACCCAG 
Myc-FOXO3a 500-650 
Fr  GATCGGATCCATGTCTGCCCAGAATTCCC 
Rv 
GATCCTCGAGTCAATTCTGTGTGGAGATGAGGG 
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Myc-FOXO3a 500-620 
Fr  GATCGGATCCATGTCTGCCCAGAATTCCC 
Rv GATCCTCGAGTCACAAGCTCCCATTGAAC 
Myc-KAT5 450-513 
Fr  GATCGGATCCAAGAAGGAGGATG 
Rv  GATCCTCGAGTCACCACTTCCC 
GST-FOXO3a 
Fr GATCGGATCCATGGCAGAGGCAC  
Rv GATCGTCGACTCAGCCTGGCAC 
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Results 
 
  
	  58	  
Here I will present results that I have obtained during my PhD program on NOTCH1-
mediated regulation of the DNA damage response (DDR). Presented in this section data 
include some unpublished results, as well as parts of already published articles 
(Adamowicz et al., 2016; Vermezovic et al., 2015). 
 
NOTCH1 inhibits DDR activation.  
It has been suggested that in the stem cell compartment (cells expressing high levels of 
NOTCH1) of the Caenorhabditis elegans gonad activation of ATM kinase is perturbed 
(Vermezovic et al., 2012). Additionally, it has been shown that expression of NOTCH1, in 
a transcriptional independent manner, can affect the phosphorylation of p53, and impact on  
the transcription of its downstream targets upon induction of DNA damage in colon cancer 
cells (Kim et al., 2007b). On the basis of this observations, I decided to investigate whether 
NOTCH1 can impact on the DDR upstream of p53 in mammalian cells and, if so, by 
which mechanism.  
In order to be activated NOTCH1, as a trans-membrane receptor, requires an interaction 
with one of its ligands. To study the role of NOTCH1 in mammalian cells, I decided to 
express a constitutive activate form of the NOTCH1 (N1ΔE) (Rustighi et al., 2009) or the 
intracellular part of NOTCH1 (N1IC) (Perumalsamy et al., 2009) in the commonly used 
cell lines HeLa and HEK293T.  
N1ΔE is NOTCH1 protein missing the extra-cellular part of NOTCH1, although it still 
posses the transmembrane region. Therefore this form of NOTCH1 (N1ΔE) still needs to 
be processed by endogenous cellular gamma secretase proteinase in order to be 
translocated to the nucleus, it does not need any interaction with NOTCH1 ligand to be 
activated. N1IC construct instead encodes just for the intracellular part of NOTCH1 that 
does not need to be processed by gamma secretase or to interact with NOTCH1 ligand, and 
therefore it directly localizes to the nucleus (for more details see the “NOTCH1 signaling” 
chapter of the introduction) 
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Thus, to study the impact of Notch1 on DDR activation, I expressed Flag-tagged N1ΔE 
construct in HeLa cells that I exposed to ionizing radiation (IR) to induce DNA double 
strand-breaks (DSBs). As shown in Figure 7A and B, I was able to observe an activation of 
the DDR in HeLa cells upon treatment with IR as measured by the formation of foci of the 
phosphorylated form of ATM (pATM) and 53BP1, which indicates the recruitment of such 
factors to DSBs. In HeLa cells that had been successfully transfected with the N1ΔE-Flag 
construct, I observed a reduction of foci formation by both pATM and 53BP1 (Figure 7A 
and B). Next, I checked if the observed inhibition of the DDR by expression of NOTCH1 
can be overcome by exposing cells to higher doses of IR. I subjected HeLa cells to 
different doses of IR: 1, 3 and 10G. As shown in Figure 7C, expression of NOTCH1 
impaired formation of 53BP1 foci formation despise higher levels of DNA damage. 
To analyze more broadly the DDR factors affected by NOTCH1 expression, I decided to 
perform an immunoblot analysis of HeLa cells infected with the N1IC-expressing 
construct tagged with the GFP. Thus, I sorted infected cells to obtain homogenous cell 
population that I subsequently exposed to IR, lysed and analyzed by western blot. 
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Figure 7. NOTCH1 inhibits DDR. Immunofluorescence analysis of the DDR activation upon IR 
treatment (2G; 1h) in HeLa cells transfected with N1ΔE-Flag: pATM (A) and 53BP1 (B). (C) 
Quantification of the immunofluorescence analysis of the DDR activation (53BP1) in the HeLa cells 
transfected with N1ΔE-Flag and subjected to different doses of IR (1G, 3G and 10G; 1h). 
 
As shown in the Figure 8A, I observed that HeLa cells expressing N1IC had impaired 
activation of the DDR as measured by the reduction of the DNA damage dependent 
phosphorylation of factors like: ATM, SMC1, KAP1 and CHK2 but not H2AX (Figure 8A 
and B). Although the observed levels of reduction of the DDR activation were moderate, 
they were consistent with the low levels of N1IC expression that I detected by measuring 
NOTCH1-induced transcription of its target gene HES1 (Figure 8C). 
	  62	  
 
Figure 8. NOTCH1-mediated inactivation of DDR. (A) Immunoblot analysis of the DDR activation 
upon IR (5G; 1h) in HeLa cells infected with MIGR1-N1IC construct or empty vector. (B) 
Quantification of the experiment shown in B. (C) qRT-PCR analysis of the mRNA levels of HES1 in 
the HeLa cells infected with MIGR1-N1IC construct or empty vector. 
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experiment in normal human mammary epithelial cells (MCF10a). As shown in Figure 9 I 
observed the same reduction in DNA damage activation as measured by the activation of 
the ATM kinase (pATM) in MCF10a cells expressing NOTCH1, as in HeLa cells. 
 
Figure 9. NOTCH1 mediated inactivation of the DDR. Immunoblot analysis of the DDR 
activation (pATM) upon IR (5G; 1h) in MCF10a cells infected with MIGR1-N1IC construct or empty 
vector. 
 
NOTCH1-mediated DDR inhibition is persistent in time 
The data shown above indicate that NOTCH1 inhibits DDR activation in the cells exposed 
to IR. It has been reported that inhibition of PARylation, although it does not affect DDR 
activation, it leads to its delay, stressing the importance of the timing at which DDR 
activation is assessed (Haince et al., 2007). Therefore I decided to check if NOTCH1-
mediated inhibition of the DDR is permanent or just transient. I thus performed 
immunofluorescence analysis of the DDR activation upon IR (53BP1, pATM) in HeLa 
cells expressing NOTCH1 (N1ΔE-Flag) at different time points after the DNA damage 
induction: 1h, 4h, 24h. As shown in Figure 10A and B, NOTCH1 expression was able to 
inhibit DDR activation throughout all time points analysed, as measured by ATM 
activation (pATM) and 53BP1 foci formation. 
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Figure 10. NOTCH1 mediated inactivation of DDR is persistent in time. Quantifications of the 
immunofluorescence analysis for the DDR activation (pATM, 53BP1) in the HeLa cells expressing 
NOTCH1 (N1ΔE-Flag) and subjected to 2G of IR.  
 
Nuclear localization of NOTCH1 is necessary for its inhibition of the DDR 
Because of the complex functions of NOTCH1 that results in its presence in different 
cellular compartments at the same time and at the different functional levels, I decided to 
investigate which form/localization of NOTCH1 is necessary for DDR inhibition (For 
more details regarding NOTCH1 cellular localization and processing see “NOTCH1 
signaling” chapter in the introduction section). To tackle this question, I utilized a set of 
published constructs encoding for the intracellular form of NOTCH1 (N1IC) bound to GFP 
with: a nuclear localization signal (GFP-N1IC-NLS) that localizes N1IC to the nucleus, or 
a nuclear exporting signal (GFP-N1IC-NES) that predominantly localizes N1IC to the 
cytosol, or  a portion of the CD8 receptor that hooks N1IC on the cellular membrane 
(CD8-N1IC-GFP)(Perumalsamy et al., 2009). 
I expressed such constructs in HeLa cells that I subsequently exposed to DSBs-inducing 
agent neocarzionostatin (NCS). As shown in the immunoblot analysis, I was able to 
express similar levels of each of the different N1IC constructs (Figure 11). Despite similar 
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expression levels, I observed a decrease of ATM activation (pATM) preferentially in the 
cells expressing N1IC construct with a nuclear localization signal (Figure 11). GFP-N1IC-
NES also showed a modest impact on ATM activation, which might suggest some 
leakiness of the system (Figure 11). 
 
Figure 11. Nuclear localization of NOTCH1 is necessary for DDR inactivation. Immunoblot 
analysis of the ATM activation in HeLa cells treated with NCS (50mg/ml) and expressing different 
NOTCH1 constructs: GFP-N1IC-NLS - nuclear form of NOTCH1; CD8-N1IC-GFP - membrane form 
of NOTCH1; GFP-N1IC-NES - cytosolic form of the NOTCH1. 
 
NOTCH1-mediated inhibition of DDR is not mediated by the transcription activity of 
NOTCH1 
After translocation to the nucleus NOTCH1 controls the transcription of its target genes. 
To test if NOTCH1-mediated inhibition of the DDR by the nuclear form of NOTCH1 is 
the result of its transcriptional activity, I decided to check if by impairing NOTCH1 
transcriptional functions I was able to prevents its DDR inhibition. 
In the nucleus NOTCH1 forms a complex with the CBF1 transcription factor as well as 
with the MAML1 co-activator to induce the transcription of its target genes. It has been 
shown that with the use of a short peptide (62aa) encoding for the MAML1 interaction 
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domain with NOTCH1 it is possible to inhibit NOTCH1-mediated transcription due to the 
formation of the transcriptionally inert complex between NOTCH1 and the peptide (Weng 
et al., 2003). Thus, I decided to use a dominant negative form of the MAML1 (DN-
MAML1 13-74) in my experiments to inhibit NOTCH1-meditated transcription. 
As shown below, the concomitant expression of the DN-MAML1 (13-74) and NOTCH1 
(N1ΔE-Flag) in HeLa cells led to the inhibition of NOTCH1-mediated transcription 
(HES1) as validated by the qRT-PCR analysis (Figure 12A). Next, I decided to check the 
DDR in this setup. Upon treatment of the cells with IR, I was able to see the induction of 
DDR as measured by the formation of the 53BP1 foci in the MOCK transfected cells, but 
in the cells expressing either NOTCH1 or NOTCH1 and DN-MAML1 (13-74) the DDR 
was impaired (Figure 12B and C).  
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Figure 12. Transcriptional activity of the NOTCH1 is dispensable for NOTCH1-mediated DDR 
inactivation. (A) Analysis of the mRNA expression levels of the HES1 by the qRT-PCR in HeLa 
cells transfected with the N1ΔE-Flag or/and DN-MAML1 (13-74) constructs. (B) 
Immunofluorescence analysis of the DDR activation (53BP1) in HeLa cells transfected with the 
N1ΔE-Flag or/and DN-MAML1 (13-74) constructs and subjected to IR (2G; 1h) (C) Quantification 
analysis of the experiment shown in B. 
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To strengthen this observation we performed an analysis of the ATM activation (pATM) 
upon IR in HeLa cells expressing wild type NOTCH1 (NOTCH1 WT-Flag) or NOTCH1 
missing transactivation domain (NOTCH1ΔTAD-Flag), which is necessary for NOTCH1-
mediated transcription activation (for more details please see the “Structure of the 
mammalian NOTCH receptors” chapter). 
As presented in the immunofluorescence analysis (Figure 13A and B), we were able to 
observe reduction of ATM activation (pATM) in the HeLa cells expressing full length 
NOTCH1 as well as NOTCH1 missing its TAD domain (Figure 13A and B). qRT-PCR 
analysis of the HES1 transcription confirmed that NOTCH1ΔTAD-Flag mutant was 
transcriptionally inactive as compared to the wild type NOTCH1 (Figure 13B). 
Experiments performed with the use of NOTCH1ΔTAD-Flag were carried by Jelena 
Vermezovic (Vermezovic et al., 2015). 
Presented results indicate that the transcriptional activity of NOTCH1 is dispensable for its 
DDR-inhibiting functions. 
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Figure 13. Transcriptional activity of NOTCH1 is dispensable for NOTCH1-mediated DDR 
inactivation. (A) Immunofluorescence analysis of the DDR activation (pATM) in HeLa cells 
transfected with the NOTCH1Flag or NOTCH1ΔTAD-Flag constructs and subjected to IR (2G; 1h). 
(B) Quantification of the immunofluorescence shown in A. (C) Analysis of the mRNA expression 
levels of the HES1 by the qRT-PCR in HeLa cells transfected with the NOTCH1-Flag or 
NOTCH1ΔTAD-Flag constructs. Experiment presented in this figure were performed by Jelena 
Vermezovic (Vermezovic et al., 2015) 
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NOTCH1 does not affect ATM kinase nuclear localization 
One of the possibilities of the observed NOTCH1-mediated DDR inactivation in the 
nucleus independently from its transcriptional activity could be to affect the localization of 
key DDR factors. Therefore I decided to check if NOTCH1 (N1ΔE-Flag) expression 
affects the nuclear localization of ATM. 
I thus performed an immunofluorescence analysis of the ATM protein localization together 
with its activation (pATM) upon DNA damage induction in the HeLa cells expressing 
NOTCH1 (N1ΔE-Flag). As presented in the panel below I was not able to observe any 
differences in the localization of ATM in NOTCH1 expressing despite its inactivation 
(Figure 14). 
 
Figure 14. NOTCH1 does not affect ATM kinase nuclear localization. Immunofluorescence 
analysis of the ATM activation and localization in the HeLa cells expressing NOTCH1 (N1ΔE-Flag) 
and exposed to IR (2G; 1h). 
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NOTCH1 forms a protein complex with ATM  
Based on the previous results I concluded that the inhibition of the DDR by NOTCH1 is 
mediated by the nuclear form of NOTCH1 and it is not dependent on its transcriptional 
activity. Therefore to understand the way in which NOTCH1 is inactivating the DDR, I 
decided to check if NOTCH1 forms a protein complex with some key DDR components. 
As ATM is the apical kinase in the DDR and it has been already published that NOTCH1 
can interact with the DNA-PKcs, which like ATM is a PI3K like kinase that structurally 
resembles ATM (Yatim et al., 2012), I tested if NOTCH1 can interact with ATM. 
To assess if ATM and NOTCH1 can form a protein complex I first expressed Flag-tagged 
NOTCH1 (N1ΔE-Flag) in HEK293T cells and immunoprecipitated it with antibodies 
against the Flag tag. As shown in the Figure 15A, I detected a protein complex between 
ATM and NOCTH1. ATM as well as NOTCH1 has been shown to have the ability to bind 
DNA (Aster et al., 1997; Smith et al., 1999). For this reason, to rule out the possibility that 
such an interaction is mediated by contaminating DNA, I repeated this immunoprecipiation 
in the presence of high concentrations of Ethidium Bromide, which by intercalation into 
DNA prevents DNA binding by DNA-binding proteins (Lai and Herr, 1992), or in the 
presence of DNase that degrades any potential contaminating DNA. Upon treatment of 
NOTCH1 immunoprecipitations with the Ethidium Bromide or DNase, I could still 
observe an interaction between ATM and NOTCH1 indicating that the formation of the 
protein complex between ATM and NOTCH1 is not mediated by the DNA binding 
abilities of both proteins (Figure 15A). 
Next, I decided to check if the observed interaction between ATM and NOTCH1 is 
affected by DNA damage induction. I performed therefore an immunoprecipitation of 
either NOTCH1 (N1ΔE-Flag) or ATM from HEK293T cells subjected or not to IR. As 
shown in the Figures 15B and C, I did not notice any differences in the interaction between 
ATM and NOTCH1 in the presence or absence of the DNA damage. To control for the 
specificity of my immunoprecipitations, I used a Flag-tagged protein that does not interact 
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with ATM (MEIS-Flag). As shown in the Figure 15C, I did not detect any interaction 
between MEIS and NOTCH1 or ATM. 
 
Figure 15. ATM forms a protein complex with NOTCH1. (A) Immunoblot analysis of the 
immunoprecipitation of NOTCH1 (N1ΔE-Flag) in the presence or absence of Ethidium Bromide 
(EtBr)(50μg/ml) or DNase (2U). (B) Immunoblot analysis of the immunoprecipitation of the ATM in 
the presence or absence of the IR (5G; 1h). (C) Immunoblot analysis of the immunoprecipitation of 
the Flag tag in the cells transfected with N1ΔE-Flag or MEIS-Flag in the presence or absence of 
the IR (5G; 1h). WCE - Whole cell extract. 
 
Since these interaction studies were performed in HEK293T cells in which I expressed 
exogenous NOTCH1, I decided to test if I can recapitulate these observation in cells 
expressing endogenous NOTCH1. Thus, I used T-cell acute lymphoblastic leukemia cells 
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called CUTLL1 that express high levels of endogenous NOTCH1 and indeed they are 
sensitive to the treatment with gamma secretase inhibitors (Palomero et al., 2006). 
First, I performed immunoprecipitations of the endogenous intracellular form of NOTCH1 
(N1IC) or ATM from CUTLL1 cells. As shown in Figure 16A, consistent with the results 
obtained in HEK293T cells with the N1ΔE-Flag construct, I was able to observe an 
interaction between endogenous ATM and endogenous NOTCH1. To further strengthen 
this result, I decided to perform an in situ proximity ligation assay (PLA). PLA assay 
allows to visualize interactions between proteins (in the 40nm range or less) in the form of 
fluorescence dots that represent interactions between proteins. I performed PLA between 
ATM and NOTCH1 in CUTLL1 cells treated or not with the NOTCH1 inhibitor (GSI), 
which inhibits processing of NOTCH1 on the plasma membrane resulting in the 
accumulation of NOCTH1 on the cellular membrane decreasing at the same time the 
nuclear levels of NOTCH1. As shown in Figure 16B, I was able to detect specific dots 
indicative of the ATM-NOTCH1 complex in CUTLL1 cells, which decreased dramatically 
upon treatment with GSI, as shown in Figure 16B and its quantification (Figure 16C) 
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Figure 16. Endogenous ATM and NOTCH1 form a protein complex. (A) Immunoblot analysis of 
the immunoprecipitation of ATM or intracellular form of NOTCH1 (N1IC) in CUTLL1 cells (B) 
Immunofluorescence analysis of PLA assays between ATM and the intracellular form of NOTCH1 
(N1IC) in CUTLL1 cells treated or not with GSI (Compound E)(1uM; 24h). (C) Quantification of the 
experiment shown in C. WCE - whole cell extract. 
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(recN1IC) and the 12th GST-ATM each encoding for the different part of ATM protein (as 
indicated in the Figure 17A). 
We were able to observe a specific interaction between recombinant NOTCH1 and GST-
ATM fragment encoding for the very C-terminal part of ATM (2842-3056aa)(Figure 17A), 
containing the FATC domain that was previously described to be a critical domain 
necessary for the ATM activation (Jiang et al., 2006). We could not observe binding with 
any other fragment, showing at the same time that the observed interaction between ATM 
(2842-3056aa fragment) and NOTCH1 is specific. As in the pulldown we used just 
recombinant NOTCH1 and GST-ATM fragments observed interaction between NOTCH1 
and ATM is direct and not mediated by the presence of other proteins (Result obtained by 
Jelena Vermezovic)(Vermezovic et al., 2015). 
Next, I decided to investigate which domain of NOTCH1 is necessary for the interaction 
with ATM. For that I used NOTCH1 (N1ΔE-Flag) and NOTCH1 mutant (N1ΔEΔANK-
Flag) missing six Ankyrin repeats (between 1873–2082aa). Ankyrin repeats are the 
protein-protein interaction domain of NOTCH1 (Bork, 1993). I performed an 
immunoprecipitation with Flag tag antibodies and as shown in Figure 17B, I was able to 
observe a reduction of the interaction between ATM and mutant NOTCH1 missing the 
Ankyrin repeats as compared to the N1ΔE-Flag control. Those result point that Ankyrin 
repeats are necessary for NOTCH1-ATM binding. 
To further understand if the interaction between ATM and NOTCH1 is critical for 
NOTCH1-mediated ATM inhibition, I performed a set of immunofluorescence 
experiments to study ATM activation (pATM) upon IR in HeLa cells expressing either full 
length NOCTH1 (N1ΔE-Flag) or the form missing the ankyrin repeats (N1ΔEΔANK-
Flag). As shown in Figure 17C, I observed that the expression of the N1ΔE-Flag resulted 
in the inhibition of ATM activation upon IR (pATM) and that the expression of the 
NOTCH1 missing the Ankyrin repeats showed reduced ability to inhibit ATM activation 
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when compared to full length NOTCH1, suggesting that NOTCH1 binding to ATM is 
necessary for the NOTCH1-mediated DNA damage activation.  
 
 
Figure 17. ATM and NOTCH1 interact with each other through the FATC and Ankyrin 
domains respectively. (A) Immunoblot analysis of the GST pull down of the recombinant 
NOTCH1 (recN1IC) with the use of GST-ATM fragments (Result generated by Jelena 
Vermezovic)(Vermezovic et al., 2015). (B) Immunoblot analysis of the immunoprecipitation of the 
NOCTH1: full length (N1ΔE) or mutant missing Ankyrin domain (N1ΔEΔANK). (C) Quantification of 
the immunofluorescence analysis of the ATM activation (pATM) in HeLa cells expression either full 
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length NOTCH1 (N1ΔE) or mutant missing Ankyrin domain (N1ΔEΔANK) upon IR (2G; 1h). WCE - 
whole cell extract. 
 
NOTCH1 directly inhibits ATM kinase activity 
To understand if NOTCH1 can directly inhibit ATM kinase activity, I decided to perform 
an in vitro ATM kinase assay. 
A number of in vitro ATM kinase assays have been established. Based on the literature it is 
possible to highlight three most commonly used ways of performing an in vitro ATM 
kinase assays. One of the most and well described methods is the one, in which ATM is 
purified (by double immunoprecipitation) in a dimer form from HEK293T cells expressing 
Flag and HA tagged ATM. In this assay purified ATM is incubated with recombinant 
MRN complex in the presence of linear double-stranded DNA, that mimics DNA DSBs 
(Lee and Paull, 2004). It is important to mention that this kind of assay is performed in the 
absence of Mn2+ ions that artificially induce ATM activation (regardless of the presence of 
the damaged DNA) by inducing the formation of a stable catalytically active ATM dimer 
(Guo et al., 2010). Another well established method to measure ATM kinase activity is to 
immunopurify endogenous ATM and incubate it with a linear double stranded DNA in the 
presence of Mn2+ ions. This method, although relatively simple to perform, usually 
generates higher background of the ATM activity, due to the presence of Mn2+ ions (Smith 
et al., 1999). Finally, it has been shown that with the use of Xenopus leavis egg extract it is 
possible to monitor ATM activity by the incubation of the egg extract with linear double 
stranded DNA (Dupré et al., 2006). Unfortunately despite its simplicity, with the use of 
this method it is not possible to claim a direct effect of the tested factors on ATM kinase 
activity because of the presence of other proteins in the egg extract. Therefore I decided to 
perform an in vitro ATM assay with the use of endogenous immunopurified ATM in the 
presence of linear double-stranded DNA, but in the absence of the Mn2+ ions. 
	  78	  
For that I performed immunopurification of the endogenous ATM from HeLa cells. As 
indicated in Figure 18 silver staining of the immunopurifed ATM showed a single pure 
band of the ATM as compared to the IgG control (MOCK IP). 
 
Figure 18. Immunopurification of the ATM. Silver staining of the ATM immunopurification. 
 
Next, I incubated ATM purified this way with recombinant GST-p53 (as a phosphorylation 
substrate) and recombinant NOTCH1 (N1IC-Flag) in the presence or absence of a linear 
double stranded DNA (1kb DNA ladder). After the incubation, I analysed GST-p53 
phosphorylation at the Serine 15 by immunoblotting. As shown in Figure 19A and B, I was 
able to observe an induction of GST-p53 phosphorylation by ATM upon addition of linear 
double stranded DNA. However, when I pre-incubated immunopurified ATM with 
recombinant NOTCH1 (N1IC-Flag) before addition of DNA and GST-p53, I detected a 
decrease in GST-p53 phosphorylation upon increasing amounts of NOTCH1. Finally, to 
determine the specificity of the signal detected, I per-incubated immunopurified ATM with 
a small molecule ATM kinase inhibitor (ATMi). As shown in Figure 19A, I observed a 
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specific decrease of GST-p53 phosphorylation in the samples treated with ATMi as 
compared to the control (DMSO), showing that the observed GST-p53 phosphorylation is 
specifically mediated by the ATM kinase under the conditions emplyed. 
 
Figure 19. In vitro ATM kinase assay. (A) Immunoblot analysis of the in vitro ATM kinase assay. 
Immunopurified ATM was incubated with recombinant GST-p53 in the presence of increasing 
amounts of recombinant NOTCH1 (N1IC-Flag) or ATMi. (B) Quantification of GST-p53 
phosphorylation at Serine 15 shown in A.  
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Inhibition of NOTCH1 increases ATM activation in NOTCH1-driven cancers  
NOTCH1 is mutated and activated in many cancers. One of the most studied are T-acute 
lymphoblasic leukemias (T-ALL), 50% of which carry a mutation in the NOTCH1 gene 
(Grabher et al., 2006; Weng et al., 2004). Indeed NOTCH1 mutations are considered 
driving mutations leading to T-ALL and necessary for T-ALL cells survival (Pear et al., 
1996; Weng et al., 2003). Therefore I decided to use T-ALL cells as the physiological 
cellular context of NOTCH1 expression to study its impact on the DDR and DNA damage-
induced cell death. 
First, I performed a qRT-PCR analysis of the expression of HES1 gene, a NOTCH1 target 
gene, to check if by the use of gammasecretase inhibitor (GSI) I was able to inhibit the 
translocation, and this way activation of NOTCH1 to the nucleus. As shown in the Figure 
20A treatment of TALL-1 cells with GSI resulted in a decrease of NOTCH1-mediated 
transcription of HES1. Next, I performed an analysis of the DDR activation in TALL-1 
cells treated or not with GSI. I observed an increase in ATM activation upon IR in GSI-
treated cells, compared to controls, as measured by an increase in the autophosphorylation 
of ATM (pATM) and ATM-dependent phosphorylation of its target proteins such as: 
Serine 966 SMC1 and Threonine 68 CHK2 (Figure 20B and C). 
On the basis of these results I concluded that the inhibition of NOTCH1 in TALL-1 cells 
leads to an increase in DDR activation. 
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Figure 20. Inhibition of NOTCH1 increases activation of the DDR in TALL-1 cells. (A) qRT-
PCR analysis of the expression of HES1 in TALL-1 cells treated or not with the GSI. (B) 
Immunoblot analysis of the DDR activation in TALL-1 cells pretreated with the GSI and subjected to 
IR (5G; 1h). (C) Quantification of the immnoblot analysis shown in B. 
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Inhibition of NOTCH1 increases DNA damage-induced cell death in NOTCH1-driven 
cancers  
The results shown before indicate that inhibition of NOTCH1 with the use of gamma 
secretase inhibitor (GSI) in NOTCH1-driven cancer cells (TALL-1) leads to an increase of 
the DDR in cells subjected to DNA damage-inducing agents, like IR. Therefore, I tested if, 
by the boosting the DDR in TALL-1 cells with GSI, I could increase DNA damage-
induced cell death in such cells. 
For that, I pretreated TALL-1 cells with GSI or an ATM inhibitor (ATMi) before 
subjecting them to IR. As shown in the chart displaying the survival of TALL-1 cells upon 
treatment with IR, I observed that cells pre-incubated with GSI had decreased survival as 
compared to control cells (Figure 21A). Moreover the effect of the GSI on the survival of 
TALL-1 cells was abolished by the use of the ATMi (Figure 21A). The effect was not a 
result of GSI cytotoxicity per se since cells treated with GSI, but not subjected to IR, 
survived better then IR-treated ones (Figure 21B).  
To understand if reduced survival of the GSI-treated cells is a result of increased cell death 
or decreased cell proliferation, I performed an immunoblot analysis of GSI and ATMi 
pretreated cells exposed to IR. As shown in Figure 21C, I observed that GSI-mediated 
NOTCH1 inhibition leads to an increase of DNA damage-induced cell death as measured 
by the cleavage of CASPASE3, a marker of apoptotic cells. This effect was inhibited by 
the use of ATMi, demonstrating that the induced increase of apoptosis in GSI-treated cells 
is dependent on ATM activation. 
This results together with the previously presented ones demonstrate that NOTCH1 
inhibits DDR activation in TALL-1 cells, which results in the inhibition of DNA damage-
induce cell death in such cells.  
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Figure 21. Inhibition of NOTCH1 increases DNA damage-induced cell death in TALL-1 cells 
exposed to IR. (A) and (B) survival analysis of the TALL-1 cells upon treatment with different 
drugs. TALL-1 cells were pretreated for 3h with indicated drugs (GSI - NOTCH1 inhibitor; ATMi - 
ATM inhibitor) followed by the exposure to IR (10G)(A) or not (B). (C) Immunoblot analysis of the 
DNA damage-induced cell death (cleaved CASPASE 3) in TALL-1 cells pretreated with GSI, ATMi 
or GSI and ATMi and exposed to IR (10G). 
 
NOTCH1 does not impair the interaction between ATM and NBS1 
To study the exact mechanism by which NOTCH1 prevents ATM activation, I decided to 
analyze all the known steps that lead to ATM activation upon DNA DSB generation. 
One of the first steps in DDR is the initial recruitment of ATM to DNA DSBs (Polo and 
Jackson, 2011). This step is mediated by the direct interaction between the N-terminal part 
of ATM kinase and the very C-terminus part of NBS1 protein (Falck et al., 2005; Nakada 
et al., 2003; You et al., 2005), which as a part of MRN complex brings ATM to the sites of 
DNA damage. 
 
 
Figure 22. NOTCH1 does not impair the interaction between ATM and NBS1. Immunoblot 
analysis of NBS1 immunoprecipitation. HEK293T cell were transfected with N1ΔE-Flag or empty 
vector and subjected or not to IR (5G; 1h) followed by the immunoprecipitation of NBS1. WCE - 
whole cell extract. 
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Therefore I immunoprecipitated NBS1 in cells expressing or not NOTCH1 (N1ΔE-Flag). 
As previously reported, I was able to detect NBS1 in a complex with ATM before and after 
DNA damage induction (Figure 22)(Falck et al., 2005). Despite high levels of NOTCH1 
expression, I was not able to see any difference in interaction between ATM and NBS1 in 
N1ΔE-Flag as compared to MOCK transfected cells (Figure 22). 
 
NOTCH1 does not inhibit ATM recruitment to DSBs 
As described above, NOTCH1 does not impact on ATM-NBS1 interaction. I therefore 
decided to test if NOTCH1 expression can impact on ATM accumulation at the DSBs 
upon IR. For this purpose I performed a cell lysate fractionation, which allowed me to 
extract the chromatin bound fraction of proteins. It has been already published that an 
ATM autophosphorylation mutant (S1981A), although initially recruited to DSBs (up to 
10min after DNA damage induction), was not retained at the DNA damage sites (1h after 
DNA damage induction) (So et al., 2009). Because I already observed that NOTCH1 
expression inhibits ATM autophosphorylation at serine 1981, I decided to test ATM 
recruitment to damaged chromatin by cell lysate fractionation one hour post irradiation. 
I transfected HEK293T cells with the EGFP or N1IC-GFP constructs that I subsequently 
FACS-sorted to enrich for NOTCH1-transfected cells. After sorting, cells were left to 
recover and exposed to IR. 
As expected I observed reduction in the ATM activation (pATM) in NOTCH1 (N1IC-
GFP) expressing cells as compared to EGFP transfected cells (Figure 23A). I could also 
observe in the chromatin bound fraction clear accumulation of ATM upon DNA damage to 
a similar extent in EGFP and N1IC-GFP transfected cells (Figure 23A and B).  
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Figure 23. NOTCH1 does not inhibit ATM recruitment to DSBs. (A) Immunoblot analysis of 
HEK293T cells transfected with EGFP or N1IC-GFP followed by FACS sorting and exposed to IR 
(10G; 1h). Chromatin fraction of the cell lysate was analyzed. (B) Quantification of the immunoblots 
are shown. 
 
This result, together with that showing lack of an impact of NOTCH1 on ATM-NBS1 
interaction, clearly show that NOTCH1 dose not affect ATM recruitment to DSBs, 
although confirming ATM inhibition at sites of damage. 
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ATM forms a protein complex with FOXO3a  
As I could not observe any kind of impact of NOTCH1 expression on ATM recruitment to 
the DNA DSBs, I decided to look into the protein factors that have been reported to play a 
direct role in ATM activation upon DNA damage. Among the many reported ATM 
interactors, like PP2A or SMAD7, the FOXO3a transcription factor stood out as a potential 
good candidate to mediate NOTCH1 functions on ATM (Goodarzi et al., 2007; Park et al., 
2015a; Tsai et al., 2008). FOXO3a has been shown to bind directly to the C-terminal part 
of ATM (between 1764-2841aa) upon DNA damage (Tsai et al., 2008). Knock-down of 
FOXO3a has been reported to result in impaired DDR activation and, more importantly, 
ATM kinase activity (Chung et al., 2012b; Tsai et al., 2008). Therefore to understand if 
FOXO3a-mediated ATM activation process is the likely mediator of ATM inactivation by 
NOTCH1, I decided to characterize ATM-FOXO3a interaction more in depth. 
 
FOXO3a interacts with ATM despite the presence of the DNA damage 
First I preformed an immunoprecipitation of endogenous FOXO3a from cells subjected or 
not to IR. As shown in the Figure 24A, ATM forms a protein complex with the FOXO3a 
both in the presence and in the absence of DNA damage. To further understand the nature 
of the observed interaction, I performed sequential immunodepletion of endogenous ATM 
or FOXO3a from the nuclear cell lysate. This kind of experiment allows to investigate if 
one of the two proteins that are in a complex is in excess and not uniquely bound to the 
other protein of interest. 
After performing a set of immunoprecipitations leading to effective immunodepletion of 
ATM from the nuclear lysate, I could not see any significant change in the levels of 
FOXO3a (Figure 24B). Instead, when I sequentially immunodepleted FOXO3a from the 
lysate, I observed a dramatic decrease in the levels of ATM (Figure 24B). 
This result indicate that the entire amount of ATM is in a complex with FOXO3a and only 
a fraction of nuclear FOXO3a is in the same complex with ATM. This is in agreement with 
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already established role of FOXO3a as a transcription factor, thus likely interacting with 
several other partners, and it is compatible with other roles of FOXO3a unrelated to ATM 
interactions. 
 
Figure 24. FOXO3a forms a protein complex with ATM in the presence and absence of the 
DNA damage. (A) Immunoblot analysis of the FOXO3a immunoprecipitation. HEK293T cells were 
lysed and subjected to IR (5G; 1h) followed by the immunoprecipitation of the FOXO3a. (B) 
Immunoblot analysis of the ATM or FOXO3a immunoprecipitation. HEK293T cells were lysed and 
the nuclear fraction was extracted (NUC), followed by the immunoprecipitation of either ATM or 
FOXO3a 
 
A!
                 IR   !
IP:!  FOXO3a!  IgG!
WCE!
IP!
ATM!
ATM!
FOXO3a!
FOXO3a!
_! +!_!
B!
ATM    !
FOXO3a       !
  L  !F   !F  !F   !A!
IP!
(NUC)!
NUC!
Extract!
ATM!
FOXO3a!
L – Starting lysate!
F – IP FOXO3a!
A – IP ATM!
NUCLEOLIN!
  L  !A   !A   !A   !F!
A   !A   !A   !F!  F   !F  !F   !A!
Cell 
Nuclear 
extract!
3 Immunoprecipitations!
Of ATM or FOXO3a !
Opposite 
Immunoprecipitation!
Of ATM or FOXO3a !
	  90	  
FOXO3a binds directly to the FATC domain of ATM  
The domain of ATM involved in the interaction between ATM and FOXO3a has been 
previously identified (between 1764-2841aa)(Tsai et al., 2008). In this study, authors 
utilized GST-ATM fragments that cover entire length of ATM (Khanna et al., 1998). 
Although authors observed specific binding of FOXO3a to the three GST-ATM fragments 
(between 1764-2841aa) they did not test one of GST-ATM fragment covering the very C-
terminal part of ATM, containing FATC domain of ATM (Tsai et al., 2008). Therefore I 
decided to re-evaluate ATM domain involved in the ATM-FOXO3a interaction. 
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Figure 25. FOXO3a interacts directly with the FATC domain of ATM. (A) Immunoblot analysis 
of immunoprecipitated Myc-ATM fragments. HEK293T cells were transfected with different Myc-
ATM constructs followed by the immunoprecipitation of the Myc tag. (B) Immunoblot analysis of the 
GST pulldowns with different GST-ATM fragments. HEK293T cells were transfected with Myc-
FOXO3a, lysed and used in the pull down experiment. (C) Immunoblot analysis of GST pulldowns 
with GST-ATM fragment (2842-3056aa) and endogenous FOXO3a. HEK293T cells were lysed and 
used in the pulldown experiment. (D) Immunoblot analysis of immunoprecipitated FOXO3a. 
HEK293T cells were transfected with different Flag-ATM constructs followed by 
immunoprecipitation of FOXO3a. (E) Immunoblot analysis of the GST pulldowns with GST-ATM 
fragment (2842-3056aa) and recombinant FOXO3a. WCE - whole cell extract. 
 
First, I performed an imunnoprecipitation of endogenous FOXO3a from lysate of cells 
transfected with three different Myc-ATM fragments spanning the entire length of ATM 
(Myc-ATM: 2-797aa; 798-1964aa and 1965-3056aa). I observed that FOXO3a is 
predominantly interacting with C-terminal fragment of ATM, although I could notice a 
weak interaction also with the N-terminal one (Figure 25A). To identify more precisely the 
ATM interaction domain with FOXO3a, I used GST-ATM fragments including GST-ATM 
fragment (2842-3056aa) that in the previous study charactering ATM-FOXO3a interaction 
was not tested (Tsai et al., 2008). As shown in the Figure 25B, 2842-3056aa GST-ATM 
fragment displayed the strongest binding affinity to ectopically expressed Myc-FOXO3a. 
Moreover, I noticed additional binding, although with a lower affinity, with a previously 
reported GST-ATM fragments (between 1239-2841aa). As I could not observe any binding 
to GST-ATM fragment encoding for 2682-3012aa of ATM I concluded that the domain of 
ATM responsible for FOXO3a binding is between 3012-3056aa of ATM. As the pull down 
with all the GST-ATM fragments was performed in cells ectopically expressing Myc-
FOXO3a, I performed a pull down with the 2842-3056aa GST-ATM fragment from a 
lysate of cells expressing just endogenous FOXO3a. As shown in Figure 25C, I confirmed 
the previous observation that FOXO3a binds specifically to the 2842-3056aa GST-ATM 
fragment. To further confirm the involvement of very C-terminal part of ATM in FOXO3a 
binding, I expressed in cells either a Flag-ATM or Flag-ATM mutant, missing the last 64aa 
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(Flag-ATMΔFATC). When I immunoprecipitated endogenous FOXO3a from the lysate of 
the cells expressing either of the above-mentioned constructs, I observed that Flag-
ATMΔFATC does not stably interact with FOXO3a (Figure 25D), confirming that the last 
64aa of ATM containing the FATC domain are essential for the ATM-FOXO3a 
interaction. 
To understand if the observed interaction between the C-terminal domain of ATM and 
FOXO3a is direct or it is mediated by other proteins, I purified from bacteria human 
recombinant FOXO3a, which I next used in pulldown experiment together with the 2842-
3056aa GST-ATM fragment. As shown in Figure 25E, I was able to pulldown recombinant 
FOXO3a together with C-terminal fragment of ATM in the absence of any other protein, 
suggesting that observed interaction between ATM FATC domain and FOXO3a is direct. 
 
NOTCH1 competes with FOXO3a for the binding to the FATC domain of ATM 
As I have shown before the interaction between NOTCH1 and ATM is mediated by FATC 
domain of ATM and ankyrin repeats of NOTCH1, I hypothesized that NOTCH1 might be 
competing with the FOXO3a for the binding to the FATC domain of ATM. To address this 
question I performed a number of pulldowns and immunoprecipitations in the presence of 
an excess of either FOXO3a or NOTCH1. 
First, to see if NOTCH1 can affect the binding between ATM and FOXO3a I performed a 
pulldown of the endogenous FOXO3a with the 2842-3056aa GST-ATM fragment in the 
cell lysate from the cells transfected with either empty vector or N1ΔE-Flag construct. 
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Figure 26. NOTCH1 impairs FOXO3a binding to ATM. (A) Immunoblot analysis of GST 
pulldowns with GST-ATM fragment (2842-3056aa). HEK293T cells were transfected with the 
N1ΔE-Flag construct lysed and incubated with the GST-ATM fragment. (B) Quantification of the 
immunofluorescence analysis of the PLA signal between ATM and FOXO3a. HeLa cells were 
transfected with the N1ΔE-Flag construct or empty vector. (C) Immunoblot analysis of the FOXO3a 
immunoprecipitation. HEK293T cells were transfected with N1ΔE-Flag construct followed by the 
immunoprecipitation of FOXO3a. WCE - whole cell extract. 
 
As shown in the Figure 26A I observed that endogenous FOXO3a forms a protein complex 
with the 2842-3056aa GST-ATM fragment, but in the presence of NOTCH1 (cells 
transfected with the N1ΔE-Flag construct) such interaction between ATM and FOXO3a 
was strongly reduced (Figure 26A). 
Next, to validate this conclusion also in living cells, I performed a PLA assay between 
ATM and FOXO3a in cells expressing or not N1ΔE-Flag construct. The 
immunofluorescence analysis revealed that the interaction between ATM and FOXO3a 
(measured as a number of dots per nucleus) in N1ΔE-Flag expressing cells was 
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significantly decreased as compared to cells transfected with the empty vector (Figure 
26B). Moreover, to test if the observed reduction of the PLA signal is specifically 
mediated by NOTCH1, I treated N1ΔE-Flag expressing cells with a NOTCH1 inhibitor 
(GSI). Rescue of the PLA signal in the GSI-treated cells to the levels observed in the 
MOCK transfected cells proved that observed reduction of the PLA signal in the N1ΔE-
Flag expressing cells is specific and mediated directly by NOTCH1 (Figure 26B). 
NOTCH1 has never been reported to interact with FOXO3a. Therefore to exclude the 
possibility that observed impairment in the interaction between ATM and FOXO3a in 
NOTCH1 expressing cells is the result of an interaction between NOTCH1 and FOXO3a I 
performed an immunoprecipitation of FOXO3a in NOTCH1 expressing cells: I could not 
detect any interaction between NOTCH1 and FOXO3a (Figure 26C). 
 
Overexpression of FOXO3a impairs NOTCH1 binding to ATM  
Next, I decided to test if the observed impairment of ATM-FOXO3a binding in NOTCH1 
expressing cells could be reversed. 
I therefore transfected cells with the N1ΔE-Flag and Myc-FOXO3a constructs. When I 
immunopurecipitated NOTCH1 from N1ΔE-Flag transfected cells, I could detect an 
interaction between ATM and NOTCH1 (Figure 27A). However in cells expressing both 
N1ΔE-Flag and Myc-FOXO3a, the formation of a protein complex between ATM and 
NOTCH1 was dramatically perturbed (Figure 27A). I obtained similar results in the 
reciprocal immunoprecipitations (Figure 27B). 
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Figure 27. Overexpression of FOXO3a impairs binding of NOTCH1 to ATM. (A) Immunoblot 
analysis of NOTCH1 immunoprecipitation. HEK293T cells were transfected with N1ΔE-Flag and 
Myc-FOXO3a constructs followed by immunoprecipitation of NOTCH1. (B) Immunoblot analysis of 
the ATM immunoprecipitation. HEK293T cells were transfected with N1ΔE-Flag and Myc-FOXO3a 
constructs followed by the immunoprecipitation of ATM. WCE - whole cell extract. 
 
NOTCH1 binds to the ATM with the higher affinity compared to FOXO3a 
To better understand the competition between FOXO3 and NOTCH1 for ATM binding, I 
decided to evaluate the strength of these interactions. 
For this purpose I transfected cells with either N1ΔE-Myc or Myc-FOXO3a constructs. 
Next, I immunoprecipitated Myc-tagged proteins from cell lysates in parallel. As shown in 
Figure 28A, both proteins (N1ΔE-Myc and Myc-FOXO3a) were expressed at similar 
levels, as judged by immunoblotting. Surprisingly, Myc immunoprecipitation reveled that 
NOTCH1 dispalys higher binding strength to ATM compared to FOXO3a in both 
irradiated and not irradiated cells (Figure 28A). To rule out that the observed difference in 
ATM binding is the result of different subcellular localizations of Myc-tagged proteins, I 
fractionated cell lysate. I observed that Myc-FOXO3a was expressed in the nucleus to a 
higher extent then N1ΔE-Myc, excluding possibility that observed higher strength of the 
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proteins cellular localization and emphasizing at the same time previously observed 
difference in the ATM binding ability of NOTCH1 (Figure 28B). 
 
 
Figure 28. NOTCH1 binds to ATM with higher strength as compared to FOXO3a. (A) 
Immunoblot analysis of NOTCH1 or FOXO3a immunoprecipitation. HEK293T cells were 
transfected with N1ΔE-Myc or Myc-FOXO3a construct and subjected to IR (5G; 1h) followed by 
immunoprecipitation of the Myc tag. (B) Immunoblot analysis of the expression of N1ΔE-Myc and 
Myc-FOXO3a. HEK293T cells were transfected with N1ΔE-Myc or Myc-FOXO3a construct, 
subjected to irradiation (5G; 1h) and fractionated (CYTO-cytosolic fraction; NUC-nuclear fraction). 
WCE - whole cell extract. 
 
These results indicate that NOTCH1 competes with FOXO3a for binding to the FATC 
domain of ATM thanks to its higher binding affinity toward ATM as compared to 
FOXO3a. 
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Overexpression of FOXO3a rescues NOTCH1-mediated ATM inhibition 
So far, these results indicate that NOTCH1 and FOXO3a can mutually impair binding of 
each other to ATM. Therefore, I decided to test if the overexpression of FOXO3a could 
rescue NOTCH1-mediated ATM inhibition.  
I thus performed an immunofluorescence analysis of ATM activation (pATM) in HeLa 
cells expressing N1ΔE-Flag as well as Myc-FOXO3a constructs. As expected, expression 
of NOTCH1 blocked ATM activation upon DNA damage, as shown in Figure 29A and B. 
However in cells expressing both N1ΔE-Flag and Myc-FOXO3a, I was able to observe a 
rescue of ATM activation. However, such recovery never reached the levels of MOCK 
transfected cells (Figure 29A and B). 
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Figure 29. Overexpression of FOXO3a rescues NOTCH1-mediated ATM inhibition. (A) 
Immunofluorescence analysis of ATM activation upon DNA damage (pATM). HeLa cells were 
transfected with N1ΔE-Flag and Myc-FOXO3a and subjected to IR (2G; 1h). (B) Quantification of 
immunofluorescence shown in A. 
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KAT5 forms a direct protein complex with FOXO3a 
The exact role of FOXO3a in ATM activation is unclear. As FOXO3a is a transcription 
factor which lacks any known enzymatic activity, I hypothesized that FOXO3a can play a 
role of a bridging protein between ATM and other factor(s) necessary for its activation. 
The only factor described in the literature that is necessary for ATM activation and has 
been reported to bind to the FATC domain of ATM is the lysine acetyltransferase 5 
(KAT5). KAT5 has been reported to acetylate ATM upon DNA damage and necessary to 
induce ATM monomerization and activation (Sun et al., 2005; Sun et al., 2010). Therefore 
I decided to investigate a possible functional connection between FOXO3a and KAT5. 
 
KAT5 interacts directly with FOXO3a 
It has been shown that KAT5 interacts with ATM in the presence and absence of DNA 
damage (Sun et al., 2005), therefore to verify in my hands this observation I performed an 
immunoprecipitation of Flag-tagged KAT5 from cells exposed or not to IR. As shown in 
Figure 30A I observed an interaction between ATM and KAT5 that did not change upon 
induction of DNA damage. This is reminiscent of the behaviour of the interaction between 
FOXO3a and ATM (Figure 24). 
According to the available database of the protein-protein interactions (Biogrid; July 
2016), no interaction between FOXO3a and KAT5 has been described. Therefore I decided 
to perform an immunoprecipitation of FOXO3a and see if I was able to detect KAT5 with 
it. As shown in Figure 30B, I observed that FOXO3a forms a protein complex with KAT5 
both in the presence and absence of DNA damage. To further prove that the observed 
interaction is specific and not a result of the DNA binding abilities of both proteins, I 
performed the immunoprecipitation of FOXO3a in the presence of Benzonase nuclease, 
which degrades DNA and RNA. Despite the treatment with Benzonase, I could still 
observe an interaction between FOXO3a and KAT5 (Figure 30C). 
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Figure 30. FOXO3a forms a protein complex with KAT5. (A) Immunoblot analysis of the Flag 
immunoprecipitation. HEK293T cells were transfected with a Flag-KAT5 construct, exposed to IR 
(5G; 1h), followed by the immunoprecipitation of the Flag tag. (B) Immunoblot analysis of the 
FOXO3a immunoprecipitation. HEK293T cells were transfected with Flag-KAT5 construct, exposed 
to IR (5G; 1h) and followed by immunoprecipitation of FOXO3a. (C) Immunoblot analysis of 
FOXO3a immunoprecipitation. HEK293T cells were transfected with Flag-KAT5 construct exposed 
to IR (5G; 1h) and followed by immunoprecipitation of FOXO3a in the presence of Benzonase 
nuclease. (D) Immunoblot analysis of the GST pulldowns. Recombinant FOXO3a was incubated 
with the GST or GST-KAT5 (asterisk). WCE - whole cell extract. 
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To understand if the interaction between FOXO3a and KAT5 is direct or mediated by the 
presence of other protein(s), I performed GST pulldown experiments with either GST or 
GST-KAT5 incubated with recombinant FOXO3a protein. In the absence of other proteins 
interaction between FOXO3a and KAT5 was still detected, although weakly (Figure 30D). 
 
The C-terminal domain of KAT5 is necessary for binding to FOXO3a 
To map the domain of KAT5 involved in the interaction with FOXO3a, I decided to use a 
set of Flag-tagged fragments of KAT5 that span the entire length of KAT5 protein (Figure 
31A). When I immunoprecipitated those fragments I noticed that FOXO3a was specifically 
binding to the C-terminal part of KAT5 (fragment number 4) (Figure 31B). Moreover 
when I preformed the same immunoprecipitation experiment with the KAT5 fragments I 
could observe that ATM was binding to the same C-terminal fragment just like FOXO3a 
(Figure 31C). To map precisely the interaction domain of KAT5 with FOXO3a and ATM, 
I immunoprecipitated the very short C-terminal fragment of KAT5 (450-513aa). As shown 
in Figure 31D, I observed that both FOXO3a and ATM bind to the very C-terminal 
fragment of KAT5 (450-513aa), suggesting that KAT5 may bind to ATM through 
FOXO3a. 
 
	   103	   
WT!
1 513 aa!
ChD!
25! 76!
ZincF!
261! 283!
AcCoA!
369! 383!
1!
1
ChD!
25! 76! 258!
2!
69!
ZincF!
261! 283!290!
3!
158!
ZincF!
261! 283! 369!
4!
513 aa!285!
AcCoA!
369! 383!
395!
KAT5 fragments no.:!
AcCoA!
NR!
NR!
A!
ChD – Chromodomain!
ZincF – Zinc Finger!
AcCoA – Acetylo-CoA binding domain!
NR – Nuclear receptor binding domain!
B!
Flag (KAT5)!
1         1         2        3         4   !
  Flag!
Flag-KAT5 Frag.:!
WCE!
IP!
FOXO3a!
Flag (KAT5)!
FOXO3a!
IgG!IP:!
C!
Flag (KAT5)!
1        1         2         3         4   !
  Flag!
Flag-KAT5 Frag.:!
WCE!
IP!
ATM!
Flag (KAT5)!
ATM!
IgG!IP:!
 Myc-KAT5 (450)!
Myc (KAT5)!
ATM!
FOXO3a!
 IP 
Myc
!
  IP
 IgG
!
+! +!
D!
	  104	  
Figure 31. The C-terminal domain of KAT5 is necessary for ATM as well as FOXO3a binding. 
(A) Cartoon representation of the 3xFlag-KAT5 fragments. (B) Immunoblot analysis of the KAT5 
immunoprecipitation. HEK293T cells were transfected with the different 3xFlag-KAT5 constructs 
followed by the immunoprecipitation of the Flag tag. (C) Immunoblot analysis of the KAT5 
immunoprecipitation. HEK293T cells were transfected with the different 3xFlag-KAT5 constructs 
followed by the immunoprecipitation of the Flag tag. (D) Immunoblot analysis of the KAT5 
immunoprecipitation. HEK293T cells were transfected with the Myc-KAT5 construct (450-513aa) 
followed by the immunoprecipitation of the Myc tag. WCE - whole cell extract. 
 
The C-terminal domain of FOXO3a is necessary to bind KAT5 
To further investigate nature of the interaction between FOXO3a and KAT5, I created five 
different Myc-tagged fragments of FOXO3a protein spanning its entire length (Figure 
32A). First, I performed an immunoprecipitation of fragments 1-3. I observed that KAT5 
was interacting specifically with the third fragment spanning the C-terminal part of 
FOXO3a (500-673aa)(Figure 32B). To determine the exact domain responsible for binding 
between KAT5 and FOXO3a, I immunoprecipitated Myc-FOXO3a fragments 3-5 
representing short fragments of the C-terminal part of FOXO3a. As shown in Figure 32C, 
after immunoprecipitation of these fragments, I detected a specific binding between KAT5 
and third and fourth Myc-FOXO3a fragments only, suggesting that the domain responsible 
for KAT5 binding lies between 620-650aa of FOXO3a. 
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Figure 32. The C-terminal domain of FOXO3a is necessary for KAT5 binding. (A) Cartoon 
representation of the generated Myc-FOXO3a fragments. (B) Immunoblot analysis of the FOXO3a 
immunoprecipitation. HEK293T cells were transfected with Flag-KAT5 and different Myc-FOXO3a 
constructs followed by the immunoprecipitation of the Myc tag. (C) Immunoblot analysis of the 
FOXO3a immunoprecipitation. HEK293T cells were transfected with the Flag-KAT5 construct and 
different Myc-FOXO3a constructs followed by the immunoprecipitation of the Myc tag. WCE - whole 
cell extract. 
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FOXO3a is necessary for KAT5 binding to ATM  
Next, I tested whether FOXO3a is necessary for the binding of KAT5 to ATM. To tackle 
this question, I used siRNA against FOXO3a (siFOXO3a) to knock down the expression of 
the FOXO3a protein and test its impact on the formation of the KAT5-ATM complex.  
First, I tested if I could detect an impairment of the DDR in siFOXO3a treated cells. As 
shown in the Figure 33A, upon knock down of the FOXO3a I could observe a partial but 
not full impairment of the ATM activation as judged by the decrease in its 
autophosphorylation (pATM) upon IR. Next, I performed an immunoprecipitation of 
endogenous KAT5 from cells treated or not with siRNAs against FOXO3a. I observed that, 
while I could coimmunoprecipitate ATM with KAT5 in cells treated with the control 
siRNA, the interaction between KAT5 and ATM was somehow decreased in siFOXO3a 
treated cells (Figure 33B). 
To strengthen this result, I preformed the same experiment in cells expressing Flag tagged 
KAT5. When I immunoprecipitated Flag tagged KAT5, I could observe the same partial 
impairment of the KAT5-ATM interactions as observed in the previous immuprecipitation 
with endogenous KAT5 (Figure 33C). 
These results show that FOXO3a is necessary for the KAT5 binding to ATM, although 
knockdown of FOXO3a leads only to a partial impairment of ATM-KAT5 interaction, 
which results also in a partial impairment of ATM activation in siFOXO3a-treated cells.  
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Figure 33. FOXO3a in necessary for KAT5 binding to ATM. (A) Immunoblot analysis of ATM 
activation. HeLa cells were transfected with siRNA against FOXO3a (siFOXO3a), exposed to IR 
(2G; 1h) and lysed. (B) Immunoblot analysis of KAT5 immunoprecipitation. HEK293T cells were 
transfected with siRNA against FOXO3a (siFOXO3a) and lysed, followed by immunoprecipitation of 
KAT5. (C) Immunoblot analysis of Flag immunoprecipitation. HEK293T cells were transfected with 
siRNA against FOXO3a (siFOXO3a) and Flag-KAT5 construct followed by immunoprecipitation of 
the Flag tag. WCE - whole cell extract. 
 
FOXO1 and FOXO4 can bind to ATM as well as to KAT5  
To understand why despite a substantial knock down of FOXO3a expression I could detect 
only a partial effect on ATM activation and ATM-KAT5 complex stability, I decided to 
investigate the potential redundancy mechanism among different members of the FOX-O 
family (for more details please see the “FOXO3a structure and regulation” chapter). 
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First, I compared the sequence of the C-terminal fragment of FOXO3a with other FOX-O 
family members (FOXO1 and FOXO4) (Figure 34A). As shown, I noticed some regions of 
the strong conservation between FOXO3a, FOXO1 and FOXO4. Therefore I decided to 
test if, like FOXO3a, FOXO1 and FOXO4 could bind to ATM and KAT5. 
 
 
Figure 34. FOXO3a is necessary for KAT5 binding to ATM. (A) Protein sequence alignment of 
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human FOXO3a, human FOXO4 and human FOXO1 as generated by Clustal X software. “*” - fully 
conserved residue. “:” - strongly similar properties of the residues. “.” - weakly similar properties of 
the residues (B) Immunoblot analysis of the FOXO1 immunoprecipitation. HEK293T cells were 
lysed, followed by the immunoprecipitation of FOXO1. (C) Immunoblot analysis of FOXO4 
immunoprecipitation. HEK293T cells were lysed, followed by immunoprecipitation of FOXO4. (D) 
Immunoblot analysis of the Flag immunoprecipitation. HEK293T cells were transfected with Flag-
KAT5 construct and lysed, followed by the immunoprecipitation of Flag tag. (E) Immunoblot 
analysis of the HEK293T cells treated with siFOXO3a. (F) GST pulldown experiment. 2842-3056aa 
GST-ATM fragment was incubated with recombinant KAT5 (recKAT5) and/or with recombinant 
FOXO3a (recFOXO3a). 
 
As shown in Figure 34B and C, immunoprecipitation experiments revealed that both 
FOXO1 as well as FOXO4 can form a protein complex with ATM. Next, I performed an 
immunoprecipitation of KAT5 (Flag-KAT5) and I observed that as in the case of ATM, 
FOXO1 and FOXO4 can interact with KAT5 too (Figure 34D). 
In addition, I performed analysis of the expression levels of each member of the FOX-O 
family in cells treated or not with siFOXO3a. As shown in Figure 34E, I observed a 
moderate increase in the expression of FOXO4 in siFOXO3a treated cells.  
Finally, following the realization that other FOX-O family proteins can bind to ATM and 
KAT5 and that FOXO4 is up-regulated in siFOXO3a treated cells, I decided to perform an 
in vitro binding assay in the absence of any redundant mechanism to test whether FOXO3a 
can mediate the interaction between ATM and KAT5. I thus performed GST pulldown 
experiments with the use of a 2842-3056aa GST-ATM fragment, recombinant KAT5 and 
recombinant FOXO3a. As shown in the immunoblot analysis of the material pulled down 
(Figure 34F), I could not detect any direct interaction between GST-ATM fragment and 
recombinant KAT5, which is in the agreement with the already published data (Sun et al., 
2010). However, in the presence of recombinant FOXO3a, binding between recombinant 
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KAT5 and GST-ATM fragment became robustly detectable, convincingly proving that 
FOXO3a mediates ATM-KAT5 interaction (Figure 34F). 
 
NOTCH1 impairs KAT5 binding to ATM  
In the previous set of results, in which I characterized the competition between NOTCH1 
and FOXO3a for the binding to the FATC domain of ATM, I showed that overexpression 
of NOTCH1 impairs the binding between FOXO3a and ATM (Figure 26). Therefore in the 
light of the results showing that FOXO3a forms a direct protein complex with KAT5 and it 
is necessary for KAT5-ATM association, I decided to test if the expression of NOTCH1 
can impact on the binding between ATM and KAT5.  
It has been reported that NOTCH1 can interact with KAT5 to repress NOTCH1 driven 
transcription of its target genes through KAT5 mediated acetylation (Kim et al., 2007a). 
Binding between NOTCH1 and KAT5 is mediated by Zinc finger and Aceltylo-CoA 
binding domains of KAT5 (between 158-395aa). Therefore to avoid the binding between 
NOTCH1 and KAT5, I decided to use a Myc-KAT5 construct expressing just the last 65aa 
of the KAT5 protein (Myc-KAT5 450-513aa). 
As shown in Figure 35, when I immunoprecipitated Myc-tagged KAT5 (450-513aa) I 
observed that NOTCH1 expression impairs the interaction between ATM and KAT5. 
Unexpectedly, I noticed that in addition to disrupting such interaction, NOTCH1 
expression also impaired the binding between KAT5 and FOXO3a (Figure 35). 
This result could arise from NOTCH1-mediated sequestration of either FOXO3a or KAT5. 
However, I had already showed that NOTCH1 does not interact with FOXO3a (Figure 26). 
I have also ruled out the possibility that NOTCH1 could sequester KAT5 since I used a C-
terminal fragment of KAT5, which should not form a binding with NOTCH1 according to 
the previously published study (Kim et al., 2007a). 
Therefore I concluded that observed reduction in the interaction between FOXO3a and 
KAT5 in cells expressing NOTCH1 is specific.  
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Figure 35. Expression of NOTCH1 impairs binding of KAT5 to ATM. Immunoblot analysis of 
the Myc tag immunoprecipitation. HEK293T cells were transfected with Myc-KAT5 (450-513aa) and 
N1ΔE-Flag constructs followed by the immunoprecipitation of Myc tag. WCE - whole cell extract. 
 
FOXO3a binding to ATM is necessary for the formation of FOXO3a-KAT5 protein 
complex 
I decided to further pursue the observation of the loss of interaction between KAT5 and 
FOXO3a in the presence of NOTCH1. 
Till now I have shown that KAT5, FOXO3a and ATM form a three proteins complex in 
which FOXO3a plays a role of a bridging protein between KAT5 and ATM. Furthermore, 
I showed that in the presence of NOTCH1, the interactions between ATM and FOXO3 as 
well as FOXO3a and KAT5 are impaired. Therefore I decided to investigate whether the 
interaction between FOXO3a and KAT5 is preserved or not in the absence of ATM 
(Figure 36A). 
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Figure 36. ATM is necessary for the formation of FOXO3a-KAT5 protein complex. (A) 
Cartoon model of the interactions between ATM/FOXO3a/KAT5 proteins. (1) Interactions between 
ATM, FOXO3a and KAT5 in the absence of NOTCH1; (2) Interactions between ATM, FOXO3a and 
KAT5 in the presence of NOTCH1; (3) Possible interactions between FOXO3a and KAT5 in the 
absence of ATM. (B) Immunoblot analysis of the Flag immunoprecipitation in WT or Atm knockout 
mESC cells. mESC cells were transfected with the Flag-KAT5 construct followed by the 
immunoprecipitation of the Flag tag. WCE - whole cell extract. 
 
I immunoprecipitated Flag-tagged KAT5 in wild type or Atm knockout mouse embryonic 
stem cells (mESCs). As shown in the Figure 36B, I was able to coimmunoprecipitate 
FOXO3a with KAT5 in the wild type mESCs, but the interaction between KAT5 and 
FOXO3a was lost in Atm knockout cells. 
These results, together with the previous immunoprecipitations experiments showing the 
disruption of FOXO3a-KAT5 interaction in the presence of NOTCH1, strongly suggest 
that the binding between KAT5 and FOXO3a is dependent on the formation of the three 
proteins complex with ATM. 
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Induction of FOXO3a nuclear localization sensitizes T-ALL cells to DNA damage-
induced cell death  
I have previously suggested a potential use of NOTCH1 inhibitors in combination with 
DNA damage inducing agents (IR) to sensitize NOTCH1-driven cancers to DNA damage-
induced cell death (Figure 21). 
Following the discovery of an ATM-FOXO3a-KAT5 three proteins complex, I decided to 
investigate the potential translational impact of these findings in the treatment of 
NOTCH1-driven cancers. I therefore decided to test the use of different drugs to induce 
FOXO3a nuclear localization, thus allowing it to increase the competition between 
FOXO3a and NOTCH1 for ATM binding leading to a more robust DDR activation in 
NOTCH1-driven cancers. 
As there are no drugs available to target specifically FOXO3a in the nucleus, I decided to 
act on the upstream signalling pathways that are involved in its nuclear localization. It has 
been shown that activation of AMPK kinase induces FOXO3a nuclear localization and 
activation of the DDR in a FOXO3a dependent manner (Hu et al., 2014). Additionally it 
has been reported that inhibition of the p38 kinase in cells not exposed to any stimuli 
increases nuclear FOXO3a accumulation (Chiacchiera et al., 2009). Therefore I decided to 
use Metformin, a widely used AMPK kinase activator, and SB203580, which inhibits p38 
kinase activity, in T-ALL cells to increase levels of FOXO3a in the nucleus. 
First, I tested if the treatment of TALL-1 cells with Metformin results in FOXO3a nuclear 
accumulation. This was studied by monitoring the changes in the expression of the 
FOXO3a target gene GADD45α. As shown in Figure 37A, I observed increased 
GADD45α expression in TALL-1 cells treated for 24h with 500µM dose of Metformin. 
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Figure 37. Metformin sensitize TALL-1 cells to DNA damage-induced cell death. (A) qRT-
PCR analysis of the GADD45α in TALL-1 cells treated with Metformin (MET). (B) Immunoblot 
analysis of the ATM activation (pATM). TALL-1 cells were pretreated with Metformin (MET) and 
exposed to IR (5G; 1h). (C) Quantification of the immunoblot shown in B. (D) Immunoblot analysis 
of DNA damage-induced cell death (cleaved CASPSE 3). TALL-1 cells were pretreated with 
Metformin (MET) and subjected to IR (10G). 
 
Next, I exposed to IR cells treated as above and I performed an immunoblot analysis of 
ATM activation (pATM). As shown in the Figure 37B and C, I observed an increase in 
ATM activation upon DNA damage in Metformin-treated cells as compared to MOCK-
treated ones. To investigate if the observed increase in DDR activation resulted in an 
increase of DNA damage-induced cell death, I measured the cleavage of the CASPASE3, a 
marker of apoptosis, in cells treated or not with Metformin followed by IR. As shown in 
the Figure 37D, Metformin-treated cells displayed a significant increase in CASPASE3 
cleavage as compared to control cells. 
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In another set of experiments I pretreated TALL-1 cells with the 10µM of SB203580 for 
24h. As in the case of Metformin I checked if the treatment with the SB203580 resulted in 
FOXO3a nuclear accumulation. As shown in the Figure 38A SB203580, pretreatment 
resulted in the increase in GADD45α transcription. Moreover I could detect an increase of 
ATM activation (pATM) in SB203580 pretreated cells upon exposure of those cells to IR 
Figure 38B and C. 
Next, I performed an analysis of the DNA damage-induced cell death (CASPASE3 
cleavage) in SB203580 pretreated cells. As shown in Figure 38D, cells treated with the 
SB203580 showed a striking increase in DNA damage-induced cell death as compared to 
untreated cells. To check if the observed cell death was restricted to ATM activation, I 
pretreated cells with an ATM inhibitor (ATMi). As shown by the immunoblot analysis 
(Figure 38E), treatment with the ATM inhibitor resulted in the complete loss of DNA 
damage-induced cell death in SB203580-treated cells, clearly demonstrating that the 
observed apoptosis was strictly ATM-dependent.  
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Figure 38. SB58023 sensitize TALL-1 cells to DNA damage. (A) qRT-PCR analysis of 
GADD45α in TALL-1 cells treated with SB203580 (SB). (B) Immunoblot analysis of ATM activation. 
TALL-1 cells were pretreated with SB203580 (SB) and exposed to irradiation (5G; 1h). (C) 
Quantification of the blot shown in B. (D) Immunoblot analysis of DNA damage-induced cell death. 
TALL-1 cells were pretreated with SB58023 (SB) and subjected to irradiation (10G). (E) 
Immunoblot analysis of DNA damage-induced cell death. TALL-1 cells were pretreated with 
SB203580 (SB) and ATM inhibitor (ATMi) and subjected to irradiation (10G). 
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NOTCH1 interacts with other PI3-like kinases 
I have previously shown that NOTCH1 interacts with ATM through the FATC domain of 
ATM. Other PI3K-like kinases involved in the DDR like ATR and DNA-PKcs posses 
similar domain structure (Figure 39A). It has been shown that FATC domains of PI3K-like 
kinases of ATM, ATR and DNA-PKcs are functionally equivalent and that the FATC 
domains of ATR and DNA-PKcs can functionally substitute for the FATC domain of ATM 
(Jiang et al., 2006). Therefore I decided to test if NOTCH1 can bind to ATR and DNA-
PKcs. 
I performed immunoprecipitation of NOTCH1 or DNA-PKcs in HEK293T cells 
expressing N1ΔE-Flag construct. As shown in (Figure 39B), I observed that NOTCH1 can 
form a protein complex with ATR and DNA-PKcs 
 
Figure 39. NOTCH1 forms a protein complex with DNA-PKcs and ATR kinases. (A) Cartoon 
depicting domain structure of the PI3K-like kinases (ATM, ATR and DNA-PKcs). (B) Immunoblot 
analysis of the DNA-PKcs or NOTCH1 immunoprecipitations. HEK293T cells were transfected with 
the N1ΔE-Flag construct followed by the immunoprecipitation of NOTCH1 or DNA-PKcs. WCE - 
whole cell extract. 
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NOTCH1 inhibits DNA-PKcs but not ATR kinase 
Due to the observed binding of NOTCH1 to ATR and DNA-PKcs kinases and the data 
showed above indicating that NOTCH1 inhibits ATM kinase activity, I tested whether 
NOTCH1 could inhibit ATR and DNA-PKcs kinases. 
For this purpose, I transfected HEK293T cells with a N1IC-GFP construct, FACS sorted 
GFP-positive cells and subjected them to IR, to test for DNA-PKcs and ATR activation, or 
UV light to test for ATR activation in the presence of NOTCH1. My immunoblot analyses 
revealed that in IR-treated cells NOTCH1 could dramatically inhibit the activation of ATR 
kinase functions as judged by the reduction of ATR-mediated phosphorylation of CHK1 
kinase at Serine 345 and Serine 317 (Figure 40). Similarly DNA-PKcs kinase activity was 
strongly reduced in NOTCH1 expressing cells exposed to IR as evaluated by the reduction 
in DNA-PKcs autophosphorylation at Serine 2056 (Figure 40), which is an exclusively 
DNA-PKcs target phosphorylation site (Uematsu et al., 2007). The reduction of 
phosphorylation of DNA-PKcs at the T2609 and T2647 sites observed in NOTCH1 
expressing cells (Figure 40), can be attributed to the reduction in ATM kinase activity, 
since it has been shown that these sites are phosphorylated by ATM (Uematsu et al., 2007). 
Surprisingly, I did not observe any significant difference in ATR-dependent 
phosphorylation of CHK1 kinase at Serine 345 and Serine 317 upon UV light treatment of 
NOTCH-expressing cells (Figure 40). These results are consistent with those showing that 
ATR activation upon treatment with IR is dependent on ATM activation and resection at 
DNA damage sites (Jazayeri et al., 2006). Therefore my results indicate that ATR kinase 
activity is not affected by NOTCH1 expression and lack of ATR activation upon treatment 
with IR is the result of NOTCH1-meditaed ATM inhibition. Differently, the kinase  
activity of DNA-PKcs seams to be affected by NOTCH1 expression.  
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Figure 40. NOTCH1 inhibits kinase activity of the DNA-PKcs but not ATR kinase. Immunoblot 
analysis of the DNA-PKcs and ATR kinases activation upon treatment with IR or UV light. 
HEK293T cells were transfected with N1IC-GFP, FACS sorted for GFP positive cells and exposed 
to IR or UV light and collected 1h afterward. 
 
NOTCH1 dose not inhibit repair of DSBs 
DNA-PKcs has been shown to be a key kinase involved in DNA damage repair by non 
homologus end joining. 
The data shown above indicate that NOTCH1 impacts on DNA-PKcs transphosphorylation 
and autophosphorylation upon DSBs induction. To test if NOTCH1 can influence the 
function of DNA-PKcs in DNA damage repair, I decided to perform a repair assay in cells 
expressing NOTCH1 in the presence or absence of the DNA-PKcs inhibitor (DNA-PKcsi). 
I thus studied over time the kinetics of phosphorylation of the histone H2AX upon DNA 
damage that has been shown to be a specific marker of DSBs accumulation.  
As shown in Figure 41, consistently with previous results, I observed an induction of the 
phosphorylation of histone H2AX upon IR, both in the MOCK as well as NOTCH1 (N1Δ
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E) transfected cells (1h time point). With time, DNA damage was detectably being 
repaired as judged by the decrease of the phosphorylation of histone H2AX (8h time 
point)(Figure 41). Such decrease was the result of DNA repair as cells treatment with 
DNA-PKcsi prevented such a decrease (Figure 41). Unexpectedly I could not observe any 
strong differences in the decrease of histone H2AX phosphorylation between NOTCH1 
and MOCK transfected cells, showing that NOTCH1 does not significantly impact on the 
repair of DNA DSBs, at least as judge by the assay so far employed (Figure 41).  
 
 
Figure 41. NOTCH1 does not inhibit DNA damage repair. Immunofluorescence analysis of 
histone H2AX phosphorylation on Serine 139 upon IR (2G) at the indicated time points in U2OS 
cells transfected with NOTCH1 (N1ΔE-Flag) and treated with DNA-PKcs inhibitor (DNA-PKcsi). 
MOCK - mock transfected cells. 
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Impact of NOTCH1 on ATM activation and its substrate specificity 
Despite intense efforts starting from the time of ATM discovery, over twenty years ago, 
the full mechanism behind ATM activation remains unknown (Savitsky et al., 1995). This 
lack of a clear vision over the processes governing ATM activation does not allow to 
pinpoint the individual contributions of different factors in the regulation of DDR 
activation. 
In this part of my thesis, I will discus how my results fit in the context of published 
literature in regard to the mechanisms regulating ATM activation. 
 
NOTCH1 and recruitment of ATM to the DSBs 
FATC domain is positioned at the very C-terminal end of ATM (between 3023-3056aa). It 
has also been shown that NBS1 binds to the N-terminal part of ATM, between 250-522aa 
(Pessina and Lowndes, 2014; You et al., 2005). Although ATM is a large protein, the 
recently published structures of ATM monomer and dimer indicate that FATC domain is in 
physical proximity to the N-terminal part of ATM (Lau et al., 2016). Moreover, it has been 
shown that mutations in the FATC domain of Tel1 (yeast ortholog of ATM) results in the 
perturbation of the binding of Xrs2 (yeast ortholog of NBS1) to ATM, which ultimately 
results in the impaired recruitment of Tel1 to DSB (Ogi et al., 2015). My results indicate 
that NOTCH1 directly binds to the FATC domain of ATM. I additionally observed that 
formation of the protein complex between ATM and NOTCH1 does not affect the 
interaction between ATM and NBS1. Moreover, NOTCH1 binding to the FATC domain of 
ATM does not perturb the accumulation of ATM at DSBs. This suggests that NOTCH1, 
despite binding to the FATC domain of ATM, does not impair the interaction of ATM with 
other proteins like NBS1 through its N-terminal part. It is worth noting that not all of Tel1 
FATC mutants in the study quoted above (Ogi et al., 2015) impaired Tel1 interaction with 
Xrs2, or Tel1 recruitment to the DSBs. 
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ATM autophosphorylation. What is its role?  
ATM kinase has been shown to phosphorylate itself more then a decade ago (Kim et al., 
1999). So far many autophosphorylation sites of ATM have been discovered and shown to 
be the result of ATM activation upon DNA damage (Kozlov et al., 2006; Matsuoka et al., 
2007). ATM autophosphorylation at Serine 1981, has been shown to be necessary for the 
first step of ATM activation, which is dissociation of an inactive ATM dimer into an active 
monomer in a process of transphosphorylation (Bakkenist and Kastan, 2003). Moreover, it 
was shown that expression of S1981A ATM mutant of in A-T cells did not restore the full 
ATM activity as compared to wild type ATM (Bakkenist and Kastan, 2003). I observed 
that NOTCH1 blocks ATM autophosphorylation at Serine 1981 (from now on referred as 
ATM autophosporylation), which results in the inhibition of ATM kinase activity, as 
judged by the decrease in phosphorylation of many ATM substrates. Thus, my observation 
of NOTCH1-mediated inhibition of ATM autophosphorylation and ATM kinase activity is 
consistent with the literature cited above. 
Unexpectedly, a seemingly contradictory set of results showed that mice and cells carrying 
an S1987A mutation in Atm (equivalent to human S1981A mutation) display normal 
unaffected DNA damage response and ATM kinase function both in vitro as well as in vivo 
(Pellegrini et al., 2006). Apart from Serine 1987, also other autophosphorylation sites 
(Serine 367 and 1893) have been shown to be dispensable for ATM activation upon DNA 
damage (Daniel et al., 2008). Therefore, to determine whether NOTCH1 mediated 
inhibition of ATM autophosphorylation results from the inhibition of ATM kinase activity 
or vice versa, I performed an ATM in vitro kinase assay, which demonstrated a NOTCH1-
mediated inhibition of the ATM kinase. It has been published that ATM mutant (S1981A) 
was able to phosphorylate p53 as well as CHK2 in vitro upon stimulation with linear 
double-stranded DNA (Lee and Paull, 2005). As I performed an ATM in vitro kinase assay 
with the use of immunopurified ATM, I could exclude any involvement of ATM 
autophosphorylation in the process of ATM kinase activation, since the anti ATM antibody 
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that I used for ATM purification was masking ATM autophosphorylation site, suggesting 
that NOTCH1-mediated inhibition of ATM kinase is direct and it is not connected with 
ATM autophosphorylation. 
It has been reported that lack of ATM autophosphorylation results in a decrease of ATM 
retention at DSBs (1h after DNA damage)(So et al., 2009), without affecting ATM primary 
recruitment (up to 10 minutes after DNA damage)(So et al., 2009). I have observed that 
NOTCH1 despite blocking ATM autophosphorylation, does not block ATM recruitment to 
DSB and its retention (up to 1h after DNA damage induction). The differences between my 
observations and the report mentioned above may arise from different experimental setups. 
I studied recruitment of ATM in a complex with NOTCH1 that inhibits ATM kinase 
activity. Differently, in this report (So et al., 2009) the authors used ATM knockout cells 
that were stably expressing YFP tagged ATM or YFP-ATM carrying a point mutation 
(S1981A) (So et al., 2009). Therefore it would be best to compare recruitment of ATM-
NOTCH1 complex with the recruitment of catalytically inactive ATM. Few years ago, two 
studies investigating DNA damage response in cells expressing kinase dead ATM mutant 
have been published (Daniel et al., 2012; Yamamoto et al., 2012). Here the authors showed 
that catalytically inactive ATM, although not able to autophosphorylate itself, was 
efficiently recruited to the DSBs (Daniel et al., 2012; Yamamoto et al., 2012). Additionally 
it has been reported that in the absence of KU70 and MRE11 activity, although ATM 
autophosphorylation upon DNA damage was perturbed, ATM protein was still efficiently 
recruited to DSBs (Hartlerode et al., 2015).  
Hence, it is clear that ATM autophosphorylation and its recruitment to DSBs is 
differentially regulated as shown by my results and others’. It is an exciting area of 
research that needs further investigation.  
 
	   125	  
Impact of NOTCH1 binding to the FATC domain of ATM on its substrate 
recognition  
One of the recently suggested roles of ATM FATC domain is its participation in ATM 
substrate recognition. Indeed, when mutations were introduced in the FATC domain of 
Tel1 kinase, its ability to phosphorylate its main substrate Rad53 (yeast ortholog of the 
CHK2 kinase) was significantly reduced without any impact on Tel1 autophosphorylation 
(Ogi et al., 2015). Is it possible that the observed reduction in ATM autophosphorylation 
and phosphorylation of its substrates in NOTCH1 expressing cells is the result of impaired 
ATM substrate recognition rather than impaired ATM kinase activity? In my work I 
showed that NOTCH1-mediated inhibition of ATM kinase activity is specific and directly 
mediated by NOTCH1 binding to the FATC domain of ATM. I have shown that 
phosphorylation of a broad spectrum of ATM substrates like CHK2, SMC1, KAP1, p53, 
DNA-PKcs and ATM itself are affected by NOTCH1 binding to ATM. Moreover, in our 
laboratory we have performed an in vitro ATM kinase assay in Xenopus laevis egg extract, 
in which we detected by immunoblot analysis a striking reduction in ATM-mediated 
phosphorylation of tens of ATM substrates (detected by pS/TQ antibody that detects 
ATM-mediated phosphorylations)(Vermezovic et al., 2015). In addition, we showed that 
NOTCH1-mediated ATM inactivation results in checkpoint inactivation, which is a 
functional readout of ATM activation (Vermezovic et al., 2015). Despite all of these 
results indicating that inhibition of phosphorylation of ATM substrates in NOTCH1 
expressing cells is the result of inhibition of ATM kinase activity, one observation stood 
out: phosphorylation of histone H2AX at Serine 139 (γH2AX), which was not affected by 
NOTCH1 expression. A separate chapter in this Discussion has been devoted to this 
observation (see chapter below).  
In regard to the possible involvement of ATM FATC domain in ATM substrate 
recognition it has been reported that an ATM mutant, missing the last 10aa of FATC 
domain, shows reduced ability to phosphorylate its substrates (Banin et al., 1998). It was 
	  126	  
reported that the interaction of ATM with MRN complex enhances ATM substrate 
recognition and thus their phosphorylation (Lee and Paull, 2004), which together with 
previously mentioned report showing the importance of FATC domain in Tel1-Xrs2 
interaction (Ogi et al., 2015) suggests that the FATC domain through its ability to regulate 
ATM-MRN interaction can impact on ATM substrate recognition. Additionally, it has 
been shown that lack of FATC domain impairs ATM activation upon oxidative stress in an 
MRN independent manner, indicating that the FATC domain under these conditions is 
necessary for ATM substrate recognition (Guo et al., 2010). Despite all of the data 
implicating FATC domain in ATM substrate recognition, in my studies I did not observe 
any impact of NOTCH1 on the ATM-MRN interaction and MRN mediated ATM 
recruitment. This suggests that if NOTCH1 impacts on ATM substrate recognition it is not 
through its impact on the interaction between MRN complex and ATM, but rather through 
the MRN-independent FATC domain substrate recognition function, like the one reported 
by Guo et al. (Guo et al., 2010). 
 
NOTCH1 does not affect phosphorylation of histone H2AX 
As shown in this thesis, I have observed that NOTCH1 blocks ATM kinase activation. 
This conclusion is based on the observed reduction of ATM autophosphorylation. Upon 
autophosphorylation, ATM mediates phosphorylation of its substrates on Serine (Ser) or 
Threonine (T) residues (Kim et al., 1999). Many of ATM phosphorylation sites have been 
identified: T68CHK2, Ser139H2AX, Ser824KAP1, T2647DNA-PKcs, T2609DNA-PKcs, 
Ser15p53 or Ser966SMC1. I observed that NOTCH1 was able to inhibit ATM-mediated 
phosphorylation of CHK2, KAP1, DNA-PKcs, p53 and SMC1 but not phosphorylation of 
H2AX. This result may seem unexpected considering that phosphorylation of H2AX by 
ATM has been described as one of the most important steps of DDR activation necessary 
for further accumulation and recruitment of secondary response proteins like 53BP1 and 
MDC1 (Kleiner et al., 2015; Stucki et al., 2005). Lack of the impact of NOTCH1 on 
	   127	  
H2AX phosphorylation might result from the redundancy among PI3K-like kinases, since 
DNA-PKcs, like ATM, has been described to phosphorylate H2AX in response to DNA 
damage (Stiff et al., 2004). Additionally, it has been shown that in ATM knockout cells 
H2AX can be phosphorylated to an extent observed in ATM proficient cells (Riballo et al., 
2004). NOTCH1 expressing cells, which were additionally treated with a DNA-PKcs 
inhibitor and exposed to IR, did not show reduced levels of H2AX phosphorylation (data 
not shown). This result differs from the one described by Stiff and colleagues (Stiff et al., 
2004), who reported that in the absence of ATM and DNA-PKcs, phosphorylation of 
H2AX is perturbed. 
It is possible that phosphorylation of H2AX upon DNA damage in NOTCH1 expressing 
cells might be mediated by other kinases that do not belong to the PI3K-like kinase family. 
Indeed, it has been reported that other protein kinases, like JNK1 and p38 can 
phosphorylate H2AX under stress conditions like UV light irradiation or serum starvation 
(Lu et al., 2008; Lu et al., 2006), Additionally it has been recently reported that VRK1 
kinase (Vaccinia related kinase 1) can phosphorylate H2AX upon DNA damage induction 
(Salzano et al., 2015). VRK1 has been previously shown to be necessary for accumulation 
and activation of DDR factors at DSBs (Sanz-García et al., 2012). Now, it has been 
reported that it can phosphorylate H2AX upon DSB formation parallel to ATM kinase. 
Moreover, it has been shown that inhibition of both kinases (ATM and VRK1) has an 
additive effect on H2AX phosphorylation (Salzano et al., 2015). 
 
NOTCH1, KAT5, ATM acetylation and its monomerization 
Monomerization of ATM kinase is a key step in its activation. This process is preceded by 
KAT5-mediated acetylation that is followed by ATM autophosphorylation (Bakkenist and 
Kastan, 2003; Sun et al., 2005). It has been shown that ATM mutants that are unable to 
undergo KAT5-mediated acetylation can neither undergo autophosphorylation nor 
dissociate from a dimer state upon DNA damage (Sun et al., 2005). Moreover authors of 
	  128	  
this report observed that catalytically inactive ATM despite KAT5-mediated acetylation 
remains in its dimer state (Sun et al., 2005).  
In my work, I suggest that NOTCH1 blocks KAT5-mediated ATM acetylation, as I 
observed that NOTCH1 binding to ATM results in displacement of KAT5 from ATM. 
Although I have never performed an experiment to test whether NOTCH1 blocks ATM 
acetylation, it has been reported that impairment of the binding between KAT5 and ATM 
results in a lack of KAT5-medited ATM acetylation (Sun et al., 2005). This rises a 
question, why would NOTCH1 impair ATM acetylation when it is already blocking its 
kinase activity? It is possible that KAT5-mediated ATM acetylation may impact on the 
ability of ATM to recognize itself as a substrate and undergo autophosphorylation. 
Although NOTCH1 displaces KAT5 from its complex with ATM, it is necessary to 
mention that KAT5 has been shown to interact directly with NOTCH1 by binding (like 
ATM) to its Ankyrin repeats (Kim et al., 2007a). As a result, it is possible that ATM that is 
in a complex with NOTCH1 is still in a complex with KAT5, which instead of FOXO3a 
binds to ATM through NOTCH1. Therefore, performing additional experiments aimed at 
understanding the impact of NOTCH1 on ATM acetylation and monomerizarion upon 
DNA damage would clarify the mechanisms of NOTCH1-mediated ATM inactivation. 	  
FOXO3a binding domain of ATM 
It has been shown that FOXO3a interacts with ATM upon DNA damage induction (Tsai et 
al., 2008). I my experiments I showed that the formation of the protein complex between 
FOXO3a and ATM is independent from the presence of DNA damage. Although this 
observation differs from previously reported ones (Chung et al., 2012a; Tsai et al., 2008), it 
has to be stressed that in those studies authors in their immunoprecipitation experiments 
have always used an antibody against the phosphorylated form of ATM (Serine 1981), 
which did not bring down ATM in cells not exposed to DNA damage, as expected. 
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In the same study, it has been shown that FOXO3a binds to ATM within a domain 
spanning 1764-2841aa (Tsai et al., 2008). Though I observed some binding of FOXO3a in 
this region, I have detected a stronger binding with the use of the GST-ATM 2842-3056aa 
fragment. It is necessary to mention that for unknown reasons this particular GST-ATM 
fragment has not been tested in the report of Tsai et al. (Tsai et al., 2008). It is possible that 
such binding of FOXO3a to the 1764-2841aa region of ATM is the result of some non-
specific binding of GST-ATM fragments, as I have observed some binding to this region 
also with FOXO3a or NOTCH1 (Vermezovic et al., 2015). This observation (interaction 
between FOXO3a and 1764-2841aa ATM region) can also be explained by the ability of 
ATM to form a homodimer (Bakkenist and Kastan, 2003). It has been shown that an ATM 
fragment containing kinase domain, can interact directly with the unphosphorylated ATM 
fragment containing ATM autophosphorylation site at Serine 1981, exactly like GST-ATM 
1764-2138aa fragment with which the biggest FOXO3a-ATM interaction was observed 
(Tsai et al., 2008). Therefore it is possible that binding between 1764-2138aa GST-ATM 
fragment and FOXO3a reported by Tsai et al., is the result of the formation of a protein 
complex between GST-ATM fragment and endogenous ATM-FOXO3a complex. In 
addition to the results obtained with the use of GST-ATM fragments while determining 
ATMs FOXO3a binding domain, to prove the involvement of FATC domain in FOXO3a 
binding, I showed that ATM lacking FATC domain loses its ability to bind FOXO3a. In 
my opinion this set of results clarifies the domains of ATM involved in its interaction with 
FOXO3a. 
Additionally, it is necessary to stress that it is not possible to exclude that the ATM region 
between 1764-2138aa contributes or stabilizes ATM-FOXO3a binding once created. For 
this purpose further experiments should be performed with the use of ATM mutants 
missing both FATC domain as well as 1764-2138aa region. 
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FOXO3a and the ATM-KAT5 interaction 
In the initial report characterizing FOXO3a as a factor necessary for ATM activation upon 
DNA damage, an exact mechanism of FOXO3a-mediated ATM activation has not been 
elucidated (Tsai et al., 2008). I observed that FOXO3a impacts on ATM activation by 
bridging KAT5 binding to ATM. An interaction between KAT5 and ATM had been 
previously characterized (Sun et al., 2005). KAT5 has been reported to bind to the FATC 
domain of ATM, which is necessary for KAT5-mediated ATM acetylation (Jiang et al., 
2006). Authors admitted that it was impossible to observe a direct interaction between 
ATM and KAT5 (Sun et al., 2010). Additionally, KAT5 has been shown to interact with 
ATM both in the presence and absence of DNA damage and that entire nuclear amount of 
ATM was in the complex with KAT5 (Sun et al., 2005). 
Consistently with those studies, I have observed that FOXO3a as KAT5 binds specifically 
to the FATC domain of ATM but unlike KAT5, such binding is direct. Furthermore, the 
interaction between ATM and FOXO3a displayed features similar to ATM-KAT5 binding: 
the interaction was independent from DNA damage and the entire nuclear ATM was in a 
complex with FOXO3a but not all of FOXO3a was in a complex with ATM. This led me 
to the discovery that KAT5 interacts directly with FOXO3a. Although it was shown that 
some members of FOX family like FOXP3 and FOXR1 are able to interact with KAT5 (Li 
et al., 2007; Li et al., 2015), this ability has never been described for FOXO3a. 
Additionally, I have shown that the interaction between KAT5 and FOXO3a, like ATM-
KAT5 and ATM-FOXO3a interactions, takes place independently from DNA damage.  
To understand whether FOXO3a can mediate the interaction between ATM and KAT5, I 
studied the domains involved in binding between ATM, FOXO3a and KAT5. KAT5 was 
binding to both FOXO3a and ATM through the domain located at its C-terminal part (450-
513aa), which suggested that KAT5 could not interact directly at the same time with ATM 
and FOXO3a. Furthermore, I observed that FOXO3a interacted with KAT5 through a 
domain located in its C-terminal fragment, between 620-650aa. At the same time I could 
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not detect any interaction between this FOXO3a fragment and ATM (data not shown). 
Consistently, FOXO3a domain necessary for interaction with ATM was characterized to 
be located between 618-625aa of FOXO3a (Tsai et al., 2008). Hence, those results suggest 
that FOXO3a can at the same time interact with ATM and KAT5, supporting a role of 
FOXO3a as protein bridging ATM-KAT5 interaction. 
I have performed an immunoprecipitation of KAT5 in cells knockdown for FOXO3a. 
However, I have repeatedly observed only a partial reduction of the interaction between 
ATM and KAT5, despite a significant reduction of FOXO3a protein levels. This 
observation led me to the discovery that also other FOX-O family members, like FOXO1 
and FOXO4, which share the conserved C-terminal structure with FOXO3a, display the 
ability to bind to KAT5. FOXO1 has been already reported to form a protein complex with 
ATM (Tsai et al., 2008). Additionally, it is possible that other FOX family members that 
were already characterized to interact with KAT5 (FOXP3; FOXR1) could bridge binding 
between ATM and KAT5. Finally, it is probable that even small levels of FOXO3a protein 
are sufficient for ATM activation, as I have observed that only a fraction of FOXO3a is in 
a complex with ATM. 
 
RAM and Ankyrin repeats. NOTCH1 or something more?  
I have observed that NOTCH1 interacts with ATM through its FATC domain. On the other 
hand, the domain of NOTCH1 I identified as necessary for ATM binding is the Ankyrin 
repeats domain. Unexpectedly, upon deletion of Ankyrin repeats, although I observed a 
decrease in the binding between ATM and NOTCH1, such reduction was partial. This 
result was consistent with a partial rescue of ATM activation by NOTCH1 Ankyrin repeats 
mutant as compared to wild type NOTCH1.  
NOTCH1 has a complex structure with many domains that participate in the formation of 
transcriptionally active complex (for more details please see “Structure of the mammalian 
NOTCH receptors” chapter of introduction). It has been reported that both RAM and 
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Ankyrin repeats domains of NOTCH1 participate in formation of NOTCH1 transcription 
initiation complex through their interaction with CBF1 (Fortini and Artavanis-Tsakonas, 
1994; Tamura et al., 1995). Thus, partial reduction of binding between ATM and Ankyrin 
repeats mutant of NOTCH1 might result from the presence of the RAM domain. It would 
be interesting to test whether the RAM domain contributes to the binding of NOTCH1 to 
ATM, as this information would be important for designing drugs targeting ATM-
NOTCH1 interaction. 
My results indicate that Ankyrin repeats probably together with the RAM domain are 
mediating NOTCH1 binding to ATM. Is it therefore possible that other proteins, which 
contain Ankyrin repeats or RAM domains interact with ATM? Indeed other Notch family 
members like NOTCH2, NOTCH3 and NOTCH4 possess Ankyrin repeats as well as RAM 
domain. I have never assessed if other Notch receptors can impact on DDR or form a 
protein complex with ATM. Thus, it is possible to conclude that NOTCH2, NOTCH3 as 
well as NOTCH4 receptors might indeed interact with ATM. Additionally, it would be 
interesting to investigate whether each of Notch receptors affect ATM activity in exactly 
the same way as NOTCH1, or differently.  
It is entirely possible that in case of NOTCH4 receptor, which much smaller in size as 
compared to NOTCH1, the effect on ATM kinase activity would be different. As I have 
discussed before, it is possible that if NOTCH1 binding to ATM affects ATM substrate 
recognition, binding of protein/s of a different structure/size could affect ATM substrate 
recognition in a different way/manner as compared to NOTCH1. Indeed in case of Notch 
receptors this kind of DDR regulation could be additionally connected to their primary role 
as transmembrane receptors, transmitting signals from environment to the nucleus.  
 
Is there more then one ATM complex? 
It has been recently reported that ATM kinase is involved in the process of peroxisome 
autophagy (pexophagy)(Zhang et al., 2015). In this study authors have reported that ATM 
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can localize at peroxisomes. Recruitment of ATM to the outer membrane of peroxisomes 
is mediated by a newly discovered ATM interactor, peroxisomal biogenesis factor 5 
(PEX5)(Zhang et al., 2015). It is important to mention that although PEX5 has been 
initially characterized to bind FATC domain due to the lack of ATM-PEX5 interaction in 
the FATC domain point mutant, it is still possible that PEX5 might be binding to N-
terminal part of ATM (for more details please see “NOTCH1 and the ATM recruitment to 
the DSBs” chapter of discussion). Described above by Zhang et al. study provides new 
insight in ATM kinase biology, which till now was mainly focused around ATM 
involvement in the DDR.  
PI3K-like kinases show many similarities, which are connected with their conserved 
structure, but also with their coactivators. ATM, ATR, DNA-PKcs and mTOR have been 
characterized to interact with their main coativators: MRN complex, PEX5, ATRIP, 
KU70/80, RICTOR and RAPTOR, through their N-terminal part (Ball et al., 2005; Davis 
et al., 2013; Watanabe et al., 2011; You et al., 2005). It has been recently described that 
binding of RICTOR, but not RAPTOR to mTOR kinase stimulates its newly discovered 
Tyrosine kinase activity (Wang and Proud, 2016; Yin et al., 2016). Thus, it is possible that 
due to structural proximity between FATC domain and N-terminal part of PI3K-like 
kinases, proteins binding to the N-terminal end of PI3K-like kinases may impact not only 
on the substrate recognition of PI3K-like kinases (like MRN in case of ATM) but also on 
their kinase activity (like RICTOR in case of mTOR).  
Consequently, as explained above, ATM can form different protein complexes: with MRN 
complex as well as with PEX5 (ATM complex 1 and 2 respectively (ATMC1 and 
ATMC2))(Figure 42). Thus, it is possible that due to an involvement of different proteins 
in the formation of ATM complexes, each ATM complex might be characterized by a 
different substrate recognition as well as kinase activity, like the one described for 
mTORC2 (Wang and Proud, 2016; Yin et al., 2016)  
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It is necessary to mention that ATM has been already characterized to exist in two different 
complexes in the nucleus. It has been reported that there is an active competition between 
MRN complex and ATM interacting protein (ATMIN) for the binding to ATM (Zhang et 
al., 2014; Zhang et al., 2012). Competition between those two factors regulates ATM 
activity in response to different stimuli: MRN - double strand breaks, ATMIN - oxidative 
and hypotonic stresses (Kanu and Behrens, 2007; Kanu et al., 2010). This suggests that 
even within one possible ATM complex, competition between ATM coactivators may 
control its function and activity.  
It would be interesting to investigate whether NOTCH1, which can affect the activation of 
ATM in a complex with MRN, can also perturb the activation of a different ATM 
complexes, like the one with ATMIN or PEX5. It is thought-provoking to describe ATM 
kinase as part of functionally different complexes, knowing that each of complexes might 
regulate ATM activity in a different way. Hence, I reckon that we should reconsider our 
knowledge in regard to ATM kinase activity. ATM may not be only phosphorylating its 
substrates on Serine and Threonine resides as previously established (Kim et al., 1999), but 
maybe also on Tyrosine ones. Based on above mentioned reports and discussion about 
ATM protein complexes, I have depicted below three possible ATM complexes, although 
it cannot be excluded that they may be even more (Figure 42). 
In my work I have described that NOTCH1 blocks ATM kinase activity by inhibiting the 
formation of a three-protein complex with FOXO3a and KAT5. Moreover, I have showed 
that NOTCH1 possesses higher affinity for ATM binding then FOXO3a. It would be 
tempting to investigate whether NOTCH1 could impact on other ATM complexes, 
allowing for a distinction between different ATM complexes, their substrate recognition 
and functions. Thus, NOTCH1 might appear as an attractive tool to study possible 
differences in the activities of ATM complexes.  
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Figure 42. Scheme of the potential ATM complexes. ATMC1 - the most well described ATM 
complex involved in DNA damage response/hypotonic stress. ATMC2 - recently described ATM 
complex involved in the pexophagy. ATMC3 - ATM complex yet to be described. 	  
How does NOTCH1 impact on DNA damage repair? 
I have observed that besides ATM, NOTCH1 can bind to other PI3K-like kinases: ATR 
and DNA-PKcs. My analysis of ATR and DNA-PKcs kinase activities has showed that 
NOTCH1 was not able to inhibit ATR activation upon UV light irradiation. On the other 
hand, I have observed a dramatic decrease of ATM-mediated transphosphorylation of 
DNA-PKcs as well as DNA-PKcs autophosphorylation in NOTCH1 expressing cells. This 
observation was in contrast with the lack of an impact of NOTCH1 on DNA damage 
repair, which unexpectedly was virtually unaffected. 
It has been reported that ATM-mediated transphosphorylation of DNA-PKcs is necessary 
for DNA-PKcs-mediated repair (Cui et al., 2005), as its inhibition may result in problems 
with DNA ends processing as well as dissociation of DNA-PKcs from DSBs, blocking 
access to XRCC4-LIGASE4 complex to DNA ends (Cui et al., 2005; Jiang et al., 2015; 
Uematsu et al., 2007). Therefore my results are in line with reports quoted above. More 
strikingly, lack of DNA-PKcs autophosphorylation (Serine 2056), which indicates 
perturbation in DNA-PKcs kinase activity, contradicts studies showing that cells 
expressing catalytically inactive DNA-PKcs kinase exhibit impairment in DSBs repair 
(Jiang et al., 2015; Kurimasa et al., 1999). 
FOXO3a!
KAT
5!
ATM !
Ac! MRN!
ATM complex 1!
(ATMC1)!
?! ATM !
Ac! PEX5!
ATM complex 2!
(ATMC2)!
?!
?!
ATM !
Ac! ?!
ATM complex 3!
(ATMC3)!
DNA Damage Response/
Hypotonic stress!
Pexophagy! Unknown processes!
?!FOXO3a!
KAT
5!
ATM !
Ac! ATMIN!
	  136	  
To understand this conundrum, it is necessary to stress that in the presence of NOTCH1 
and a specific small molecule DNA-PKcs inhibitor, I have observed an inhibition of DNA 
damage repair. This directly shows that NOTCH1 is not inhibiting DNA-PKcs kinase 
activity, but rather just its autophosphorylation. Additionally levels of DNA damage repair 
inhibition by DNA-PKcs inhibitor were moderately increased in NOTCH1 expressing cells 
as compared to MOCK transfected cells. Thus, it seems that NOTCH1 does not inhibit 
DNA-PKcs kinase activity and therefore DNA damage repair, in agreement with published 
studies.  
An explanation for these opposing results of DNA damage repair assay and inhibition of 
DNA-PKcs autophosphorylation may be related to the impact of NOTCH1 on ATM 
substrate recognition. We can speculate that NOTCH1 does not inhibit DNA-PKcs kinase 
activity but, rather, its substrate recognition that would result in an inability of DNA-PKcs 
to autophosphorylate itself, while at the same time being able to recognize and 
phosphorylate other substrates necessary for DNA damage repair. If correct, this is an 
exciting result showing that not all of DNA-PKcs dependent phosphorylations are 
necessary for DNA damage repair, something which has been already proven for some of 
DNA-PKcs substrates like: XRCC4, LIGASE IV, ARTEMIS (Goodarzi et al., 2006; 
Sharma et al., 2016; Wang et al., 2004) or KU70/80 heterodimer (Douglas et al., 2005). 
More importantly, NOTCH1-mediated impairment of DNA-PKcs substrate recognition, 
would allow researchers to investigate the difference between DNA-PKcs substrates 
phosphorylation in the presence or absence of NOTCH1 to identify the most critical targets 
of DNA-PKcs, necessary for DNA damage repair. 
What is the difference between ATM and DNA-PKcs that allows DNA-PKcs to preserve 
its critical activity and facilitate DNA damage repair as compared to ATM? Although it 
has been shown that DNA-PKcs and ATM share the same domain structure, both proteins 
differ dramatically in size (ATM - 3056aa; DNA-PKcs - 4128aa)(Paull, 2015). This results 
in much bigger length of DNA-PKcs domains as compered to ATM (52aa difference for 
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FAT domain and 102aa difference for kinase domain) with the exception of the FATC 
domain (33aa each protein). This could explain a similar NOTCH1 binding ability toward 
both kinases. It is possible that the bigger size of DNA-PKcs FAT and kinase domains may 
result in a milder effect of NOTCH1 on its substrate recognition abilities as compered to 
ATM.  
Another possible explanation for the differential effect of NOTCH1 on ATM and DNA-
PKcs activities might be connected with the processes that lead to ATM and DNA-PKcs 
activation. The observed differences in NOTCH1-mediated inhibition of ATM and DNA-
PKcs may arise from their different mechanisms of activation upon DNA damage. ATM in 
a process of activation undergoes acetylation followed by its autophosphorylation and 
monomerization (Bakkenist and Kastan, 2003; Sun et al., 2005). Differently, DNA-PKcs in 
response to DNA damage first forms a heterodimer with KU70/80 subunits and later a 
synapsis at the DNA ends with another DNA-PKcs- KU70/80 heterodimer (Spagnolo et 
al., 2006). Therefore if NOTCH1 inhibits ATM activation by blocking its monomerization 
mediated by KAT5 acetylation (Sun et al., 2005), maybe in the case of DNA-PKcs this 
form of inhibition does not occur. 
I have observed that NOTCH1 displaces KAT5 from FATC domain of ATM. It has been 
reported that FATC domains of ATM, ATR and DNA-PKcs are functionally equivalent 
(Jiang et al., 2006). Therefore it is possible that NOTCH1 binds to DNA-PKcs through its 
FATC domain and impairs binding of KAT5. As the absence of KAT5 was shown to affect 
DNA-PKcs autophosphorylation (Jiang et al., 2006) it cannot be excluded that NOTCH1-
mediated inhibition of DNA-PK autophosphorylation results from impaired interactions 
between KAT5 and DNA-PKcs. However it has been reported that KAT5-mediated 
acetylation on DNA-PKcs is of much lower level when compared with ATM (Jiang et al., 
2006). Moreover, a recent study has shown that mutation of DNA-PKcs acetylation sites, 
has no impact on the efficiency of DNA damage repair or on the kinetics of DNA-PKcs 
recruitment to DSBs (Mori et al., 2016). It is necessary to mention that it has not been 
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assessed whether the DNA-PKcs acetylation sites analyzed were actual KAT5 target sites 
(Mori et al., 2016).  
NOTCH1 has been shown to be expressed in neural stem cells (NSCs) (Hitoshi et al., 
2002). Our group has reported that NSCs upon treatment with DNA damaging agents 
undergo differentiation (Schneider et al., 2013) It is possible to speculate that one of the 
roles of NOTCH1 in NSCs could be preventing DNA damage-induced differentiation, by 
inhibiting DDR signaling at its initiation point, that is ATM activation. This would be an 
effective mechanism to preserve NSCs identity. Indeed it has been shown that DNA 
damage-induced differentiation of NSCs into astrocytes is an ATM dependent process 
(Schneider et al., 2013). Every day cells of our body have to deal with substantial amounts 
of DNA damage (Ciccia and Elledge, 2010), thus it would be useful for an organism to 
have an mechanism to modulate DDR in the NSCs, allowing for the repair mechanism to 
deal with DNA damage, preventing at the same time from spontaneous differentiation and 
eradication of NSCs from organism. 
NOTCH1 could tune down DDR and consequently with it apoptosis and stem cell 
differentiation, to favor DNA damage repair instead. Thus, one could ask whether 
NOTCH1 would favor an error-prone DNA damage repair by NHEJ, as HDR due to 
NOTCH1-mediated ATM inhibition should be perturbed (Bakr et al., 2015; Beucher et al., 
2009). I have never tested HDR in NOTCH1 expressing cells, I cannot exclude that 
NOTCH1 could impact on HDR. It has been recently reported that inhibition of HDR 
factors in NOTCH1-driven tumor in C. elegans leads to its sensitization to DNA damage 
inducing agents (Deng et al., 2015). This result suggests that HDR is not affected in the 
presence of NOTCH1, despite the high radioresistance of those tumor cells, probably due 
to NOTCH1-mediated ATM inhibition (Deng et al., 2015). 
Recently a report has been published showing that the stem cell specific transcription 
factor SALL4 favors ATM activation and DSBs repair in stem cells through its ability to 
bind to RAD50 and stabilize the MRN complex (Xiong et al., 2015). This study shows that 
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there are yet additional mechanisms, which can impact on DDR as well as DNA damage 
repair apart from NOTCH1. It is necessary to stress that while performing my experiments, 
I used systems in which I ectopically expressed large quantities of NOTCH1 (N1ΔE or 
N1IC constructs), which resulted in dramatic decrease of ATM kinase activity. It is thus 
unlikely that this kind of situation would ever take pace in biological/endogenous systems 
where the NOTCH1 expression levels are much lower. Indeed when we have performed 
assessment of DDR activation in endogenous NOTCH1 system, by coculturing together 
cells expressing NOTCH1 receptor with cells expressing NOTCH1 ligand, we observed 
that downregulation of DDR was only moderate although reproducible (Vermezovic et al., 
2015). 
I would like to propose that role of NOTCH1 in DDR is not a full ATM inhibition, rather 
moderate impairment of its activity, to modulate the balance between amount of DNA 
damage that cell has to deal with and signaling it induces. That kind of DDR modulation 
would result in suppression of DNA damage-induced cell apoptosis or in case of NSCs, 
differentiation, giving cells time for repair to occur. 
 
Summary - working model of the ATM activation 
Here I would like to summarize all of the results described in this thesis regarding the 
mechanism of NOTCH1-mediated modulation of ATM activation. Based on my 
observations that NOTCH1 mediates ATM inactivation by perturbing the formation of a 
three-protein complex (ATM, FOXO3a and KAT5) and published reports characterizing 
involvement of: NOTCH1 (Vermezovic et al., 2015), FOXO3a (Chung et al., 2012a; Tsai 
et al., 2008) and KAT5 (Ayrapetov et al., 2014; Jiang et al., 2006; Sun et al., 2005; Sun et 
al., 2010; Sun et al., 2009) in ATM activation, I have elaborated a model, which includes 
all of the results presented in this thesis and places them in the context of published studies 
(Figure 43). 
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In this model, I propose that upon DNA damage induction ATM is recruited to the DNA 
DSBs in a form of three-protein complex together with KAT5 and FOXO3a. KAT5 at the 
site of the damage interacts with tri-methylated histone H3K9 that is generated by 
SUV39h1 methyl trasferase immediately after DNA damage. This leads to the activation of 
KAT5 acetlytrasferase activity that results in acetylation. Upon acetylation ATM 
undergoes autophosphorylation, monomerization and starts phosphorylation of its 
substrates priming DDR cascade induction (Figure 43). 
In the presence of NOTCH1, ATM is still recruited to DSB, but due to NOTCH1 binding 
to ATM, the formation of the three-protein complex between FOXO3a, KAT5 and ATM is 
perturbed. This results in the displacement of FOXO3a that mediates ATM-KAT5 
interaction, from ATM. At the site of DNA damage, ATM in complex with NOTCH1 is 
unable to undergo activation due to the lack of KAT5-mediated acetylation. Therefore, 
ATM in complex with NOTCH1 despite being recruited to the DSBs persists in its inactive 
dimeric state (Figure 43) 
 
Figure 43. Working model of ATM activation in the absence (1) and presence (2) of NOTCH1.  
 
On a hunt for an application  
Based on the molecular mechanism of NOTCH1-mediated ATM inactivation, I have 
performed a set of experiments to evaluate if by increasing levels of FOXO3a in the 
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nucleus and by that competition between FOXO3a and NOTCH1 in NOTCH1-driven 
cancer cells, I could boost DDR activation. I have observed that with the use of drugs like 
Metformin and SB203580, I was able to increase DDR activation as well DDR-induced 
cell death in NOTCH1-driven cancers. Moreover I have observed similar effects with the 
use of NOTCH1 inhibitors (GSIs). As I have mentioned in the introduction, NOTCH1 has 
been proposed to be a prototypical oncogene (Pear et al., 1996). It has been reported that 
NOTCH1 is a target of many mutations and translocations that results in an increase in its 
expression and/or stabilization. Mutations affecting NOTCH1 have been shown to be very 
frequently present in T-ALL (almost 50% of cases) or breast tumors (Pece et al., 2004; 
Weng et al., 2004). Additionally it has been recently reported that NOTCH1 expression 
leads to the radioresistance of tumor cells in mice xenografts (Theys et al., 2013). 
Therefore increasing the competition between NOTCH1 and FOXO3a for ATM binding 
could occur beneficial in combination with genotoxic agents. Due to a high toxicity of 
GSIs and their side effects, it may not be feasible to use GSIs in the near future in a 
combinational therapy with DNA damage inducing agents to treat NOTCH1-driven 
cancers (Andersson and Lendahl, 2014). Indeed, no GSI have been approved by the Food 
and Drug Administration (U.S.A.) for the treatment of NOTCH-driven cancers (Andersson 
and Lendahl, 2014). 
Unlike GSIs, Metformin is a non-toxic drug widely used in treatment of the type II 
diabetics (Witters, 2001). Although more in vivo experiments are necessary, my results fit 
with published reports indicating that Meformin can induce ATM activation in FOXO3a 
dependent manner (Hu et al., 2014; Vazquez-Martin et al., 2011). Additional studies have 
showed Metformin-mediated increase in DDR activation (Fasih et al., 2014; Menendez et 
al., 2011). It is necessary to mention that I have observed a striking effect of SB203580 on 
DNA damage-induced cell death. Such effect can be attributed to a complex role of p38 
kinase in different cellular processes, indeed it has been shown that p38 can play a pro-
survival role in the response to the DNA damage (Thornton and Rincon, 2009). 
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Apart from using drugs already available, it could be useful to search for a new inhibitor 
targeting specifically ATM-NOTCH1 interaction. As NOTCH1 and FOXO3a compete 
with each other for the ATM binding, a small molecule inhibitor that would target and 
inhibit binding between ATM and NOTCH1 at the same time should not be able to impair 
ATM-FOXO3a interaction. It should therefore target directly the NOTCH1 domain 
involved in the interaction with ATM. A compound with these features might be useful not 
only in the previously mentioned T-ALL cancers, but also in other types of tumors, in 
which DDR is inhibited by NOTCH1. 
   
	   143	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 	    
	  144	  
 
 
Adamowicz, M., Vermezovic, J., and d'Adda di Fagagna, F. (2016). NOTCH1 Inhibits 
Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5/Tip60 
Complex. Cell reports. 
Alatwi, H.E., and Downs, J.A. (2015). Removal of H2A. Z by INO80 promotes 
homologous recombination. EMBO reports. 
Álvarez-Quilón, A., Serrano-Benítez, A., Lieberman, J.A., Quintero, C., Sánchez-
Gutiérrez, D., Escudero, L.M., and Cortés-Ledesma, F. (2014). ATM specifically mediates 
repair of double-strand breaks with blocked DNA ends. Nature communications 5, 3347. 
Andersson, E.R., and Lendahl, U. (2014). Therapeutic modulation of Notch signalling--are 
we there yet? Nat Rev Drug Discov 13, 357-378. 
Aster, J.C., Robertson, E.S., Hasserjian, R.P., Turner, J.R., Kieff, E., and Sklar, J. (1997). 
Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or 
nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate 
transcription. The Journal of biological chemistry 272, 11336-11343. 
Ayrapetov, M.K., Gursoy-Yuzugullu, O., Xu, C., Xu, Y., and Price, B.D. (2014). DNA 
double-strand breaks promote methylation of histone H3 on lysine 9 and transient 
formation of repressive chromatin. Proceedings of the National Academy of Sciences of 
the United States of America 111, 9169-9174. 
Bakkenist, C.J., and Kastan, M.B. (2003). DNA damage activates ATM through 
intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506. 
Bakr, A., Oing, C., Köcher, S., Borgmann, K., Dornreiter, I., Petersen, C., Dikomey, E., 
and Mansour, W.Y. (2015). Involvement of ATM in homologous recombination after end 
resection and RAD51 nucleofilament formation. Nucleic acids research 43, 3154-3166. 
Baldi, A., De Falco, M., De Luca, L., Cottone, G., Paggi, M.G., Nickoloff, B.J., Miele, L., 
and De Luca, A. (2004). Characterization of tissue specific expression of Notch-1 in 
human tissues. Biology of the cell / under the auspices of the European Cell Biology 
Organization 96, 303-311. 
Ball, H.L., Myers, J.S., and Cortez, D. (2005). ATRIP binding to replication protein A-
single-stranded DNA promotes ATR-ATRIP localization but is dispensable for Chk1 
phosphorylation. Molecular biology of the cell 16, 2372-2381. 
Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C.W., Chessa, L., Smorodinsky, N.I., 
Prives, C., Reiss, Y., Shiloh, Y., et al. (1998). Enhanced phosphorylation of p53 by ATM 
in response to DNA damage. Science (New York, N.Y.) 281, 1674-1677. 
Baskaran, R., Wood, L.D., Whitaker, L.L., Canman, C.E., Morgan, S.E., Xu, Y., Barlow, 
C., Baltimore, D., Wynshaw-Boris, A., Kastan, M.B., et al. (1997). Ataxia telangiectasia 
mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 
387, 516-519. 
	   145	  
Beucher, A., Birraux, J., Tchouandong, L., Barton, O., Shibata, A., Conrad, S., Goodarzi, 
A.A., Krempler, A., Jeggo, P.A., and Löbrich, M. (2009). ATM and Artemis promote 
homologous recombination of radiation-induced DNA double-strand breaks in G2. The 
EMBO journal 28, 3413-3427. 
Biggs, W.H., Cavenee, W.K., and Arden, K.C. (2001). Identification and characterization 
of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the 
mouse. Mammalian genome : official journal of the International Mammalian Genome 
Society 12, 416-425. 
Boder, E., and Sedgwick, R.P. (1958). Ataxia-telangiectasia; a familial syndrome of 
progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary 
infection. Pediatrics 21, 526-554. 
Bork, P. (1993). Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile 
modules that cross phyla horizontally? Proteins 17, 363-374. 
Bray, S.J. (2016). Notch signalling in context. Nature reviews. Molecular cell biology. 
Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J.R., Cumano, A., Roux, 
P., Black, R.A., and Israël, A. (2000). A novel proteolytic cleavage involved in Notch 
signaling: the role of the disintegrin-metalloprotease TACE. Molecular cell 5, 207-216. 
Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson, M.J., Arden, 
K.C., Blenis, J., and Greenberg, M.E. (1999). Akt promotes cell survival by 
phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868. 
Burma, S., Chen, B.P., Murphy, M., Kurimasa, A., and Chen, D.J. (2001). ATM 
phosphorylates histone H2AX in response to DNA double-strand breaks. The Journal of 
biological chemistry 276, 42462-42467. 
Cannavo, E., and Cejka, P. (2014). Sae2 promotes dsDNA endonuclease activity within 
Mre11-Rad50-Xrs2 to resect DNA breaks. Nature 514, 122-125. 
Carreira, A., Hilario, J., Amitani, I., Baskin, R.J., Shivji, M.K.K., Venkitaraman, A.R., and 
Kowalczykowski, S.C. (2009). The BRC repeats of BRCA2 modulate the DNA-binding 
selectivity of RAD51. Cell 136, 1032-1043. 
Castrillon, D.H., Miao, L., Kollipara, R., Horner, J.W., and DePinho, R.A. (2003). 
Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. 
Science (New York, N.Y.) 301, 215-218. 
Celeste, A., Fernandez-Capetillo, O., Kruhlak, M.J., Pilch, D.R., Staudt, D.W., Lee, A., 
Bonner, R.F., Bonner, W.M., and Nussenzweig, A. (2003). Histone H2AX 
phosphorylation is dispensable for the initial recognition of DNA breaks. Nature Cell 
Biology 5. 
Chapman, J.R., Barral, P., Vannier, J.-B.B., Borel, V., Steger, M., Tomas-Loba, A., 
Sartori, A.A., Adams, I.R., Batista, F.D., and Boulton, S.J. (2013). RIF1 is essential for 
53BP1-dependent nonhomologous end joining and suppression of DNA double-strand 
break resection. Molecular cell 49, 858-871. 
	  146	  
Chen, M.-S.S., Ryan, C.E., and Piwnica-Worms, H. (2003). Chk1 kinase negatively 
regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Molecular and 
cellular biology 23, 7488-7497. 
Chiacchiera, F., Matrone, A., Ferrari, E., Ingravallo, G., Lo Sasso, G., Murzilli, S., 
Petruzzelli, M., Salvatore, L., Moschetta, A., and Simone, C. (2009). p38alpha blockade 
inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-
dependent transcription. Cell Death Differ 16, 1203-1214. 
Chun, H.H., and Gatti, R.A. (2004). Ataxia-telangiectasia, an evolving phenotype. DNA 
repair 3, 1187-1196. 
Chung, Y.M., Park, S.-H.H., Tsai, W.-B.B., Wang, S.-Y.Y., Ikeda, M.-A.A., Berek, J.S., 
Chen, D.J., and Hu, M.C. (2012a). FOXO3 signalling links ATM to the p53 apoptotic 
pathway following DNA damage. Nature communications 3, 1000. 
Chung, Y.M., Park, S.H., Tsai, W.B., Wang, S.Y., Ikeda, M.A., Berek, J.S., Chen, D.J., 
and Hu, M.C. (2012b). FOXO3 signalling links ATM to the p53 apoptotic pathway 
following DNA damage. Nat Commun 3, 1000. 
Ciccia, A., and Elledge, S.J. (2010). The DNA damage response: making it safe to play 
with knives. Molecular cell 40, 179-204. 
Cui, X., Yu, Y., Gupta, S., and Cho, Y.M. (2005). Autophosphorylation of DNA-
dependent protein kinase regulates DNA end processing and may also alter double-strand 
break repair pathway choice. … and cellular biology. 
d'Adda di Fagagna, F. (2008). Living on a break: cellular senescence as a DNA-damage 
response. Nat Rev Cancer 8, 512-522. 
D'Souza, B., Meloty-Kapella, L., and Weinmaster, G. (2010). Canonical and non-canonical 
Notch ligands. Current topics in developmental biology 92, 73-129. 
Daniel, J.A., Pellegrini, M., Lee, B.S., and Guo, Z. (2012). Loss of ATM kinase activity 
leads to embryonic lethality in mice. The Journal of cell …. 
Daniel, J.A., Pellegrini, M., Lee, J.-H.H., Paull, T.T., Feigenbaum, L., and Nussenzweig, 
A. (2008). Multiple autophosphorylation sites are dispensable for murine ATM activation 
in vivo. The Journal of cell biology 183, 777-783. 
Davis, A.J., Lee, K.-J.J., and Chen, D.J. (2013). The N-terminal region of the DNA-
dependent protein kinase catalytic subunit is required for its DNA double-stranded break-
mediated activation. The Journal of biological chemistry 288, 7037-7046. 
Deng, X., Michaelson, D., Tchieu, J., Cheng, J., Rothenstein, D., Feldman, R., Lee, S.-
g.G., Fuller, J., Haimovitz-Friedman, A., Studer, L., et al. (2015). Targeting Homologous 
Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors. PloS one 10. 
Doil, C., Mailand, N., Bekker-Jensen, S., Menard, P., Larsen, D.H., Pepperkok, R., 
Ellenberg, J., Panier, S., Durocher, D., Bartek, J., et al. (2009). RNF168 binds and 
amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair 
proteins. Cell 136, 435-446. 
	   147	  
Douglas, P., Gupta, S., Morrice, N., Meek, K., and Lees-Miller, S.P. (2005). DNA-PK-
dependent phosphorylation of Ku70/80 is not required for non-homologous end joining. 
DNA repair 4, 1006-1018. 
Dumaz, N., and Meek, D.W. (1999). Serine15 phosphorylation stimulates p53 
transactivation but does not directly influence interaction with HDM2. The EMBO journal 
18, 7002-7010. 
Dupré, A., Boyer-Chatenet, L., and Gautier, J. (2006). Two-step activation of ATM by 
DNA and the Mre11-Rad50-Nbs1 complex. Nature structural & molecular biology 13, 
451-457. 
Esashi, F., Galkin, V.E., Yu, X., Egelman, E.H., and West, S.C. (2007). Stabilization of 
RAD51 nucleoprotein filaments by the C-terminal region of BRCA2. Nature structural & 
molecular biology 14, 468-474. 
Falck, J., Coates, J., and Jackson, S.P. (2005). Conserved modes of recruitment of ATM, 
ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611. 
Falck, J., Mailand, N., Syljuåsen, R.G., Bartek, J., and Lukas, J. (2001). The ATM-Chk2-
Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 
842-847. 
Fasih, A., Elbaz, H.A., Hüttemann, M., Konski, A.A., and Zielske, S.P. (2014). 
Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway. 
Radiation research 182, 50-59. 
Fortini, M.E., and Artavanis-Tsakonas, S. (1994). The suppressor of hairless protein 
participates in notch receptor signaling. Cell 79, 273-282. 
Foster, S.S., Balestrini, A., and Petrini, J.H. (2011). Functional interplay of the Mre11 
nuclease and Ku in the response to replication-associated DNA damage. Molecular and 
cellular biology 31, 4379-4389. 
Frank, S.R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H.-M.M., Livingston, 
D.M., and Amati, B. (2003). MYC recruits the TIP60 histone acetyltransferase complex to 
chromatin. EMBO reports 4, 575-580. 
Fryer, C.J., White, J.B., and Jones, K.A. (2004). Mastermind recruits CycC:CDK8 to 
phosphorylate the Notch ICD and coordinate activation with turnover. Molecular cell 16, 
509-520. 
Furuyama, T., Kitayama, K., Shimoda, Y., Ogawa, M., Sone, K., Yoshida-Araki, K., 
Hisatsune, H., Nishikawa, S.-i., Nakayama, K., Nakayama, K., et al. (2004). Abnormal 
angiogenesis in Foxo1 (Fkhr)-deficient mice. The Journal of biological chemistry 279, 
34741-34749. 
Furuyama, T., Nakazawa, T., Nakano, I., and Mori, N. (2000). Identification of the 
differential distribution patterns of mRNAs and consensus binding sequences for mouse 
DAF-16 homologues. The Biochemical journal 349, 629-634. 
	  148	  
Gaughan, L., Brady, M.E., Cook, S., Neal, D.E., and Robson, C.N. (2001). Tip60 is a co-
activator specific for class I nuclear hormone receptors. The Journal of biological 
chemistry 276, 46841-46848. 
Geiger, K., Hagenbuchner, J., Rupp, M., Fiegl, H., Sergi, C., Meister, B., Kiechl-
Kohlendorfer, U., Müller, T., Ausserlechner, M.J., and Obexer, P. (2012). 
FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in 
neuroblastoma. Molecular biology of the cell 23, 2226-2234. 
Gerhardt, D.M., Pajcini, K.V., D'Altri, T., Tu, L., Jain, R., Xu, L., Chen, M.J., Rentschler, 
S., Shestova, O., Wertheim, G.B., et al. (2014). The Notch1 transcriptional activation 
domain is required for development and reveals a novel role for Notch1 signaling in fetal 
hematopoietic stem cells. Genes & development 28, 576-593. 
Goodarzi, A.A., Douglas, P., Moorhead, G.B., and Lees-Miller, S.P. (2007). Utilizing 
protein phosphatase inhibitors to define PP2A as a regulator of ataxia-telangiectasia 
mutated. Methods in molecular biology (Clifton, N.J.) 365, 47-59. 
Goodarzi, A.A., Noon, A.T., Deckbar, D., Ziv, Y., Shiloh, Y., Löbrich, M., and Jeggo, 
P.A. (2008). ATM signaling facilitates repair of DNA double-strand breaks associated with 
heterochromatin. Molecular cell 31, 167-177. 
Goodarzi, A.A., Yu, Y., Riballo, E., Douglas, P., Walker, S.A., Ye, R., Härer, C., 
Marchetti, C., Morrice, N., Jeggo, P.A., et al. (2006). DNA-PK autophosphorylation 
facilitates Artemis endonuclease activity. The EMBO journal 25, 3880-3889. 
Gordon, W.R., Vardar-Ulu, D., Histen, G., Sanchez-Irizarry, C., Aster, J.C., and Blacklow, 
S.C. (2007). Structural basis for autoinhibition of Notch. Nature structural & molecular 
biology 14, 295-300. 
Gottlieb, T.M., and Jackson, S.P. (1993). The DNA-dependent protein kinase: requirement 
for DNA ends and association with Ku antigen. Cell 72, 131-142. 
Grabher, C., von Boehmer, H., and Look, A.T. (2006). Notch 1 activation in the molecular 
pathogenesis of T-cell acute lymphoblastic leukaemia. Nature reviews. Cancer 6, 347-359. 
Greer, E.L., and Brunet, A. (2005). FOXO transcription factors at the interface between 
longevity and tumor suppression. Oncogene 24, 7410-7425. 
Guarani, V., Deflorian, G., Franco, C.A., Krüger, M., Phng, L.-K.K., Bentley, K., 
Toussaint, L., Dequiedt, F., Mostoslavsky, R., Schmidt, M.H.H., et al. (2011). Acetylation-
dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 
473, 234-238. 
Guo, Z., Kozlov, S., Lavin, M.F., Person, M.D., and Paull, T.T. (2010). ATM activation by 
oxidative stress. Science (New York, N.Y.) 330, 517-521. 
Gupta, A., Sharma, G.G., Young, C.S., Agarwal, M., Smith, E.R., Paull, T.T., Lucchesi, 
J.C., Khanna, K.K., Ludwig, T., and Pandita, T.K. (2005). Involvement of human MOF in 
ATM function. Molecular and cellular biology 25, 5292-5305. 
Gursoy-Yuzugullu, O., Ayrapetov, M.K., and Price, B.D. (2015). Histone chaperone 
Anp32e removes H2A.Z from DNA double-strand breaks and promotes nucleosome 
	   149	  
reorganization and DNA repair. Proceedings of the National Academy of Sciences of the 
United States of America 112, 7507-7512. 
Gursoy-Yuzugullu, O., House, N., and Price, B.D. (2016). Patching Broken DNA: 
Nucleosome Dynamics and the Repair of DNA Breaks. Journal of molecular biology 428, 
1846-1860. 
Haince, J.-F.F., Kozlov, S., Dawson, V.L., Dawson, T.M., Hendzel, M.J., Lavin, M.F., and 
Poirier, G.G. (2007). Ataxia telangiectasia mutated (ATM) signaling network is modulated 
by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging 
agents. The Journal of biological chemistry 282, 16441-16453. 
Harper, J.W., Elledge, S.J., Keyomarsi, K., Dynlacht, B., Tsai, L.H., Zhang, P., 
Dobrowolski, S., Bai, C., Connell-Crowley, L., and Swindell, E. (1995). Inhibition of 
cyclin-dependent kinases by p21. Molecular biology of the cell 6, 387-400. 
Hartlerode, A.J., Morgan, M.J., Wu, Y., Buis, J., and Ferguson, D.O. (2015). Recruitment 
and activation of the ATM kinase in the absence of DNA-damage sensors. Nat Struct Mol 
Biol 22, 736-743. 
Hein, K., Mittler, G., Cizelsky, W., Kühl, M., Ferrante, F., Liefke, R., Berger, I.M., Just, 
S., Sträng, J.E., Kestler, H.A., et al. (2015). Site-specific methylation of Notch1 controls 
the amplitude and duration of the Notch1 response. Science signaling 8. 
Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A.J., Nye, J.S., Conlon, R.A., 
Mak, T.W., Bernstein, A., and van der Kooy, D. (2002). Notch pathway molecules are 
essential for the maintenance, but not the generation, of mammalian neural stem cells. 
Genes & development 16, 846-858. 
Hosaka, T., Biggs, W.H., Tieu, D., Boyer, A.D., Varki, N.M., Cavenee, W.K., and Arden, 
K.C. (2004). Disruption of forkhead transcription factor (FOXO) family members in mice 
reveals their functional diversification. Proceedings of the National Academy of Sciences 
of the United States of America 101, 2975-2980. 
Hsieh, J.J., Henkel, T., Salmon, P., Robey, E., Peterson, M.G., and Hayward, S.D. (1996). 
Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism 
resembling that of Epstein-Barr virus EBNA2. Molecular and cellular biology 16, 952-959. 
Hu, T., Chung, Y.M., Guan, M., Ma, M., Ma, J., Berek, J.S., and Hu, M.C. (2014). 
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose 
metformin or SN-38 through FOXO3 activation. Sci Rep 4, 5810. 
Huen, M.S., Huang, J., Leung, J.W., Sy, S.M., Leung, K.M., Ching, Y.-P.P., Tsao, S.W., 
and Chen, J. (2010). Regulation of chromatin architecture by the PWWP domain-
containing DNA damage-responsive factor EXPAND1/MUM1. Molecular cell 37, 854-
864. 
Ismail, I.H., Gagné, J.-P.P., Genois, M.-M.M., Strickfaden, H., McDonald, D., Xu, Z., 
Poirier, G.G., Masson, J.-Y.Y., and Hendzel, M.J. (2015). The RNF138 E3 ligase displaces 
Ku to promote DNA end resection and regulate DNA repair pathway choice. Nature cell 
biology 17, 1446-1457. 
	  150	  
Jacobs, F.M., van der Heide, L.P., Wijchers, P.J., Burbach, J.P., Hoekman, M.F., and 
Smidt, M.P. (2003). FoxO6, a novel member of the FoxO class of transcription factors 
with distinct shuttling dynamics. The Journal of biological chemistry 278, 35959-35967. 
Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C., Lukas, J., and Jackson, S.P. 
(2006). ATM- and cell cycle-dependent regulation of ATR in response to DNA double-
strand breaks. Nature cell biology 8, 37-45. 
Jiang, W., Crowe, J.L., Liu, X., Nakajima, S., Wang, Y., Li, C., Lee, B.J., Dubois, R.L., 
Liu, C., Yu, X., et al. (2015). Differential phosphorylation of DNA-PKcs regulates the 
interplay between end-processing and end-ligation during nonhomologous end-joining. 
Molecular cell 58, 172-185. 
Jiang, X., Sun, Y., Chen, S., Roy, K., and Price, B.D. (2006). The FATC domains of PIKK 
proteins are functionally equivalent and participate in the Tip60-dependent activation of 
DNA-PKcs and ATM. The Journal of biological chemistry 281, 15741-15746. 
Kaidi, A., and Jackson, S.P. (2013). KAT5 tyrosine phosphorylation couples chromatin 
sensing to ATM signalling. Nature 498, 70-74. 
Kanu, N., and Behrens, A. (2007). ATMIN defines an NBS1-independent pathway of 
ATM signalling. The EMBO journal 26, 2933-2941. 
Kanu, N., Penicud, K., Hristova, M., Wong, B., Irvine, E., Plattner, F., Raivich, G., and 
Behrens, A. (2010). The ATM cofactor ATMIN protects against oxidative stress and 
accumulation of DNA damage in the aging brain. The Journal of biological chemistry 285, 
38534-38542. 
Khanna, K.K., Keating, K.E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., 
Gabrielli, B., Chan, D., Lees-Miller, S.P., et al. (1998). ATM associates with and 
phosphorylates p53: mapping the region of interaction. Nat Genet 20, 398-400. 
Kijas, A.W., Lim, Y.C., Bolderson, E., Cerosaletti, K., Gatei, M., Jakob, B., Tobias, F., 
Taucher-Scholz, G., Gueven, N., Oakley, G., et al. (2015). ATM-dependent 
phosphorylation of MRE11 controls extent of resection during homology directed repair by 
signalling through Exonuclease 1. Nucleic acids research 43, 8352-8367. 
Kim, M.Y., Ann, E.J., Kim, J.Y., Mo, J.S., Park, J.H., Kim, S.Y., Seo, M.S., and Park, H.S. 
(2007a). Tip60 histone acetyltransferase acts as a negative regulator of Notch1 signaling 
by means of acetylation. Mol Cell Biol 27, 6506-6519. 
Kim, S.B., Chae, G.W., Lee, J., Park, J., Tak, H., Chung, J.H., Park, T.G., Ahn, J.K., and 
Joe, C.O. (2007b). Activated Notch1 interacts with p53 to inhibit its phosphorylation and 
transactivation. Cell death and differentiation 14, 982-991. 
Kim, S.T., Lim, D.S., Canman, C.E., and Kastan, M.B. (1999). Substrate specificities and 
identification of putative substrates of ATM kinase family members. The Journal of 
biological chemistry 274, 37538-37543. 
Kleiner, R.E., Verma, P., Molloy, K.R., Chait, B.T., and Kapoor, T.M. (2015). Chemical 
proteomics reveals a γH2AX-53BP1 interaction in the DNA damage response. Nature 
chemical biology 11, 807-814. 
	   151	  
Koecher, S., Rieckmann, T., and Rohaly, G. (2012). Radiation-induced double-strand 
breaks require ATM but not Artemis for homologous recombination during S-phase. 
Nucleic acids …. 
Kops, G.J., Dansen, T.B., Polderman, P.E., Saarloos, I., Wirtz, K.W., Coffer, P.J., Huang, 
T.-T.T., Bos, J.L., Medema, R.H.H., and Burgering, B.M. (2002). Forkhead transcription 
factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321. 
Kozlov, S.V., Graham, M.E., Peng, C., Chen, P., Robinson, P.J., and Lavin, M.F. (2006). 
Involvement of novel autophosphorylation sites in ATM activation. The EMBO journal 25, 
3504-3514. 
Kurash, J.K., Lei, H., Shen, Q., Marston, W.L., Granda, B.W., Fan, H., Wall, D., Li, E., 
and Gaudet, F. (2008). Methylation of p53 by Set7/9 mediates p53 acetylation and activity 
in vivo. Molecular cell 29, 392-400. 
Kurimasa, A., Kumano, S., Boubnov, N.V., Story, M.D., Tung, C.S., Peterson, S.R., and 
Chen, D.J. (1999). Requirement for the kinase activity of human DNA-dependent protein 
kinase catalytic subunit in DNA strand break rejoining. Molecular and cellular biology 19, 
3877-3884. 
Lai, J.S., and Herr, W. (1992). Ethidium bromide provides a simple tool for identifying 
genuine DNA-independent protein associations. Proceedings of the National Academy of 
Sciences of the United States of America 89, 6958-6962. 
Lam, E.W., Brosens, J.J., Gomes, A.R., and Koo, C.-Y.Y. (2013). Forkhead box proteins: 
tuning forks for transcriptional harmony. Nature reviews. Cancer 13, 482-495. 
Lau, W.C., Li, Y., Liu, Z., Gao, Y., Zhang, Q., and Huen, M.S. (2016). Structure of the 
human dimeric ATM kinase. Cell cycle (Georgetown, Tex.) 15, 1117-1124. 
Lee, J.-H.H., and Paull, T.T. (2004). Direct activation of the ATM protein kinase by the 
Mre11/Rad50/Nbs1 complex. Science (New York, N.Y.) 304, 93-96. 
Lee, J.-H.H., and Paull, T.T. (2005). ATM activation by DNA double-strand breaks 
through the Mre11-Rad50-Nbs1 complex. Science (New York, N.Y.) 308, 551-554. 
Li, B., and Comai, L. (2001). Requirements for the nucleolytic processing of DNA ends by 
the Werner syndrome protein-Ku70/80 complex. Journal of Biological Chemistry. 
Li, B., Samanta, A., Song, X., Iacono, K.T., Bembas, K., Tao, R., Basu, S., Riley, J.L., 
Hancock, W.W., Shen, Y., et al. (2007). FOXP3 interactions with histone acetyltransferase 
and class II histone deacetylases are required for repression. Proceedings of the National 
Academy of Sciences of the United States of America 104, 4571-4576. 
Li, X., Wang, W., Wang, J., Malovannaya, A., Xi, Y., Li, W., Guerra, R., Hawke, D.H., 
Qin, J., and Chen, J. (2015). Proteomic analyses reveal distinct chromatin-associated and 
soluble transcription factor complexes. Molecular systems biology 11, 775. 
Logeat, F., Bessia, C., Brou, C., LeBail, O., Jarriault, S., Seidah, N.G., and Israël, A. 
(1998). The Notch1 receptor is cleaved constitutively by a furin-like convertase. 
Proceedings of the National Academy of Sciences of the United States of America 95, 
8108-8112. 
	  152	  
Lu, C., Shi, Y., Wang, Z., Song, Z., Zhu, M., Cai, Q., and Chen, T. (2008). Serum 
starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway. 
FEBS letters 582, 2703-2708. 
Lu, C., Zhu, F., Cho, Y.-Y.Y., Tang, F., Zykova, T., Ma, W.-y.Y., Bode, A.M., and Dong, 
Z. (2006). Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the 
activation of caspase-3. Molecular cell 23, 121-132. 
Ma, Y., Pannicke, U., Schwarz, K., and Lieber, M.R. (2002). Hairpin opening and 
overhang processing by an Artemis/DNA-dependent protein kinase complex in 
nonhomologous end joining and V(D)J recombination. Cell 108, 781-794. 
Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J., Lukas, C., and 
Lukas, J. (2007). RNF8 ubiquitylates histones at DNA double-strand breaks and promotes 
assembly of repair proteins. Cell 131, 887-900. 
Matsumoto, Y., Suzuki, N., Namba, N., Umeda, N., Ma, X.J., Morita, A., Tomita, M., 
Enomoto, A., Serizawa, S., Hirano, K., et al. (2000). Cleavage and phosphorylation of 
XRCC4 protein induced by X-irradiation. FEBS letters 478, 67-71. 
Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R., Hurov, K.E., Luo, J., 
Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007). ATM and ATR 
substrate analysis reveals extensive protein networks responsive to DNA damage. Science 
(New York, N.Y.) 316, 1160-1166. 
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., and Elledge, S.J. (2000). 
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proceedings of the 
National Academy of Sciences of the United States of America 97, 10389-10394. 
Matsuzaki, H., Daitoku, H., Hatta, M., Aoyama, H., Yoshimochi, K., and Fukamizu, A. 
(2005). Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to 
phosphorylation. Proceedings of the National Academy of Sciences of the United States of 
America 102, 11278-11283. 
Mazin, A.V., Mazina, O.M., Bugreev, D.V., and Rossi, M.J. (2010). Rad54, the motor of 
homologous recombination. DNA repair 9, 286-302. 
McGill, M.A., and McGlade, C.J. (2003). Mammalian numb proteins promote Notch1 
receptor ubiquitination and degradation of the Notch1 intracellular domain. The Journal of 
biological chemistry 278, 23196-23203. 
Menendez, J.A., Cufí, S., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., Vellon, L., 
and Vazquez-Martin, A. (2011). Metformin and the ATM DNA damage response (DDR): 
accelerating the onset of stress-induced senescence to boost protection against cancer. 
Aging 3, 1063-1077. 
Mori, E., Davis, A.J., Hasegawa, M., and Chen, D.J. (2016). Lysines 3241 and 3260 of 
DNA-PKcs are important for genomic stability and radioresistance. Biochemical and 
biophysical research communications 477, 235-240. 
Murr, R., Loizou, J.I., Yang, Y.-G.G., Cuenin, C., Li, H., Wang, Z.-Q.Q., and Herceg, Z. 
(2006). Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair 
of DNA double-strand breaks. Nature cell biology 8, 91-99. 
	   153	  
Nakada, D., Matsumoto, K., and Sugimoto, K. (2003). ATM-related Tel1 associates with 
double-strand breaks through an Xrs2-dependent mechanism. Genes Dev 17, 1957-1962. 
Nam, Y., Sliz, P., Pear, W.S., Aster, J.C., and Blacklow, S.C. (2007). Cooperative 
assembly of higher-order Notch complexes functions as a switch to induce transcription. 
Proceedings of the National Academy of Sciences of the United States of America 104, 
2103-2108. 
Nasrin, N., Ogg, S., Cahill, C.M., Biggs, W., Nui, S., Dore, J., Calvo, D., Shi, Y., Ruvkun, 
G., and Alexander-Bridges, M.C. (2000). DAF-16 recruits the CREB-binding protein 
coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 
cells. Proceedings of the National Academy of Sciences of the United States of America 
97, 10412-10417. 
Neumann, M., Vosberg, S., Schlee, C., Heesch, S., Schwartz, S., Gökbuget, N., Hoelzer, 
D., Graf, A., Krebs, S., Bartram, I., et al. (2014). Mutational spectrum of adult T-ALL. 
Oncotarget. 
Nick McElhinny, S.A., Snowden, C.M., McCarville, J., and Ramsden, D.A. (2000). Ku 
recruits the XRCC4-ligase IV complex to DNA ends. Molecular and cellular biology 20, 
2996-3003. 
Nicolette, M.L., Lee, K., Guo, Z., Rani, M., Chow, J.M., Lee, S.E., and Paull, T.T. (2010). 
Mre11-Rad50-Xrs2 and Sae2 promote 5' strand resection of DNA double-strand breaks. 
Nature structural & molecular biology 17, 1478-1485. 
Nilsson, I., and Hoffmann, I. (2000). Cell cycle regulation by the Cdc25 phosphatase 
family. Progress in cell cycle research 4, 107-114. 
Nimonkar, A.V., Genschel, J., Kinoshita, E., Polaczek, P., Campbell, J.L., Wyman, C., 
Modrich, P., and Kowalczykowski, S.C. (2011). BLM-DNA2-RPA-MRN and EXO1-
BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break 
repair. Genes & development 25, 350-362. 
Oberg, C., Li, J., Pauley, A., Wolf, E., Gurney, M., and Lendahl, U. (2001). The Notch 
intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 
homolog. The Journal of biological chemistry 276, 35847-35853. 
Ochi, T., Blackford, A.N., Coates, J., Jhujh, S., Mehmood, S., Tamura, N., Travers, J., Wu, 
Q., Draviam, V.M., Robinson, C.V., et al. (2015). DNA repair. PAXX, a paralog of 
XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science 
(New York, N.Y.) 347, 185-188. 
Ogi, H., Goto, G.H., Ghosh, A., Zencir, S., Henry, E., and Sugimoto, K. (2015). 
Requirement of the FATC domain of protein kinase Tel1 for localization to DNA ends and 
target protein recognition. Mol Biol Cell 26, 3480-3488. 
Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J.H., 
Bird, T.D., Fong, C.-T.T., Mefford, H.C., Smith, R.J.H., et al. (1993). GeneReviews(®). 
University of Washington, Seattle. 
	  154	  
Paik, J.-H.H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., 
Horner, J.W., Carrasco, D.R., et al. (2007). FoxOs are lineage-restricted redundant tumor 
suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323. 
Palomero, T., Barnes, K.C., Real, P.J., Glade Bender, J.L., Sulis, M.L., Murty, V.V., 
Colovai, A.I., Balbin, M., and Ferrando, A.A. (2006). CUTLL1, a novel human T-cell 
lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high 
sensitivity to gamma-secretase inhibitors. Leukemia 20, 1279-1287. 
Park, S., Kang, J.M., Kim, S.J., Kim, H., Hong, S., Lee, Y.J., and Kim, S.-J.J. (2015a). 
Smad7 enhances ATM activity by facilitating the interaction between ATM and Mre11-
Rad50-Nbs1 complex in DNA double-strand break repair. Cellular and molecular life 
sciences : CMLS 72, 583-596. 
Park, S., Kang, J.M., Kim, S.J., Kim, H., Hong, S., Lee, Y.J., and Kim, S.J. (2015b). 
Smad7 enhances ATM activity by facilitating the interaction between ATM and Mre11-
Rad50-Nbs1 complex in DNA double-strand break repair. Cell Mol Life Sci 72, 583-596. 
Paull, T.T. (2015). Mechanisms of ATM Activation. Annual review of biochemistry 84, 
711-738. 
Paull, T.T., and Gellert, M. (1999). Nbs1 potentiates ATP-driven DNA unwinding and 
endonuclease cleavage by the Mre11/Rad50 complex. Genes & development 13, 1276-
1288. 
Pear, W.S., Aster, J.C., Scott, M.L., Hasserjian, R.P., Soffer, B., Sklar, J., and Baltimore, 
D. (1996). Exclusive development of T cell neoplasms in mice transplanted with bone 
marrow expressing activated Notch alleles. The Journal of experimental medicine 183, 
2283-2291. 
Pece, S., Serresi, M., Santolini, E., Capra, M., Hulleman, E., Galimberti, V., Zurrida, S., 
Maisonneuve, P., Viale, G., and Di Fiore, P.P. (2004). Loss of negative regulation by 
Numb over Notch is relevant to human breast carcinogenesis. The Journal of cell biology 
167, 215-221. 
Pei, H., Zhang, L., Luo, K., Qin, Y., Chesi, M., Fei, F., Bergsagel, P.L., Wang, L., You, Z., 
and Lou, Z. (2011). MMSET regulates histone H4K20 methylation and 53BP1 
accumulation at DNA damage sites. Nature 470, 124-128. 
Pellegrini, M., Celeste, A., Difilippantonio, S., Guo, R., Wang, W., Feigenbaum, L., and 
Nussenzweig, A. (2006). Autophosphorylation at serine 1987 is dispensable for murine 
Atm activation in vivo. Nature 443, 222-225. 
Peng, C.Y., Graves, P.R., Thoma, R.S., Wu, Z., Shaw, A.S., and Piwnica-Worms, H. 
(1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by 
phosphorylation of Cdc25C on serine-216. Science (New York, N.Y.) 277, 1501-1505. 
Perumalsamy, L.R., Nagala, M., Banerjee, P., and Sarin, A. (2009). A hierarchical cascade 
activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates 
neglect-induced death in mammalian cells. Cell death and differentiation 16, 879-889. 
	   155	  
Pessina, F., and Lowndes, N.F. (2014). The RSF1 histone-remodelling factor facilitates 
DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins. 
PLoS biology 12. 
Peterson, S.E., Li, Y., Wu-Baer, F., Chait, B.T., Baer, R., Yan, H., Gottesman, M.E., and 
Gautier, J. (2013). Activation of DSB processing requires phosphorylation of CtIP by 
ATR. Molecular cell 49, 657-667. 
Polo, S.E., and Jackson, S.P. (2011). Dynamics of DNA damage response proteins at DNA 
breaks: a focus on protein modifications. Genes Dev 25, 409-433. 
Qiu, L., Joazeiro, C., Fang, N., Wang, H.Y., Elly, C., Altman, Y., Fang, D., Hunter, T., and 
Liu, Y.C. (2000). Recognition and ubiquitination of Notch by Itch, a hect-type E3 
ubiquitin ligase. The Journal of biological chemistry 275, 35734-35737. 
Riballo, E., Kühne, M., Rief, N., Doherty, A., Smith, G.C., Recio, M.-J.J., Reis, C., Dahm, 
K., Fricke, A., Krempler, A., et al. (2004). A pathway of double-strand break rejoining 
dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Molecular 
cell 16, 715-724. 
Rustighi, A., Tiberi, L., Soldano, A., Napoli, M., Nuciforo, P., Rosato, A., Kaplan, F., 
Capobianco, A., Pece, S., Di Fiore, P.P., et al. (2009). The prolyl-isomerase Pin1 is a 
Notch1 target that enhances Notch1 activation in cancer. Nat Cell Biol 11, 133-142. 
Salzano, M., Sanz-García, M., Monsalve, D.M., Moura, D.S., and Lazo, P.A. (2015). 
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced 
by DNA damage. Epigenetics 10, 373-383. 
Santini, S., Stagni, V., Giambruno, R., Fianco, G., Di Benedetto, A., Mottolese, M., 
Pellegrini, M., and Barilà, D. (2014). ATM kinase activity modulates ITCH E3-ubiquitin 
ligase activity. Oncogene 33, 1113-1123. 
Sanz-García, M., Monsalve, D.M., Sevilla, A., and Lazo, P.A. (2012). Vaccinia-related 
kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 
foci in response to ionizing radiation-induced DNA damage. The Journal of biological 
chemistry 287, 23757-23768. 
Sartori, A.A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J., and 
Jackson, S.P. (2007). Human CtIP promotes DNA end resection. Nature 450, 509-514. 
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A., 
Smith, S., Uziel, T., Sfez, S., et al. (1995). A single ataxia telangiectasia gene with a 
product similar to PI-3 kinase. Science 268, 1749-1753. 
Sawicka, M., Wanrooij, P.H., Darbari, V.C., Tannous, E., Hailemariam, S., Bose, D., 
Makarova, A.V., Burgers, P.M., and Zhang, X. (2016). The dimeric architecture of 
checkpoint kinases Mec1ATR and Tel1ATM reveal a common structural organisation. The 
Journal of biological chemistry. 
Schneider, L., Pellegatta, S., Favaro, R., Pisati, F., Roncaglia, P., Testa, G., Nicolis, S.K., 
Finocchiaro, G., and d'Adda di Fagagna, F. (2013). DNA damage in mammalian neural 
stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-
STAT. Stem cell reports 1, 123-138. 
	  156	  
Shafman, T., Khanna, K.K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, 
M., Zhang, N., Watters, D., et al. (1997). Interaction between ATM protein and c-Abl in 
response to DNA damage. Nature 387, 520-523. 
Sharma, M.K., Imamichi, S., Fukuchi, M., Samarth, R.M., Tomita, M., and Matsumoto, Y. 
(2016). In cellulo phosphorylation of XRCC4 Ser320 by DNA-PK induced by DNA 
damage. Journal of radiation research 57, 115-120. 
Shibata, A., Moiani, D., Arvai, A.S., Perry, J., Harding, S.M., Genois, M.-M.M., Maity, R., 
van Rossum-Fikkert, S., Kertokalio, A., Romoli, F., et al. (2014). DNA double-strand 
break repair pathway choice is directed by distinct MRE11 nuclease activities. Molecular 
cell 53, 7-18. 
Shieh, S.Y., Ahn, J., Tamai, K., Taya, Y., and Prives, C. (2000). The human homologs of 
checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-
inducible sites. Genes & development 14, 289-300. 
Shiloh, Y. (1997). Ataxia-telangiectasia and the Nijmegen breakage syndrome: related 
disorders but genes apart. Annual review of genetics 31, 635-662. 
Shiloh, Y., and Lederman, H.M. (2016). Ataxia-telangiectasia (A-T): An emerging 
dimension of premature ageing. Ageing research reviews. 
Singh, A., Ye, M., Bucur, O., Zhu, S., Tanya Santos, M., Rabinovitz, I., Wei, W., Gao, D., 
Hahn, W.C., and Khosravi-Far, R. (2010). Protein phosphatase 2A reactivates FOXO3a 
through a dynamic interplay with 14-3-3 and AKT. Molecular biology of the cell 21, 1140-
1152. 
Smith, G.C., Cary, R.B., Lakin, N.D., Hann, B.C., Teo, S.H., Chen, D.J., and Jackson, S.P. 
(1999). Purification and DNA binding properties of the ataxia-telangiectasia gene product 
ATM. Proceedings of the National Academy of Sciences of the United States of America 
96, 11134-11139. 
So, S., Davis, A.J., and Chen, D.J. (2009). Autophosphorylation at serine 1981 stabilizes 
ATM at DNA damage sites. J Cell Biol 187, 977-990. 
Spagnolo, L., Rivera-Calzada, A., Pearl, L.H., and Llorca, O. (2006). Three-dimensional 
structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its 
implications for DNA DSB repair. Molecular cell 22, 511-519. 
Stewart, G.S., Maser, R.S., Stankovic, T., Bressan, D.A., Kaplan, M.I., Jaspers, N.G., 
Raams, A., Byrd, P.J., Petrini, J.H., and Taylor, A.M. (1999). The DNA double-strand 
break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like 
disorder. Cell 99, 577-587. 
Stiff, T., O'Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., and Jeggo, P.A. (2004). ATM 
and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing 
radiation. Cancer research 64, 2390-2396. 
Strooper, D.B., Annaert, W., Cupers, P., and Saftig, P. (1999). A presenilin-1-dependent γ-
secretase-like protease mediates release of Notch intracellular domain. Nature. 
	   157	  
Stucki, M., Clapperton, J.A., Mohammad, D., Yaffe, M.B., Smerdon, S.J., and Jackson, 
S.P. (2005). MDC1 directly binds phosphorylated histone H2AX to regulate cellular 
responses to DNA double-strand breaks. Cell 123, 1213-1226. 
Sun, Y., Jiang, X., Chen, S., Fernandes, N., and Price, B.D. (2005). A role for the Tip60 
histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci U S 
A 102, 13182-13187. 
Sun, Y., Jiang, X., and Price, B.D. (2010). Tip60: connecting chromatin to DNA damage 
signaling. Cell Cycle 9, 930-936. 
Sun, Y., Jiang, X., Xu, Y., Ayrapetov, M.K., Moreau, L.A., Whetstine, J.R., and Price, 
B.D. (2009). Histone H3 methylation links DNA damage detection to activation of the 
tumour suppressor Tip60. Nat Cell Biol 11, 1376-1382. 
Sun, Y., Xu, Y., Roy, K., and Price, B.D. (2007). DNA damage-induced acetylation of 
lysine 3016 of ATM activates ATM kinase activity. Mol Cell Biol 27, 8502-8509. 
Sung, P., Krejci, L., Komen, V.S., and Sehorn, M.G. (2003). Rad51 recombinase and 
recombination mediators. Journal of Biological …. 
Takeuchi, S., Koike, M., Park, S., Seriu, T., Bartram, C.R., Taub, H.E., Williamson, I.K., 
Grewal, J., Taguchi, H., and Koeffler, H.P. (1998). The ATM gene and susceptibility to 
childhood T-cell acute lymphoblastic leukaemia. British journal of haematology 103, 536-
538. 
Tamura, K., Taniguchi, Y., Minoguchi, S., Sakai, T., Tun, T., Furukawa, T., and Honjo, T. 
(1995). Physical interaction between a novel domain of the receptor Notch and the 
transcription factor RBP-J kappa/Su(H). Current biology : CB 5, 1416-1423. 
Taylor, A.M., Groom, A., and Byrd, P.J. (2004). Ataxia-telangiectasia-like disorder 
(ATLD)-its clinical presentation and molecular basis. DNA repair 3, 1219-1225. 
Theys, J., Yahyanejad, S., Habets, R., Span, P., Dubois, L., Paesmans, K., Kattenbeld, B., 
Cleutjens, J., Groot, A.J., Schuurbiers, O.C., et al. (2013). High NOTCH activity induces 
radiation resistance in non small cell lung cancer. Radiotherapy and oncology : journal of 
the European Society for Therapeutic Radiology and Oncology 108, 440-445. 
Thornton, T.M., and Rincon, M. (2009). Non-classical p38 map kinase functions: cell 
cycle checkpoints and survival. International journal of biological sciences 5, 44-51. 
Thorslund, T., Ripplinger, A., Hoffmann, S., Wild, T., Uckelmann, M., Villumsen, B., 
Narita, T., Sixma, T.K., Choudhary, C., Bekker-Jensen, S., et al. (2015). Histone H1 
couples initiation and amplification of ubiquitin signalling after DNA damage. Nature. 
Tran, H., Brunet, A., Grenier, J.M., Datta, S.R., Fornace, A.J., DiStefano, P.S., Chiang, 
L.W., and Greenberg, M.E. (2002). DNA repair pathway stimulated by the forkhead 
transcription factor FOXO3a through the Gadd45 protein. Science (New York, N.Y.) 296, 
530-534. 
Tsai, W.B., Chung, Y.M., Takahashi, Y., Xu, Z., and Hu, M.C. (2008). Functional 
interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 
10, 460-467. 
	  158	  
Uematsu, N., Weterings, E., Yano, K.-i., Morotomi-Yano, K., Jakob, B., Taucher-Scholz, 
G., Mari, P.-O.O., van Gent, D.C., Chen, B.P., and Chen, D.J. (2007). 
Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. 
The Journal of cell biology 177, 219-229. 
Varon, R., Vissinga, C., Platzer, M., and Cerosaletti, K.M. (1998). Nibrin, a novel DNA 
double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 
Vassilev, A., Yamauchi, J., Kotani, T., and Prives, C. (1998). The 400 kDa subunit of the 
PCAF histone acetylase complex belongs to the ATM superfamily. Molecular cell. 
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufi, S., Martin-Castillo, B., and Menendez, 
J.A. (2011). Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated 
DNA damage-like response. Cell Cycle 10, 1499-1501. 
Vermezovic, J., Adamowicz, M., Santarpia, L., Rustighi, A., Forcato, M., Lucano, C., 
Massimiliano, L., Costanzo, V., Bicciato, S., Del Sal, G., et al. (2015). Notch is a direct 
negative regulator of the DNA-damage response. Nat Struct Mol Biol 22, 417-424. 
Vermezovic, J., Stergiou, L., Hengartner, M.O., and d'Adda di Fagagna, F. (2012). 
Differential regulation of DNA damage response activation between somatic and germline 
cells in Caenorhabditis elegans. Cell death and differentiation 19, 1847-1855. 
Vogt, P.K., Jiang, H., and Aoki, M. (2005). Triple layer control: phosphorylation, 
acetylation and ubiquitination of FOXO proteins. Cell cycle (Georgetown, Tex.) 4, 908-
913. 
Wang, F., Marshall, C.B., Yamamoto, K., Li, G.Y., Plevin, M.J., You, H., Mak, T.W., and 
Ikura, M. (2008). Biochemical and structural characterization of an intramolecular 
interaction in FOXO3a and its binding with p53. J Mol Biol 384, 590-603. 
Wang, X., and Proud, C.G. (2016). mTORC2 is a tyrosine kinase. Cell research 26, 1-2. 
Wang, Y.-G.G., Nnakwe, C., Lane, W.S., Modesti, M., and Frank, K.M. (2004). 
Phosphorylation and regulation of DNA ligase IV stability by DNA-dependent protein 
kinase. The Journal of biological chemistry 279, 37282-37290. 
Watanabe, R., Wei, L., and Huang, J. (2011). mTOR signaling, function, novel inhibitors, 
and therapeutic targets. Journal of nuclear medicine : official publication, Society of 
Nuclear Medicine 52, 497-500. 
Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P., Silverman, L.B., Sanchez-Irizarry, C., 
Blacklow, S.C., Look, A.T., and Aster, J.C. (2004). Activating mutations of NOTCH1 in 
human T cell acute lymphoblastic leukemia. Science (New York, N.Y.) 306, 269-271. 
Weng, A.P., Nam, Y., Wolfe, M.S., Pear, W.S., Griffin, J.D., Blacklow, S.C., and Aster, 
J.C. (2003). Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition 
of notch signaling. Molecular and cellular biology 23, 655-664. 
Witters, L.A. (2001). The blooming of the French lilac. The Journal of clinical 
investigation. 
	   159	  
Wold, M.S. (1997). Replication protein A: a heterotrimeric, single-stranded DNA-binding 
protein required for eukaryotic DNA metabolism. Annual review of biochemistry 66, 61-
92. 
Wu, G., Lyapina, S., Das, I., Li, J., Gurney, M., Pauley, A., Chui, I., Deshaies, R.J., and 
Kitajewski, J. (2001). SEL-10 is an inhibitor of notch signaling that targets notch for 
ubiquitin-mediated protein degradation. Molecular and cellular biology 21, 7403-7415. 
Wu, L., Aster, J.C., Blacklow, S.C., Lake, R., Artavanis-Tsakonas, S., and Griffin, J.D. 
(2000). MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-
activator for NOTCH receptors. Nature genetics 26, 484-489. 
Xiong, J., Todorova, D., Su, N.-Y.Y., Kim, J., Lee, P.-J.J., Shen, Z., Briggs, S.P., and Xu, 
Y. (2015). Stemness factor Sall4 is required for DNA damage response in embryonic stem 
cells. The Journal of cell biology 208, 513-520. 
Xu, Y., Ayrapetov, M.K., Xu, C., Gursoy-Yuzugullu, O., Hu, Y., and Price, B.D. (2012). 
Histone H2A.Z controls a critical chromatin remodeling step required for DNA double-
strand break repair. Molecular cell 48, 723-733. 
Yamamoto, K., Wang, Y., Jiang, W., Liu, X., Dubois, R.L., Lin, C.S., Ludwig, T., 
Bakkenist, C.J., and Zha, S. (2012). Kinase-dead ATM protein causes genomic instability 
and early embryonic lethality in mice. J Cell Biol 198, 305-313. 
Yatim, A., Benne, C., Sobhian, B., Laurent-Chabalier, S., Deas, O., Judde, J.G., Lelievre, 
J.D., Levy, Y., and Benkirane, M. (2012). NOTCH1 nuclear interactome reveals key 
regulators of its transcriptional activity and oncogenic function. Mol Cell 48, 445-458. 
Yin, Y., Hua, H., Li, M., Liu, S., Kong, Q., Shao, T., Wang, J., Luo, Y., Wang, Q., Luo, T., 
et al. (2016). mTORC2 promotes type I insulin-like growth factor receptor and insulin 
receptor activation through the tyrosine kinase activity of mTOR. Cell research 26, 46-65. 
Yoo, S., and Dynan, W.S. (1999). Geometry of a complex formed by double strand break 
repair proteins at a single DNA end: recruitment of DNA-PKcs induces inward 
translocation of Ku protein. Nucleic acids research 27, 4679-4686. 
You, Z., Chahwan, C., Bailis, J., Hunter, T., and Russell, P. (2005). ATM activation and its 
recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol Cell Biol 25, 
5363-5379. 
Yu, Y., Wang, W., Ding, Q., Ye, R., Chen, D., Merkle, D., Schriemer, D., Meek, K., and 
Lees-Miller, S.P. (2003). DNA-PK phosphorylation sites in XRCC4 are not required for 
survival after radiation or for V(D)J recombination. DNA repair 2, 1239-1252. 
Zhang, J., Tripathi, D.N., Jing, J., Alexander, A., Kim, J., Powell, R.T., Dere, R., Tait-
Mulder, J., Lee, J.-H.H., Paull, T.T., et al. (2015). ATM functions at the peroxisome to 
induce pexophagy in response to ROS. Nature cell biology 17, 1259-1269. 
Zhang, T., Cronshaw, J., Kanu, N., Snijders, A.P., and Behrens, A. (2014). UBR5-
mediated ubiquitination of ATMIN is required for ionizing radiation-induced ATM 
signaling and function. Proceedings of the National Academy of Sciences of the United 
States of America 111, 12091-12096. 
	  160	  
Zhang, T., Penicud, K., Bruhn, C., Loizou, J.I., Kanu, N., Wang, Z.-Q.Q., and Behrens, A. 
(2012). Competition between NBS1 and ATMIN controls ATM signaling pathway choice. 
Cell reports 2, 1498-1504. 
Zhu, S., and Peng, A. (2016). Non-homologous end joining repair in Xenopus egg extract. 
Scientific reports 6, 27797. 
 
 
  
	   161	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgments 	  	  	  	  
 
  
	  162	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Na samym początku chciałbym podziękować swoim Rodzicom, którzy inspirowali mnie 
przez cały czas.  
 
Chcialbym też przed wszystkim podziękować Jelenie Vermezovic, która wzięła mnie pod 
swoje skrzydła i była moim naukowym opiekunem w przeciągu trwania mojej pracy w 
IFOM.  
 
Serdeczne podziękowania dla Fabrizio d’Adda di Fagagna za stworzenie możliwości i 
warunków do przeprowadzenia powyższej pracy.  
 
Kończąc chciałbym podziękować wszystkim których udało mi się poznać w Mediolanie.  
 
Dziękuję za życzliwość, cierpliwość i wspomnienia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   163	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
